Future Directions in Biocatalysis
This page intentionally left blank
Future Directions in Biocatalysis
Edited by
TOMOKO MATSUDA Tokyo Institute of Technology, Yokohama, Japan
Amsterdam • Boston • Heidelberg • London • New York • Oxford
Paris • San Diego • San Francisco • Singapore • Sydney • Tokyo
Elsevier Radarweg 29, PO Box 211, 1000 AE Amsterdam, The Netherlands Linacre House, Jordan Hill, Oxford OX2 8DP, UK First edition 2007 Copyright © 2007 Elsevier B.V. All rights reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher Permissions may be sought directly from Elsevier’s Science & Technology Rights Department in Oxford, UK: phone (+44) (0) 1865 843830; fax (+44) (0) 1865 853333; email:
[email protected]. Alternatively you can submit your request online by visiting the Elsevier web site at http://elsevier.com/locate/permissions, and selecting Obtaining permission to use Elsevier material Notice No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made Library of Congress Cataloging-in-Publication Data A catalog record for this book is available from the Library of Congress British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library ISBN: 978-0-444-53059-2 For information on all Elsevier publications visit our website at books.elsevier.com Printed and bound in The Netherlands 07
08
09
10
11
10
9
8
7
6
5
4
3
2
Working together to grow libraries in developing countries www.elsevier.com | www.bookaid.org | www.sabre.org
1
v
Contents
Preface
xi
Part 1 Novel reaction conditions for biotransformation
1
CHAPTER 1
Biotransformation in ionic liquid
3
Toshiyuki Itoh 1. Introduction 2. Ionic Liquids as a Reaction Medium for Biotransformation 3. Lipase-Catalyzed Reaction in an Ionic Liquid Solvent System 4. Activation of Lipase by an Ionic Liquid 5. Various Biotransformations in an Ionic Liquid Solvent System 6. Concluding Remarks References
3
3
7
10
15
18
18
CHAPTER 2
Temperature control of the enantioselectivity in the lipase-catalyzed
resolutions
21
Takashi Sakai 1. 2. 3. 4.
Introduction Finding of the “Low-Temperature Method” in the Lipase-Catalyzed Kinetic Resolution Theory of Temperature Effect on the Enantioselectivity General Applicability of the “Low-Temperature Method” Examined 4.1. Application to solketal and other primary and secondary alcohols 4.2. Resolution of (±)-2-hydroxy-2-(pentafluorophenyl)acetonitrile 4.3. Immobilization of lipase on porous ceramic support (Toyonite) for acceleration 4.4. Structural optimization of organic bridges on Toyonite 4.5. Practical resolution of azirine 1 by the “low-temperature method” combined
with Toyonite-immobilized lipase and optimized acylating agent 4.6. Resolution of (2R∗ 3S ∗ )- and (2R∗ 3R∗ )-3-methyl-3-phenyl-2-aziridinemethanols 4.7. Resolution of 5-(hydroxymethyl)-3-phenyl-2-isoxazoline 4.8. Application of temperature control to asymmetric protonation 4.9. Lipase-catalyzed resolutions at high temperatures up to 120 C 5. Low-Temperature Reactions in Literatures 6. Lipase-Catalyzed Resolution of Primary Alcohols: Promising Candidates for the
“Low-Temperature Method” 7. Conclusion References
21
22
23
28
28
30
31
32
33
34
36
37
37 37
40
45
45
vi
Contents
CHAPTER 3
Future directions in photosynthetic organisms-catalyzed reactions
51
Kaoru Nakamura 1. Introduction 2. Reduction Reaction 3. Oxidation and Hydroxylation 4. Removal of Organic and Inorganic Substances in Wastewater 5. Conclusion References
51
51
55
56
57
57
CHAPTER 4
Catalysis by enzyme–metal combinations
59
Mahn-Joo Kim, Jaiwook Park, Yangsoo Ahn, Palakodety R. Krishna 1. Introduction 2. Dynamic Kinetic Resolutions by Enzyme–Metal Combinations 2.1. DKR of secondary alcohols 3. Asymmetric Transformations by Enzyme–Metal Combinations 3.1. Asymmetric transformation of ketone 3.2. Asymmetric transformation of enol ester 3.3. Asymmetric transformation of ketoxime 4. Conclusion Acknowledgements References
59
60
60
73
73
75
76
78
78
79
Part 2 Uncomon kind of biocatalytic reaction
81
CHAPTER 5
Biological Kolbe–Schmitt carboxylation
83
Possible use of enzymes for the direct carboxylation of organic substrates
Toyokazu Yoshida, Toru Nagasawa 1. Introduction 2. Enzymes Catalyzing the Carboxylation of Phenolic Compounds 2.1. 4-Hydroxybenzoate decarboxylase (EC 4.1.1.61) 2.2. 3,4-Dihydroxybenzoate decarboxylase (EC 4.1.1.63) 2.3. Phenolphosphate carboxylase (EC 4.1.1.-) in Thauera aromatica 2.4. 2,6-Dihydroxybenzoate decarboxylase 2.5. 2,3-Dihydroxybenzoate decarboxylase 3. Enzymes Catalyzing the Direct Carboxylation of Heterocyclic Compounds 3.1. Pyrrole-2-carboxylate decarboxylase 3.2. Indole-3-carboxylate decarboxylase 4. Structure Analysis of Decarboxylases Catalyzing CO2 Fixation 4.1. Class I decarboxylases 4.2. Class II decarboxylases 4.3. Phenylphosphate carboxylase 5. Conclusion References
83
84
85
87
88
91
95
95
96
99
101
102
103
103
103
104
Contents
vii
CHAPTER 6
Discovery, redesign and applications of Baeyer–Villiger monooxygenases 107
Daniel E. Torres Pazmin˜ o, Marco W. Fraaije 1. Introduction 2. Biocatalytic Properties of Recombinant Available BVMOs 2.1. Discovery of novel BVMOs 2.2. Exploring sequenced (meta)genomes for novel BVMOs 2.3. Screening the metagenome for novel BVMOs 2.4. Redesign of BVMOs 3. Conclusions: Future Directions References
CHAPTER 7
Enzymes in aldoxime–nitrile pathway: versatile tools in biocatalysis
107
110
112
114
118
119
122
125
129
Yasuhisa Asano 1. Introduction 2. Screening for New Microbial Enzymes by Enrichment and Acclimation
Culture Techniques 3. Development of Nitrile-Degrading Enzymes 4. Screening for Heat-Stable NHase 5. Screening for NHase with PCR 6. Nitrile Synthesis Using a New Enzyme, Aldoxime Dehydratase 6.1. Aldoxime-converting enzymes 6.2. Isolation of microorganisms having aldoxime dehydratase activity 6.3. Purification, characterization and primary structure determination of aldoxime
dehydratase 6.4. Synthesis of nitriles from aldoxime with aldoxime dehydratase 6.5. Distribution of aldoxime dehydratase 6.6. Molecular screening for “aldoxime–nitrile pathway” 7. Conclusions Acknowledgments References
CHAPTER 8
Addition of hydrocyanic acid to carbonyl compounds
129
129
131
131
132
133
133
134
134
135
136
136
137
137
137
141
Franz Effenberger, Anja Bohrer, Siegfried Fo¨ rster 1. Introduction 2. Optimized Reaction Conditions for the HNL-Catalyzed Formation of Chiral Cyanohydrins 3. Synthetic Potential of Chiral Cyanohydrins in Stereoselective Synthesis 3.1. Chiral 2-hydroxy carboxylic acids 3.2. Optically active 1,2-amino alcohols 3.3. Stereoselective substitution of the hydroxyl group in chiral cyanohydrins 3.4. Stereoselective synthesis of substituted cyclohexanone cyanohydrins
141
143
145
145
147
148
149
viii
Contents
4. Crystal Structures of Hydroxynitrile Lyases and Mechanism of Cyanogenesis 4.1. Crystal structures of HNLs 4.2. Reaction mechanism of cyanogenesis 4.3. Changing substrate specificity and stereoselectivity applying Trp128 mutants of
wt-MeHNL 5. Conclusions References
149
151
151
152
153
154
Part 3 Novel compounds synthesized by biotransformations
157
CHAPTER 9
Chiral heteroatom-containing compounds
159
Piotr Kiełbasinski, Marian Mikołajczyk ´ 1. Introduction 2. Organosulfur Compounds 2.1. C-chiral hydroxy sulfides and derivatives 2.2. C-chiral hydroxyalkyl sulfones 2.3. C-chiral alkyl sulfates 2.4. Other C-chiral organosulfur compounds 2.5. S-chiral sulfinylcarboxylates 2.6. S-chiral hydroxy sulfoxides 2.7. S-chiral sulfinamides 2.8. S-chiral sulfoximines 3. Organophosphorus Compounds 3.1. C-chiral hydroxy phosphorus derivatives 3.2. C-chiral amino phosphorus compounds 3.3. P-chiral phosphoro-acetates 3.4. P-chiral hydroxy phosphoryl compounds 3.5. P-chiral hydroxy phosphorus P-boranes 3.6. Stereocontrolled transformations of organophosphorus acid esters 4. Organosilanes 5. Organogermanes 6. Future Perspectives References
CHAPTER 10
Enzymatic polymerization
159
160
160
163
165
166
166
168
169
171
172
172
180
183
186
191
192
196
197
197
199
205
Hiroshi Uyama 1. Introduction 2. Enzymatic Synthesis of Polyesters 2.1. Ring-opening polymerization to polyesters 2.2. Polycondensation of dicarboxylic acid derivatives and glycols to polyesters 2.3. Enzymatic synthesis of functional polyesters 3. Enzymatic Synthesis of Phenolic Polymers 3.1. Enzymatic oxidative polymerization of phenols 3.2. Enzymatic synthesis of functional phenolic polymers
205
206
207
212
219
228
228
233
Contents 3.3. Artificial urushi 3.4. Enzymatic synthesis and biological properties of flavonoid polymers 4. Concluding Remarks References
CHAPTER 11
Synthesis of naturally occurring �-D-glucopyranosides based on
enzymatic �-glucosidation using �-glucosidase from almond
ix 238
240
244
245
253
Hiroyuki Akita 1. Introduction 2. Synthesis of -d-Glucopyranoside Under Kinetically Controlled Condition 2.1. Synthesis of naturally occurring -d-glucopyranoside 3. Synthesis of -d-Glucopyranoside Under Equilibrium-Controlled Condition 3.1. Immobilization of -d-glucosidase using prepolymer 3.2. Enzymatic transglucosidation 3.3. Synthesis of naturally occurring benzyl -d-glucopyranoside 3.4. Synthesis of phenethyl -d-glycopyranoside 3.5. Synthesis of (3Z)-hexenyl -d-glycopyranoside 3.6. Synthesis of geranyl -d-glycopyranoside 3.7. Synthesis of Sacranosides A (89) and B (90) 3.8. Synthesis of naturally occurring n-octyl -d-glucopyranosides 3.9. Synthesis of naturally occurring hexyl -d-glucopyranosides 3.10. Synthesis of naturally occurring phenylpropenoid -d-glucopyranoside 4. Future Aspect 5. Conclusion References
253
255
259
262
263
263
267
270
272
275
277
278
280
282
287
289
289
Part 4 Use of molecular biology technique to find novel biocatalyst
291
CHAPTER 12
Future directions in alcohol dehydrogenase-catalyzed reactions
293
Jon D. Stewart 1. Introduction 2. Future Progress in the Discovery Phase of Dehydrogenases 2.1. Accurately predicting dehydrogenase structures 2.2. Predicting dehydrogenase substrate acceptance and stereoselectivities. 2.3. Rapid screening of novel dehydrogenases 2.4. Dehydrogenases for large substrates 2.5. Dehydrogenase modules within larger assemblies as monofunctional catalysts 2.6. Dehydrogenase catalysis of other 1,2-carbonyl additions 3. Future Progress in Dehydrogenase Process Development 3.1. Improving the kinetic properties of dehydrogenases 3.2. Reductions of highly hydrophobic substrates 3.3. Cofactorless dehydrogenases? 4. Conclusions Acknowledgments References
293
295
295
296
296
299
299
300
300
301
301
302
302
303
303
x
Contents
CHAPTER 13
Enzymatic decarboxylation of synthetic compounds
305
Kenji Miyamoto, Hiromichi Ohta 1. Introduction 2. Arylmalonate Decarboxylase 2.1. Discovery of arylmalonate decarboxylase and its substrate specificity 2.2. Purification of the enzyme and cloning of the gene 2.3. Reaction mechanism 2.4. Inversion of enantioselectivity based on the reaction mechanism and homology 2.5. Addition of racemase activity 3. Transketolase-Catalyzed Reaction 3.1. Substrate specificity and stereochemical source of TKase-catalyzed reaction 3.2. Application of TKase-catalyzed reaction in organic syntheses 3.3. Tertiary structure and mutagenesis studies 4. Future Trends of this Area 4.1. Application of decarboxylation reaction to dialkylmalonates 4.2. Decarboxylation of various carboxylic acids 4.3. Oxidative decarboxylation of -hydroxycarboxylic acids 4.4. Carboxylation 4.5. Development of biotransformation via enolate 4.6. Utilization of database and informatics 5. Conclusion References
Index
305
309
310
311
312
317
319
321
322
322
329
331
331
332
333
336
337
339
339
340
345
xi
Preface
Important topics in biocatalysis for organic synthesis are described in this book, for experts and non-experts. Especially, the book focuses on those reactions that are under development now and will be more significant in the future. Therefore, each chapter describing a specific theme summarizes not only the present state but also the direction of the research. The prospects and dreams that will become possible, using biocatalysis, in the future to construct a sustainable society are also included. The book consists of four sections: the enzymatic reaction under unusual conditions, unique biocatalytic reactions, valuable compounds synthesized using biocatalysis and latest molecular biology methods to make useful biocatalysts. The first section dealing with unusual reaction conditions for biocatalysis begins with the use of ionic liquid as a solvent to develop green chemistry. Then, the reaction under extreme temperatures, use of light energy as a driving force to proceed biocatalysis and catalysis by enzyme-metal combinations are described. The second section covers very unique reactions such as carboxylation using decarboxylases and carbon dioxide, Baeyer-Villiger reaction using monooxygenases, reactions in aldoxime-nitrile pathway including dehydration in aqueous solvent and addition of nitrile to carbonyl compounds to synthesize chiral cyanohydrin. The third section highlights novel compounds synthesized using biocatalysts. Chiral heteroatomcontaining compounds such as chiral phosphorus compounds, polymer materials and sugars are selected to demonstrate the usefulness of biocatalysts. The last section describes the use of molecular biology technique to find novel biocatalysts. Alcohol dehydrogenase and decarboxylase are chosen as an example for the use of techniques since detailed and interesting researches have been conducted using these enzymes. Through this book, I hope to introduce the novelty and future directions in biocatalysis. Importantly, I wish to contribute to conserve and beautify the natural environment by editing the book, showing the power of enzymes, treasure from Mother Nature, to catalyze the necessary reaction for mankind in an environmentalfriendly manner. Tomoko Matsuda
This page intentionally left blank
Part One Novel reaction conditions for biotransformation
This page intentionally left blank
Future Directions in Biocatalysis Edited by Tomoko Matsuda © 2007 Elsevier B.V. All rights reserved.
3
Chapter 1
Biotransformation in ionic liquid Toshiyuki Itoh Department of Materials Science, Faculty of Engineering, Tottori University, Tottori, Japan
Abstract The use of ionic liquids (ILs) to replace organic or aqueous solvents in biocatalysis processes has recently gained much attention and great progress has been accomplished in this area; lipase-catalyzed reactions in an IL solvent system have now been established and several examples of biotransformation in this novel reaction medium have also been reported. Recent developments in the application of ILs as solvents in enzymatic reactions are reviewed.
1. INTRODUCTION Ionic liquids (ILs) have very good properties as reaction medium in chemical reactions: they are non-volatile, non-flammable, have low toxicity and good solu bility for many organic and inorganic materials.1 It has long been recognized that an enzymatic reaction proceeds in an aqueous buffer solution under appropriate pH conditions and an enzyme quickly loses its activity in a highly concentrated aqueous salt solution.2 Therefore it seems a foolish notion that enzymatic reaction occurs in a salt medium from the standpoint of biology. However, the use of ILs to replace traditional organic solvents in chemical reactions has recently gained much attention, and even as a novel reaction medium for biotransformation. Lipasecatalyzed reactions in an IL solvent system have now been established,1b−e and several types of non-lipase enzymatic reactions have also been reported recently. I wish to review recent progress in the area of “enzymatic reactions in an IL solvent system” in this chapter.
2. IONIC LIQUIDS AS A REACTION MEDIUM FOR BIOTRANSFORMATION Cull and co-authors3a reported a microbe-mediated transformation of benza mide from benzonitrile in a mixed solvent of IL, 1-butyl-3-methylimidazolium
4
Toshiyuki Itoh
Figure 1: The first enzymatic reaction conducted in a pure ionic liquid solvent system.
hexafluorophosphate ([bmim][PF6 ]), with water (1:4) in July 2000. Then Russell and co-authors3b reported that thermolysin-catalyzed amidation of CBz-asparagine with l-phenylalanine methyl ester proceeded in a mixed solvent of [bmim][PF6 ] with aqueous buffer solution. These examples showed that the IL had no inhibitory action against the enzymes because [bmim][PF6 ] was insoluble in water and enzy matic reactions took place in the water layer. The first example of enzymatic reac tion in a pure IL solvent system was reported by the Sheldon group in December 2000.4 The authors successfully demonstrated two types of Candida antarctica lipase (CAL-B) catalyzed reaction in a pure IL: CAL-B catalyzed amidation of octanoic acid with ammonia and also the formation of octanoic peracid by the reaction of octanoic acid with hydrogen peroxide (Fig. 1). However, the reactions were not enantioselective ones, though the most important aspect of the biocatalysis reaction should be in the enantioselective reaction. We5a and Kragl6 independently reported the first enantioselective lipasecatalyzed reaction in February–March 2001. Since lipase was anchored by the IL solvent and remained in it after the extraction work-up of the product, we succeeded in demonstrating that recyclable use of the lipase in the [bmim][PF6 ] solvent system was possible (Fig. 2).5a Typically the reaction was carried out as follows: to a mixture of lipase in the IL were added this racemic alcohol and vinyl acetate as the acyl donor. The resulting mixture was stirred at 35 C and the reaction course was monitored by GC analysis. After the reaction, ether was added to the reaction mixture to form a biphasic layer, and product acetate and unreacted alcohol were extracted with ether quantitatively. The enzyme remained in the IL phase as expected (Fig. 2). Two months later, Kim and co-workers7a reported similar results and Lozano and Ibora7bd reported other examples of lipase-catalyzed reaction in June. Further Park and Kazlauskas7c reported full details of lipase-catalyzed reaction in an IL solvent
Biotransformation in ionic liquid
5
Figure 2: Lipase-catalyzed reaction system anchored to the solvent. system in August 2001. Studies on the enzymatic reaction in an IL solvent system were thus launched in 2000–2001. We initially tested Candida antarctica lipase using imidazolium salt as sol vent because CAL was found to be the best enzyme to resolve our model substrate 5-phenyl-1-penten-3-ol (1a); the acylation rate was strongly dependent on the anionic part of the solvents. The best results were recorded when [bmim][BF4 ] was employed as the solvent, and the reaction rate was nearly equal to that of the refer ence reaction in diisopropyl ether. The second choice of solvent was [bmim][PF6 ]. On the contrary, a significant drop in the reaction rate was obtained when the reaction was carried out in TFA salt or OTf salt. From these results, we concluded that BF4 salt and PF6 salt were suitable solvents for the present lipase-catalyzed reaction.5a Acylation of 1a was accomplished by these four enzymes: Candida antarctica lipase, lipase QL from Alcaligenes, Lipase PS from Burkholderia cepa cia and Candida rugosa lipase. In contrast, no reaction took place when PPL or PLE was used as catalyst in this solvent system. These results were established in March 2000 but we encountered a serious problem in that the results were significantly dependent on the lot of the ILs that we prepared ourselves. The problem was very serious because sometimes the reaction did not proceed at all. So we attempted to purify the ILs and established a very successful procedure (Fig. 3): the salt was first washed with a mixed solvent of hexane and ethyl acetate (2:1 or 4:1), treated with activated charcoal and passed into activated alumina neutral type I as an acetone solution. It was evaporated and dried under reduced
6
Toshiyuki Itoh
Figure 3: Purification protocol of imidazolium ionic liquid.
pressure at 50 C for 24 h to obtain very clean imidazolium salt. Using the ILs, we succeeded in obtaining more reproducible results; I recommend this as also being very useful to recycle the IL. In fact, we always recycle our ILs after the reaction and have not wasted any in the past. We are still using ILs that have a 7-year history. After establishing the reproducibility of our results of lipasecatalyzed reaction, we submitted our first paper in December 2000 and the paper was accepted on January 5, 2001. Although we lost the chance to be the first to publish in the field for this reason, we learned many things about ILs during that time and these are now important bases of our research group. Very pure ILs are commercially available now and we can use them, but I imagine that all research groups encountered the same problem in the early days of this field, because very clean ILs are required for a biocatalysis system compared to chemical reactions. This story highlights a very important point; we should pay attention to the qual ity of the IL when we evaluate the appropriate one for our desired biocatalyst reaction.
Biotransformation in ionic liquid
7
3. LIPASE-CATALYZED REACTION IN AN IONIC LIQUID SOLVENT SYSTEM We succeeded in showing that recycling of the enzyme was indeed possible in our IL solvent system, though the reaction rate gradually dropped with repetition of the reaction process.5a Since vinyl acetate was used as acyl donor, acetaldehyde was produced by the lipase-catalyzed transesterification. It is well known that acetaldehyde acts as an inhibitor of enzymes because it forms a Schiff base with amino residue in the enzyme. However, due to the very volatile nature of acetaldehyde, it easily escapes from the reaction mixture and therefore has no inhibitory action on the lipase. However, this drop in reactivity was assumed to be caused by the inhibitory action of acetaldehyde oligomer which had accumulated in the [bmim][PF6 ] solvent system. In fact, it was confirmed that the reaction was inhibited by addition of acetaldehyde trimer.5c One of the most important characteristics of IL is its wide temperature range for the liquid phase with no vapor pressure, so next we tested the lipase-catalyzed reaction under reduced pressure. It is known that usual methyl esters are not suit able for lipase-catalyzed transesterification as acyl donors because reverse reaction with produced methanol takes place. However, we can avoid such difficulty when the reaction is carried out under reduced pressure even if methyl esters are used as the acyl donor, because the produced methanol is removed immediately from the reaction mixture and thus the reaction equilibrium goes through to produce the desired product.8 To realize this idea, proper choice of the acyl donor ester was very important. The desired reaction was accomplished using methyl phenylth ioacetate as acyl donor. Various methyl esters can also be used as acyl donor for these reactions; methyl nonanoate was also recommended and efficient optical resolution was accomplished. Using our system, we demonstrated the completely recyclable use of lipase. The transesterification took place smoothly under reduced pressure at 10 Torr at 40 C when 0.5 equivalent of methyl phenylthioacetate was used as acyl donor, and we were able to obtain this compound in optically pure form. Five repetitions of this process showed no drop in the reaction rate (Fig. 4).5bc Recently Kato reported nice additional examples of lipase-catalyzed reaction based on the same idea that CAL-B-catalyzed esterification or amidation of carboxylic acid was accomplished under reduced pressure conditions.9 However, it still remained a problem that the system could not be applied to volatile substrates. We hypothesized that oligomerization of acetaldehyde may be caused by the proton derived from the water molecule trapped by hydrogen bonding at 2-position of the imidazolium ring, because it was suggested that the acidity of the 2-position of imidazolium cation is very high.10 Hence we prepared 1-butyl-2,3-dimethylimidazolium (bdmim) salt and used it as solvent. As we expected, no accumulation of an acetaldehyde oligomer was observed in this solvent system by1 H NMR analysis. The reaction proceeded very smoothly and we were able to use the enzyme repeatedly 10 times while still maintaining perfect
8
Toshiyuki Itoh
Figure 4: Lipase-catalyzed reaction under reduced pressure conditions.
Novozyme-435 Vinyl acetate
OAc
Ph Me
N
N Me
Relative rate (%conv./h)
OH + Ph
Ph Bu BF4
40
300
30
200
100
20
0 Run 1
E value
OH
1 2
3
4
5
6
7
8
9
10
Figure 5: Recyclable use of lipase in [bdmim][BF4 ] solvent system. enantioselectivity and high reactivity (Fig. 5).5d It has now been confirmed that we can use the enzyme more than 20 times for several months using this system. Imidazolium PF6 or BF4 salts were frequently used as solvent for the present lipase-catalyzed reaction. However, these salts are very expensive, and we should develop cheaper ILs. Imidazolium alkyl sulfates might be good candidates because various types of alkyl sulfates can be easily prepared. The imidazolium alkyl sulfate was prepared starting from the corresponding ammonium alkyl sulfate as follows: ammonium alkyl sulfates ([NH4 ][RSO4 ]) are easily prepared by the reaction of
Biotransformation in ionic liquid
9
an alcohol with sulfuric amide, and subsequent anion exchange reaction with [bmim][Cl] gave the corresponding [bmim][RSO4 ].5e The lipase-catalyzed transesterification proceeded in these solvent systems and optically pure acetate was obtained with excellent enantioselectivity. Ethoxyethyl sulfate and phenoxyethyl sulfate gave excellent results and the acetates were obtained with > 99% ee.5e However, interestingly, no reaction took place when [bmim][EtSO4 ] was used as solvent. We recently prepared various types of differently fluorinated alkyl sulfate ILs and discovered that the hydrophobicity was dependent on the content ratio of the fluorine on the alkyl sulfate anion and 2,2,3,3,4,4,5,5-octafluoropentyl sulfate salts showed hydrophobic properties. Melting point and viscosity were also depen dent on the fluorine contents of the anionic part, while conductivity was deter mined by the cationic part and not influenced by the fluorine contents. Efficient lipase-catalyzed transesterification was demonstrated using hydrophobic 1-butyl 3-methylimidazolium 2,2,3,3,4,4,5,5-octafluoropentyl sulfate ([bmim][C5F8]) as solvent (Fig. 6).11 Kim and co-workers12 recently reported an excellent example of dynamic kinetic resolution (DKR) using lipase-ruthenium combo catalyst in an IL solvent system (Fig. 7). Applied to this protocol, the authors succeeded in preparing (R) ester or (S)-ester using lipase PS or subtilisin, respectively. An IL solvent system is truly appropriate for DKR because racemization takes place easily in a highly polar solvent. Lipase-catalyzed reaction is useful for polyester synthesis and IL was employed successfully as solvent. Uyama and Kobayashi13 demonstrated an effi cient polyester synthesis; lipase-catalyzed esterification of agipic acid with butan 1,4-diol proceeded smoothly in [bmim][BF4 ] solvent, particularly under reduced pressure conditions (Fig. 8). Further Russel14 and Nara15 independently reported efficient examples of the lipase-catalyzed polyester synthesis in an IL solvent system.
Figure 6: Lipase PS-catalyzed acylation in hydrophobic alkylsulfate IL.
10
Toshiyuki Itoh
Figure 7: Efficient DKR reaction in an IL solvent system.
Figure 8: Lipase-catalyzed polyester synthesis using IL solvent system. 4. ACTIVATION OF LIPASE BY AN IONIC LIQUID Lozano and co-workers7b reported an interesting stabilization effect of IL for lipase-catalyzed reaction; the authors discovered that the presence of an appropriate substrate was essential for stabilization of enzyme in an IL solvent. The half lifetime of native CAL was only 3.2 h in [emim][PF6 ] solvent, while it lengthened remarkably to 7500 h in the presence of the substrate. The authors succeeded in demonstrating an efficient lipase-recyclable use system based on scCO2 solvent (Fig. 9).1617 In the reaction, it was essential to use an IL as a co-solvent. Lozano, Iborra and co-workers recently reported an interesting stabilizing effect of two types of water-immiscible ILs ([emim][TFSI] and [BuMe3 N][TFSI]) for CAL B-catalyzed transesterification of vinyl butyrate.18 The synthetic activity and the stability of the enzyme in these IL solvent systems were markedly enhanced as compared to those in hexane. CAL-B maintained its activity higher than 75% after 4 days of incubation in [emim][TFSI] solvent, while it showed an activ ity of only 25% when incubated in both water and hexane media at 50 C. Comparison of the ratio of -helix and -sheet by CD spectra showed the activity was closely related with -helix content which reduced to 31% imme diately after lipase was added to hexane and had reached only 2% after 4 days in hexane. On the contrary, no significant reduction of -helix content was
Biotransformation in ionic liquid
11
°
Figure 9: Lipase recyclable use reactor using a mixed solvent of scCO2 with IL.
obtained in [emim][TFSI] solvent. Based on these results, the authors concluded that -helix content might play an important role in maintaining the enzymatic activity. Polyethyleneglycol (PEG) treatment is known to cause stabilization of an enzyme. Goto and co-workers prepared PEG-coated lipase and demonstrated that transesterification of vinyl cinnamate with butanol proceeded smoothly using PEGlipase PS in [omim][PF6 ] solvent system.19 The Russell group investigated the details of PEG treatment on the lipase activity in various types of ILs and reported that this activity was mainly dependent on the anionic part of the ILs (Fig. 10)14 ; high activity was obtained for imidazolium PF6 salt, while no activity was observed for [NO3 ], [OAc], [CH3 SO3 ], [OTf] or [TFA] salt. The authors proposed that nitric anion or acetate anion might have a strong interaction with some parts of the enzyme protein due to the highly nucleophilic nature of these anions and caused deactivation of the enzyme activity.14 Sheldon’s group also investigated the relationship of activity and IL species; CAL-B showed no catalytic activity in some ILs, such as [emim][EtSO4 ], [bmim][lactate], [EtNH3 ][NO3 ] or [bmim][NO3 ], though the enzyme was soluble in these solvents. On the other hand, high activity was obtained in [bmim][PF6 ] or [bmim][BF4 ] although the enzyme was insoluble in them. Interestingly deactivation was recorded for [emim][EtSO4 ], while the enzyme worked in [emim][MeSO4 ]. The authors speculated that this deactivation by the IL might be caused by con formational change due to the interaction of the anionic part of the IL with lipase protein based on the results of FT-IR analysis of the protein.20
12
Toshiyuki Itoh
Figure 10: Lipase-catalyzed acylation: the reaction depended on the counter anionic part of IL. A mixed solvent system of an IL with organic solvent sometimes gave very nice results: Lundell21 reported that enhanced enantioselectivity was obtained when lipase-catalyzed acylation was carried out in a mixed solvent system of [emim][TFSI] with t-BuOMe (1:1), while poor enantioselectivity was recorded for that in the pure [emim][TFSI] solvent (Fig. 11). Ganske and co-workers22ab reported that lipase-catalyzed acylation of a glucose derivative proceeded smoothly in a mixed solvent of [bmim][BF4 ] with t-BuOH, while no reaction took place in [bmim][BF4 ] (Fig. 12). These results taught us that a mixed solvent system of IL with organic solvent may be a good solution if the desired reaction did not take place in a pure IL solvent. Modified enantioselectivity was reported if the reaction was carried out in an IL solvent instead of traditional organic solvent.23 For instance, Kazlauskas and Kim independently reported that the regioselectivity of lipase-catalyzed reaction was enhanced if the reaction was carried out in an IL solvent system (Fig. 13).7c24 Recently Wu and co-workers reported another chip of lipase-catalyzed reaction: a
Figure 11: Lipase-catalyzed reaction in a mixed solvent system using microwave
reaction conditions at 80 C.
Biotransformation in ionic liquid
13
Figure 12: Lipase-catalyzed regioselective esterification of glucose in a mixed
solvent of IL with t-BuOH.
Figure 13: Enhanced regioselectivity of lipase-catalyzed acylation in IL solvent system.
significant enhanced enantioselectivity was obtained for Candida rugosa lipasecatalyzed acylation of ibuprofen in [bmim][BF4 ] compared to the isooctane solvent system (Fig. 14).25 Interestingly no enantioselectivity was obtained for [bmim][MeSO4 ], [bmim][OctylSO4 ], [(n-C6 H13 3 C14 H29 PN3 ], [Bu3 MeP][OTs] or [mmim][MeSO4 ] solvent. These results clearly showed that appropriate choice of the IL is the key point of the reaction.
Figure 14: Great diversity in enantioselectivity among IL solvent systems.
14
Toshiyuki Itoh
We investigated lipase-catalyzed acylation of 1-phenylethanol in the pres ence of various additives, in particular an IL additive using diisopropyl ether as solvent. Enhanced enantioselectivity was obtained when a BEG-based novel IL, i.e., imidazolium polyoxyethylene(10) cetyl sulfate, was added at 3–10 mol% vs. substrate in the Burkholderia cepacia lipase (lipase PS-C) catalyzed transesterification using vinyl acetate in diisopropyl ether or a hexane solvent system.5g Recently Kim reported another very interesting salt-mediated activation of a lipase: lipase PS was mixed with the IL and resulted in “ionic liquid-coated lipase PS” which showed more enhanced enantioselectivity than commercial lipase PS-C in toluene, though no significant modification of the reaction rate was obtained.26 We discovered that lyophilization was essential to activate the lipase effectively by the IL. The novel IL [bdmim][cetyl-PEG10-sulfate] (IL1) worked as an excellent activator of lipase PS-catalyzed acetylation of various types of secondary alcohols using vinyl acetate as acyl donor in i-Pr2 O solvent, while maintaining excellent enantioselectivity. More than 500- to 1000-fold acceler ation was accomplished for some substrates (Fig. 15 and Table 1).27 On the contrary, previously established activation protocol such as PEG coating of a lipase could accelerate the reaction but caused no significant enhanced enantios electivity; also using toluene as solvent sometimes provided enhanced enantios electivity for some substrates, but other times caused a significant reduction in the reaction rate. Since similar activation was observed for CRL, we expect that the activation effect of IL1 might be general for various lipases. We believe this work not only represents a significant advance in the manner of prepara tion of optically active compounds using an enzymatic reaction but also pro vides a new aspect in the application of an IL for such a reaction. Since the present activation was significantly dependent on the substrate, we are also hoping that further optimization of the cationic part of the ILs may make it possible to apply the present protocol of lipase activation to various broader types of substrates.
Figure 15: Results of activation effect by IL1-coating on the lipase PS-catalyzed
enantioselective acylation.
Biotransformation in ionic liquid
15
Table 1 Typical examples of results of activation effect of IL1 coating on the lipase PS-catalyzed enantioselective acylation of (±-1 Substrate
OH
Ratea (above) and E value (below)
Specific activityb of IL1-PS vs. PS-C
Lipase PS
IL1-PS
Rate: 65 E = 16
Rate: 1000 E > 200
15
Rate: 100 E = 39
Rate: 9800 E = 40
98
Rate: 13 E > 200
Rate: 14 E > 200
1
Rate: 10 × 10−2 E = 199
Rate: 11 E > 200
1100
Rate: 12 × 10−2 E > 200
Rate: 6 E > 200
500
(±)-1a
OH NC (±)-1b OH (±)-1c
OH (±)-1d HO
(±)-1e a b
Rate: mM h−1 mg (enzyme)−1 . Rate was determined by GC analysis. Specific activity was calculated by the rate of IL1-PS divided by that of PS-C.
5. VARIOUS BIOTRANSFORMATIONS IN AN IONIC LIQUID SOLVENT SYSTEM An IL solvent system is applicable to not only lipase but also other enzymes, though examples are still limited for lipase-catalyzed reaction in a pure IL solvent. But several types of enzymatic reaction or microbe-mediated reaction have been reported in a mixed solvent of IL with water. Howarth28 reported Baker’s yeast reduction of a ketone in a mixed solvent of [bmim][PF6 ] with water (10:1) (Fig. 16). Enhanced enantioselectivity was obtained compared to the reaction in a buffer solution, while the chemical yield dropped. Antibody-catalyzed aldol condensation was demonstrated in a [bmim][PF6 ] solvent system by Kitazume and co-workers29 (Fig. 17). They tested recyclable use of antibody catalyst in the solvent system and, very interestingly, found that the chemical yield was increased for the second cycle (89%) over the initial run (21%).
16
Toshiyuki Itoh
Figure 16: Baker’s yeast reduction of ketones in a mixed solvent of IL with
water.
Figure 17: Antibody-mediated aldol reaction in IL solvent system.
Okrasa and co-workers reported an interesting combination reaction of glucose oxidase and peroxidase in a mixed solvent of [bmim][PF6 ] with water (Fig. 18). Asymmetric oxidation of sulfide was accomplished successfully in the reaction system.30 Griengl reported the first example of hydroxynitrile lyase-catalyzed cyanohydrin formation in a mixed solvent system of [bmim][BF4 ] and buffer (pH 3.7) (1:1) (Fig. 19).31a In the reaction, a mixed solvent system was essential, but excellent results were obtained. Matsuda32 recently reported an elegant solution for using a delicate enzyme system in an IL solvent system (Fig. 20). The authors prepared Geotrichum candidum IFO5767 dried cell on water-absorbing polymer BL-100 and used
Figure 18: Glucose oxidase-mediated asymmetric oxidation of sulfide in IL
solvent system.
Biotransformation in ionic liquid
17
Figure 19: Enantioselective cyanohydrin formation using hydroxynitrile lyase in
IL solvent system.
Figure 20: Use of IL as reaction medium for asymmetric reduction by
Geotrichum candidum.
it for the asymmetric reduction of methyl ketones. The system made it pos sible to realize easy work-up and provided the corresponding alcohol with excellent enantioselectivity. Of interest was that the reactivity of the enzyme significantly depended on the counter anion of IL. The reaction proceeded smoothly in imidazolium PF6 , BF4 or TFSI salt, while no reaction took place in imidazolium OTf, EtSO4 , MeSO4 or NO3 salt as solvent. As reported in the reactions of lipases,1420 nitric anion or sulfate anion might have a strong interaction with some parts of the enzyme protein, due to the highly nucleophilic nature of these anions, and caused deactivation of the enzyme activity. Chiappe and co-workers33 reported chloroperoxide (CPO)-catalyzed oxi dation in hydrophilic ILs as co-solvents (Fig. 21). The authors investigated the hydrophilic ILs on the activity of CPO and found that CPO showed a higher toler ance toward IL than organic solvent; good activity was obtained when the reaction was carried out in a mixed solvent of [mmim][Me2 PO4 ] and buffer (pH 5.0) (1:1) rather than buffer solution.
18
Toshiyuki Itoh
Figure 21: CPO-catalyzed chlorination in IL solvent system.
6. CONCLUDING REMARKS There might be at least four advantages of the enzymatic reaction using an IL solvent system: (1) the purification process is very easy; (2) the reaction does not waste any water discarded with the organic solvent; (3) it is possible to use the enzyme repeatedly in this system; and (4) it is possible to activate the reaction using an IL-type supporting material. It is now completely established that ILs might be good candidates as the solvent of lipase-catalyzed reaction. However, we should consider the risk of using novel material. For example, Rogers warned that PF6 may be decomposed by moisture at higher temperature and produce toxic hydrogen fluoride.34a The authors also reported that cellulase was inhibited by the addition of [bmim][Cl]; chloride anion caused change of the folding pattern of the enzyme protein, which led to deactivation of the enzyme.34b However, imidazolium cation was reported to be easily degraded in the metabolism system.35 I believe that IL is superior to the conventional organic solvent if we try to create an enzymatic reaction under anhydrous conditions. To meet the challenge in chemistry of developing practical processes, the proper choice of a reaction medium is very important. Breakthroughs have sometimes come along with innovation of a reaction medium in chemical reactions and this is true even in enzymatic reactions. I hope this chapter may provide a hint for the reader’s research.
REFERENCES 1. Reviews see: (a) Wasserscheid, P.; Welton, T. (Eds). Ionic Liquids in Synthesis; Wiley-VCH: Weinheim, 2003. (b) Rogers, R. D.; Seddon, K. R. (Eds). Ionic Liquids as Green Solvents, ACS Symposium Series 856; American Chemical Society: Washington, DC, 2002. (c) Park, S.; Kazlauskas, R. J. Curr. Opin. Biotechnol. 2003, 14, 432. (d) Kragl, U.; Eckstein, M.; Kaftzik, N.
Biotransformation in ionic liquid
2.
3.
4. 5.
6. 7.
8.
9. 10. 11. 12. 13. 14. 15. 16. 17.
18. 19. 20. 21. 22. 23.
19
Curr. Opin. Biotechnol. 2003, 14, 565. (e) Jain, N.; Kumar, A.; Chauhan, S.; Chauhan, S. M. S. Tetrahedron 2005, 61, 1015. (f) Zhao, H. J. Mol. Catal. B Enzym. 2005, 37, 16. Reviews see: (a) Wong, C.-H.; Whitesides, G. M. Enzymes in Synthetic Organic Chemistry; Pergamon: Oxford, 1994. (b) Bornscheuer, U. T.; Kazlauskas, R. J. Hydrolases in Organic Synthesis: Regio- and Stereoselective Biotransformations; Wiley: Chichester, 1999. (a) Cull, S. G..; Holbrey, J. D.; Vargas-Mora, V.; Seddon, K. R.; Lye, G. J. Biotechnol. Bioeng. 2000, 69, 227. (b) Erbeldinger, M.; Mesiano, A. J.; Russell, A. J. Biotechnol. Prog. 2000, 16, 1131. Lau, R. M.; van Rantwijk, F.; Seddon, K. R.; Sheldon, R. A. Org. Lett. 2000, 2, 4189. (a) Itoh, T.; Akasaki, E.; Kudo, K.; Shirakami, S. Chem. Lett. 2001, 262. (b) Itoh, T.; Akasaki, E.; Nishimura, Y. Chem. Lett. 2002, 154. (c) Itoh, T.; Nishimura, Y.; Kashiwagi, M.; Onaka, M. In Ionic Liquids as Green Solvents: Progress and Prospects, ACS Symposium Series 856; Rogers, R. D.; Seddon, K. R. (Eds); American Chemical Society: Washington, DC; Chapter 21, pp. 251–261, 2003. (d) Itoh, T.; Ouchi, N.; Hayase, S.; Nishimura, Y. Chem. Lett. 2003, 32, 654. (e) Itoh, T.; Nishimura, Y.; Ouchi, N.; Hayase, S. J. Mol. Catal. B Enzym. 2003, 26, 41. (f) Itoh, T.; Ouchi, N.; Nishimura, Y.; Han, S.-H.; Katada, N.; Niwa, M.; Onaka, M. Green Chem. 2003, 5, 494. (g) Itoh, T.; Han, S.-H.; Matsushita, Y.; Hayase, S. Green Chem. 2004, 6, 437. Schöfer, S. H.; Kaftzik, N.; Wasserscheid, P.; Kragl, U. Chem. Commun. 2001, 425. (a) Kim, K.-W.; Song, B.; Choi, M.-Y.; Kim, M.-J. Org. Lett. 2001, 3, 1507. (b) Lozano, P.; De Diego, T.; Guegan, J. P.; Vaultier, M.; Iborra, J. L. Biotechnol. Bioeng. 2001, 75, 563. (c) Park, S.; Kazlauskas, R. J. J. Org. Chem. 2001, 66, 8395. (d) Lozano, P.; De Diego, T.; Carrie, D.; Vaultier, M.; Iborra, J. L. Biotech. Lett. 2001, 23, 1529. (a) Haraldsson, G. G.; Gudmundsson, B. O.; Almarsson, O. Tetrahedron Lett. 1993, 34, 5791. (b) Haraldsson, G. G.; Thorarensen, A. Tetrahedron Lett. 1994, 35, 7681. (c) Sugai, T.; Takizawa, M.; Bakke, M.; Ohtsuka, Y.; Ohta, H. Biosci. Biotech. Biochem. 1996, 60, 2059. (d) Cordova, A.; Janda, K. D. J. Org. Chem. 2001, 66, 1906. Irimescu, I.; Kato, K. Tetrahedron Lett. 2004, 45, 523. Tsuzuki, S.; Tokuda, H.; Hayamizu, K.; Watanabe, M. J. Phys. Chem. B 2005, 109, 16474. Tsukada, Y.; Iwamoto, K.; Furutani, H.; Matsushita, Y.; Abe, Y.; Matsumoto, K.; Monda, K.; Hayase, S.; Kawatsura, M.; Itoh, T. Tetrahedron Lett. 2006, 48, 1801. Kim, M.-J.; Kim, H. M.; Kim, D.; Ahn, Y.; Park, J. Green Chem. 2004, 6, 471. Uyama, H.; Takamoto, T.; Kobayashi, S. Polym. J. 2002, 34, 94. Kaar, J. L.; Jesionowski, A. M.; Berberich, J. A.; Moulton, R.; Russell, A. J. J. Am. Chem. Soc. 2003, 125, 4125. Nara, S. J.; Harjani, J. R.; Salunkhe, M. M.; Mane, A. T.; Wadgaonkar, P. P. Tetrahedron Lett. 2003, 44, 1371. Lozano, P.; De Diego, T.; Carrié, D.; Vaultier, M.; Iborra, J. L. Chem. Commun. 2002, 692. Recent other examples of stabilization of enzyme using IL as co-solvent in scCO2 solvent system: Reetz, M. T.; Wiesenhöfer, W.; Franció, G.; Leitner, W. Adv. Synth. Catal. 2003, 345, 1221. De Diego, T.; Lozano, P.; Gmouh, S.; Vaultier, M.; Iborra, J. L. Biomacromolecules 2005, 6, 1457. (a) Maruyama, T.; Nagasawa, S.; Goto, M. Biotechnol. Lett. 2002, 24, 1341. (b) Maruyama, T.; Yamamura, H.; Kotani, T.; Kamiya, N.; Goto, M. Org. Biomol. Chem. 2004, 2, 1239. Madeira, L. R.; Sorgedrager, M. J.; Carrea, G.; Van Rantwijk, F.; Secundo, F.; Sheldon, R. A. Green Chem. 2004, 6, 483. Lundell, K.; Kurki, T.; Lindroos, M.; Kanerva, L. T. Adv. Synth. Catal. 2005, 347, 1110. (a) Ganske, F.; Bornscheuer, U. T. J. Mol. Catal. B Enzym. 2005, 36, 40. (b) Ganske, F.; Bornscheuer, U. T. Org. Lett. 2005, 7, 3097. (a) Lou, W.-Y.; Zong, M.-H.; Wu, H.; Xu, R.; Wang, J.-F. Green Chem. 2005, 7, 500. (b) Xin, J.-Y.; Zhao, Y.-J.; Shi, Y.-G.; Xia, C.-G.; Li, S.-B. World J. Microbiol. Biotechnol.
20
24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35.
Toshiyuki Itoh 2005, 21, 193. (c) Nara, S. J.; Mohile, S. S.; Harjani, J. R.; Naik, P. U.; Salunkhe, M. M. J. Mol. Catal. B Enzym. 2004, 28, 39. (d) Noel, M.; Lozano, P.; Vaultier, M.; Iborra, J. L. Biotechnol. Lett. 2004, 26, 301. (e) Rasalkar, M. S.; Potdar, M. K.; Salunkhe, M. M. J. Mol. Catal. B Enzym. 2004, 27, 267. (f) Mohile, S. S.; Potdar, M. K.; Harjani, J. R.; Nara, S. J.; Salunkhe, M. M. J. Mol. Catal. B Enzym. 2004, 30, 185. (g) Ulbert, O.; Frater, T.; Belafi-Bako, K.; Gubicza, L. J. Mol. Catal. B Enzym. 2004, 31, 39. (h) Roberts, N. J.; Seago, A.; Carey, J. S.; Freer, R.; Preston, C.; Lye, G. J. Green Chem. 2004, 6, 475. (i) Kamal, A.; Chouhan, G. Tetrahedron Lett. 2004, 45, 8801. (j) Eckstein, M.; Wasserscheid, P.; Kragl, U. Biotechnol. Lett. 2002, 24, 763. Kim, M.-J.; Choi, M. Y.; Lee, J. K.; Ahn, Y. J. Mol. Catal. B Enzym. 2003, 26, 115. Yu, H.; Wu, J.; Bun, C. C. Chirality 2004, 17, 16. Lee, J. K.; Kim, M.-J. J. Org. Chem. 2002, 67, 6845. Itoh, T.; Matsushita, Y.; Abe, Y.; Han, S.-H.; Wada, S.; Hayase, S.; Kawatsura, M.; Takai, M.; Morimoto, M.; Hirose, Y. Chem. Eur. J. 2006, 12, 9228. Howarth, J.; James, P.; Dai, J. Tetrahedron Lett. 2001, 42, 7517. Kitazume, T.; Jiang, Z.; Kasai, K.; Mihara, Y.; Suzuki, M. J. Fluorine Chem. 2003, 121, 205. Okrasa, K.; Guibé-Jampel, E.; Therisod, M. Tetrahedron Asymm. 2003, 14, 2487. (a) Gaisberger, R. P.; Fechter, M. H.; Griengl, H. Tetrahedron Asymm. 2004, 15, 2959. (b) Matsumoto, M.; Mochizuki, K.; Fukunishi, K.; Kondo, K. Sep. Purif. Technol. 2004, 40, 97. Matsuda, T.; Yamagishi, Y.; Koguchi, S.; Iwai, N.; Kitazume, T. Tetrahedron Lett. 2006, 47, 4619. Chiappe, C.; Neri, L.; Pieraccini, D. Tetrahedron Lett. 2006, 47, 5089. (a) Swatloski, R.P.; Hobrey, J. D.; Rogers, R. D. Green Chem. 2003, 5, 361. (b) Turner, M. B.; Spear, S. K.; Huddlestone, J. G.; Holbrey, J. D.; Rogers, R. D. Green Chem. 2003, 5, 443. Jastorff, B.; Störmann, R.; Ranke, J.; Mölter, K.; Stock, F.; Oberheitmann, B.; Hoffmann, W.; Hoffmann, J.; Nüchter, M.; Ondruschke, B.; Filser, J. Green Chem. 2003, 5, 136.
Future Directions in Biocatalysis Edited by Tomoko Matsuda © 2007 Elsevier B.V. All rights reserved.
21
Chapter 2
Temperature control of the enantioselectivity in the lipase-catalyzed resolutions Takashi Sakai Division of Chemistry and Biochemistry, Graduate School of Natural Science and Technology, Okayama University, Okayama, Japan
Abstract In the lipase-catalyzed resolution, temperature control of enantioselectivity has been generally accepted for its simplicity and theoretical reliability. Lowering the reaction temperature usually enhances the enantioselectivity. Here, the historical and theoretical backgrounds of the temperature control of enantioselectivity and its applicability to the method are described. Recent literatures for the lipase-catalyzed resolutions to which the “low-temperature method” seems to be promising to enhance the enantioselectivity are also summarized.
1. INTRODUCTION Recently, a variety of methods for increasing the enantioselectivity in lipasecatalyzed reaction1ab have been developed, involving modulation of organic media; additive, acyl donor; and immobilization support. Ionic liquid1cd and supercritical CO2 1e−g recently emerged as efficient reaction media and/or supporting material in enzymatic reactions. Beside these methods, temperature control in the lipasecatalyzed resolution of alcohols is now accepted as a theoretically reliable and gener ally applicable method, since we demonstrated that a lipase exerts its function even at very low temperatures down to −80� C in an organic solvent.2af In our first attempt for resolution of 3-phenyl-2H-azirine-2-methanol (1), the enantioselectivity was found to be maximal at −40� C in ether as reported in 1997. We recently demonstrated that temperature modulation is generally effective in the lipase-catalyzed resolution of primary and secondary alcohols.2a−h Enzymes have long been believed to be tem perature labile and have been used at around ambient temperatures; however, our finding opened the way to the wide range of temperature control of enantioselectivity in enzymatic reactions like chemical asymmetric reaction. Although unusual temperature-induced rate control of enzymatic reaction was well investigated before 1970,3 the temperature control of enantioselectivity in enzymatic reaction (PLE, −10� C) was initially reported by Jones and co-workers
22
Takashi Sakai
in 1986.4a Since then, many attempts4b−i were reported, although the reactions were mostly carried out above 0� C. The rational explanations for the temperature effect were then proposed by Overbeeke and Hult5 with lipases and by Phillips6a−f and co-workers with secondary alcohol dehydrogenase and PLE. In 1997, we reported that the temperature effect is observable with regulation below to very low tem perature, and practically applicable to the lipase-catalyzed resolution of alcohols.2a Moreover, an immobilized lipase on porous ceramic particles (Toyonite), now com mercially available as Amano lipase PS-C II, was found to be highly effective for enhancement of the reaction rate even at low temperatures.2c−h The immobilized lipase was also found to be effective for high-temperature reaction up to 120� C, in which bulky alcohol can be resolved without loss of enantioselectivity,7 maintain ing the transition-state structure.8 On the other hand, the low-temperature method can also be applicable to hydrolytic asymmetric protonation of enol acetate.8 Here, the features and current applications of the temperature modulation of enantiose lectivity are summarized. In addition, reported examples for the lipase-catalyzed resolution of primary alcohols are listed.
2. FINDING OF THE “LOW-TEMPERATURE METHOD” IN THE LIPASE-CATALYZED KINETIC RESOLUTION We first examined the lipase-catalyzed resolution of azirine-2-methanol 1,2a which we expected to have a versatile synthetic utility.2h9 As expected for primary alcohols,710 the enantioselectivity obtained in the transesterification with lipase PS in ether was low (E 11 = 17 at best) at room temperature despite considerable efforts such as screening of lipases, solvents, additives, and acylating agents.12−17 As the final choice, we examined the reaction at low temperatures because of its high reaction rate and found that lowering the temperature to −40� C increased the E value of 17 (at 30� C) to a practically acceptable level of 99; however, further lowering the temperature rather decreased the enantioselectivity (Scheme 1).
N OH
Ph (±)-1
N Ph
N
CH2OH H
(S)-1
Lipase PS Vinyl acetate, Et2O 30°C: E = 17 –40°C: E = 99
+
Ph
H CH2OAc
(R)-2
Scheme 1: “Low-temperature method” in the lipase-catalyzed resolution of
3-phenyl-2H-azirine-2-methanol (1) for enhancement of the enantioselectivity.
Temperature control of enantioselectivity
23
3. THEORY OF TEMPERATURE EFFECT ON THE ENANTIOSELECTIVITY Lowering the temperature in the lipase-catalyzed resolution usually enhances the enantioselectivity. The phenomenon does not come from the temperature-induced conformational change of lipase, but it is understandable on the basis of the theory of physical organic chemistry as explained below.56 In general, the enantioselectivity (E value11 ) in a kinetic-control reaction is determined by the ratio of the rates of two enantiomers and defined by Equation 1: E=
kA ‡ = e−G /RT kB
(1)
where kA and kB are the rate constants for a faster-reacting enantiomer (A) and a slower-reacting enantiomer (B). G‡ is the difference in the transition-state energies (G‡ = G‡fast −G‡slow for each reaction process, and R is gas constant. The lipase-catalyzed kinetic resolution is represented in the same way. Equation 1 is changed to Equation 2: G‡ = −RT ln E
(2)
Figure 1 shows the plots for the relation between G‡ and E at three different temperatures: 50, 0, and −50� C. At the lower temperature (−50� C), the curve flattens quickly, and E value of 100 requires G‡ = 2047 cal mol−1 , less than those of 2506 (at 0� C) and 2965 cal mol−1 (at 50� C), and thus a small difference in transition-state energy (G‡ ) between the enantiomers gives a large effect on the enantioselectivity. Thus, lowering the temperature increases the
ΔΔG‡ = –RT In E
–ΔΔG‡ (cal mol–1)
3500 3000
2965
2500
2506
2000
2047 cal mol–1
1500
1000 500 0
0
20
40 60 E (= kA/kB)
80
100
Figure 1: Relation between G and E value.
24
Takashi Sakai
enantioselectivity if the temperature-induced change of G‡ were small between the temperatures. From the transition-state theory the reaction rate is represented by Equa tion 3, where NA is Avogadro number and h is Plank’s constant: � � RT −G‡ k= exp (3) NA h RT Equation 3 is transformed to Equation 5 by combination with Equation 4: G‡ = H ‡ − TS ‡ H ‡ ln k = R
(4)
� � 1 RT S ‡ + ln + T NA h R
(5)
The relation between ln k and 1/T for the reaction in Scheme 1 is shown in Fig. 2, where H ‡ and S ‡ for faster (A)- and slower (B)-enantiomers are tentatively estimated to be H ‡ = 4 kcal mol−1 , S ‡ = 47 cal deg−1 mol−1 and H ‡ = 7 kcal mol−1 , S ‡ = 9 cal deg−1 mol−1 , respectively, on the basis of the observed data of H ‡ (−3 kcal mol−1 ) and S ‡ (−43 cal deg−1 mol−1 ) which are calculated below (Figs 4 and 5). Figure 2 shows that lowering the temperature (1/T ) decreases both rates (ln kA and ln kB ) by following nearly straight lines, respectively, because the contribution of the second term, lnRT/NA h, is negli gible. Therefore, lowering the temperature increases the difference in the reaction
35
Tr = 425°C
30
Ln k
25 A 20 B 15
10 0.001
0.002
0.003
0.004
0.005
0.006
1/T (K –1)
Figure 2: Relation between ln k and 1/T for faster-reacting and slower-reacting
enantiomers.
Temperature control of enantioselectivity
25
rates for both enantiomers. The temperature effect on the enantioselectivity is thus primarily governed by the difference of H ‡ in the first term of Equation 5. On the other hand, Fig. 2 shows that raising the temperature decreases the enantios electivity, giving racemic product at 425� C. The temperature is called racemic temperature (Tr ).6f Handling of the experimental data for the temperature effect and their theo retical consideration are described as follows. Temperature effect cannot be accu rately discussed by use of Equation 2 because G‡ itself is temperature dependent ‡ ‡ ‡ ‡ − Hslow and S ‡ = Sfast − Sslow : (Equation 6), where H ‡ = Hfast G‡ = H ‡ − TS ‡
(6)
Combination of Equations 2 and 6 gives the Eyring equation 7: H ‡ ln E = R
� � 1 S ‡ + T R
(7)
Figure 3 shows the plot between temperature (T ) and observed enantioselec tivity (E value) for the reaction in Scheme 1. Lowering the temperature suddenly increases the E value until −40� C. The temperature effect can also be represented by the relation between ln E and 1/T as shown in Fig. 4, where ln E is increased linearly from 30 to −40� C to reach the best E value of 99. In contrast, further lowering the temperature rather decreases the E value by following another line. Therefore, the plot consists of two lines intersecting at −40� C, and this temperature is called “inversion temperature” (Tinv ).18−20 The linear correlation suggests that the conformation of lipase is maintained in a course of the observed temperature range. At Tinv (−40� C), the transition-state structure may be changed for some rea sons: a temperature-induced structural change of enzyme and/or a solute–solvent 120 100
E
80 60 40 20 0 3.0
3.5
4.0 1/T (× 10–3, K –1)
4.5
5.0
Figure 3: Relation between observed E value and 1/T for the lipase-catalyzed reaction of (1) (Scheme 1).
26
Takashi Sakai
5
30
12
–23
°C
–40
Ln E
99 4
54
3
20
2
7.4
E
1 0 3.0
3.5
4.0 1/T (× 10–3, K –1)
4.5
5.0
Figure 4: Relation between ln E and 1/T for the lipase-catalyzed reaction of (1) (Scheme 1).
cluster change,18−20 and so on. The phenomena of Tinv are interesting and further study is required to reveal the reason. The temperature effect is theoretically broadened until 1/T = 0 as shown in Fig. 5, and the line is extrapolated to give the value of S ‡ (ln E = S ‡ /R). From the slope of the line, the value of H ‡ is calculated (H ‡ = −30 kcal mol−1 , S ‡ = −43 cal deg−1 mol−1 ). By this line, raising the tempera ture decreases the E value to reach the racemic temperature (Tr ); however, further raising the temperature begins to increase the E value again toward opposite R/S
Tr = 426
6.0
–40 –70°C
30
5.0 4.0
Ln E
(R)
3.0 2.0
(a)
1.0
(b)
0.0
E=1
–1.0
(S)
–2.0
–3.0 –4.0 0.0
1.0
2.0
3.0
4.0
5.0
1/T (× 10–3, K –1)
Figure 5: Broad range of relation between ln E and 1/T for the lipase-catalyzed
reaction of (1) (Scheme 1).
Temperature control of enantioselectivity
27
selectivity. Tr can be calculated to be 425 � C by Equation 8, which is derived from Equation 6 (G‡ = 0). Usually the observable temperature effect is enthalpydriven like this. On the other hand, in an entropy-driven reaction having a large S ‡ (line a) or a small H ‡ (line b), Tr is observable in a range of lower temperatures. If the Tr is observed at 30 � C, E value is increased by both lowering and raising the temperature from 30 � C, but to opposite R/S enantiomers. H ‡ Tr = S ‡
(8)
Example of the entropy-driven reaction is rare for enzymatic reaction. One example in which Tr appeared at around room temperature in the enantioselective oxidation of secondary alcohols with secondary alcohol dehydrogenase (SADH) from a thermophilic bacterium, Thermoanaerobactor ethanolicus is shown in Fig. 6.6f The reaction of 2-butanol gave an oxidation product together with a remaining optically active alcohol, showing a linear temperature effect log E 6f − 1/T having Tr at 26 � C. Thus, raising or lowering the temperature from 26 � C increases the R or S selectivity of the remaining alcohol, respectively. However, OH R R
Thermoanaerobactor ethanolicus
OH
R = C2H5
O R
R = C3H7 R = C4H9
S R Tr (70°C)
Tr (26°C)
1.0 R 0.5
Log E
0.0 –0.5 –1.0 S
Tr (260°C)
–1.5 –2.0 –2.5 2.8
3.0
3.2 1/T (× 10–3, K –1)
3.4
3.6
Figure 6: Enantioselective oxidation of secondary alcohols with secondary alcohol dehydrogenase (SADH), from a thermophilic bacterium (log E is used in the original paper).
28
Takashi Sakai
a similar reaction with 2-pentanol raised the Tr to 70 � C, and that with 2-hexanol further raised the Tr to 260 � C. These results suggest that the chain length changes the structure of the rate-determining step.
4. GENERAL APPLICABILITY OF THE “LOW-TEMPERATURE METHOD” EXAMINED 4.1. Application to solketal and other primary and secondary alcohols The “low-temperature method” has been applied to some primary and sec ondary alcohols (Fig. 7).2b For example, solketal, 2,2-dimethyl-1,3-dioxolane-4 methanol21 (3) had been known to show low enantioselectivity in the lipasecatalyzed resolution (lipase AK, Pseudomonas fluorescens; E = 16 at 23� C, 27 at 0� C);21a however, the E value was successfully raised up to 55 by lowering the temperature to −40� C (Table 1). Further lowering the temperature rather decreased the E value and the rate was markedly retarded. Interestingly, the loss of the enan tioselectivity below −40� C is not caused by the irreversible structural damage of lipase because the lipase once cooled below −40� C could be reused by allowing it to warm higher than −40� C, showing that the lipase does not lose conformational flexibility at such low temperatures. Similar temperature effect using other racemic alcohols such as 2-hydroxy methyl-1,4-benzodioxane (4), 2-phenylpropanol (5), and 1-cyclohexylethanol (6) was also observed as shown in Fig. 8, obeying Equation 7. These results suggest that the temperature effect is widely applicable regardless of primary or secondary alcohols and an origin of lipase. The thermodynamic parameters (H ‡ and S ‡ ) and the racemic tem peratures Tr (H ‡ /S ‡ 56 estimated for these alcohols are shown in Table 2. The results indicate that the enantioselectivity in all of these reactions is gov erned by the activation-enthalpy differences (H ‡ ), which originates from the difference in the steric and electronic interactions operating between the fasterand slower-reacting enantiomers in the transition state. The higher enantioselec tivity for secondary alcohol 6 comes from the larger negative H ‡ , and the low selectivity for 5 depends on the smaller ones. The negative values of H ‡ are compensated by the negative values of S ‡ in all cases.
OH OH
Ph 1
O
O
N
O 3
OH
O 4
OH
OH
Ph 5
6
Figure 7: Substrates for the lipase-catalyzed resolutions at low temperatures.
Temperature control of enantioselectivity
29
Table 1 Temperature effect in the lipase-catalyzed kinetic resolution of solketal
Entry Temp. (� C) Lipase (mg) Time (h) Ester (% ee) Alcohol (% ee) Conv.b
E
1 2 3 4 5 6 7 8
9 20 26 31 39 55 27 44
30 0 −10 −20 −30 −40 −50 −60
20 20 60 60 100 200c 200c 200c
3 6 8 11 16 24 48 48
63 88 84 92 93 93 74 93
69 25 77 32 39 63 97 51
052 022 048 026 030 041 057 035
MW =ca. 33 000. Lipase (ca. 1% w/w) is absorbed on Celite.
Calculated from ee(s).
c TTN is ca. 3000 at 50% conversion.
a
b
13
8
–23
–40
–51
–73 (°C)
(E ) 6
403
1
Ln E
3 4 4
55 5 6 7.4
2
0
3
4 1/T (× 10–3, K –1)
5
Figure 8: Correlation between ln E and 1/T for the lipase-catalyzed resolution of 1, 3–6.
30
Takashi Sakai
Table 2
Thermodynamic parameters for the lipase-catalyzed resolutions (i-Pr 2 O, vinyl acetate)
Compound
Lipase
1 3 4 5 5 6
PSa AKb AK PS AK PS
a b
H ‡ (kcal mol−1 )
S ‡ (cal deg−1 mol−1 )
Tr (� C)
−301 ± 013 −353 ± 020 −224 ± 012 −113 ± 005 −074 ± 005 −373 ± 025
−431 ± 050 −718 ± 079 −135 ± 040 −177 ± 096 −151 ± 019 −302 ± 092
425 219 1386 365 217 962
With vinyl butyrate. In Et2 O.
4.2. Resolution of (±)-2-hydroxy-2-(pentafluorophenyl)acetonitrile The “low-temperature method” was then applied to the resolution of (±) 2-hydroxy-2-(pentafluorophenyl)acetonitrile (7) (Fig. 9),2c which is usable for the syntheses of a variety of ethane diols, amino alcohols containing C6 F5 groups as novel chiral ligands.22 After screening lipases such as Amano PS and AK, lipase LIP (Pseudomonas aeruginosa lipase immobilized on Hyflo Super-Cel, Toyobo,
F
CN
F
F OAc
OH
F F F
Lipase
F
AcOCH=CH2 i-Pr2O
F
(±)-7
F
CN
CN
F
F
OH
F F
F
F
(S)-8
(R)-7
7 (E = 1097)
Ln E
6 (403) 5 (148) 4 (55) 3 (20)
In E = –8.35 + 3.94 × 10–3 (1/T ) 3.2 (40)
3.4 (21)
3.6 (5)
3.8 (–10°C)
1/T ( × 10–3, K–1)
Figure 9: Correlation between ln E and 1/T in the lipase LIP-catalyzed transesterification of (±)-7.
Temperature control of enantioselectivity
31
Co., Ltd, Japan) was found to be the best choice (E = 113, 1.5 h, 44% conv. at 30� C). The E value was increased regularly by lowering the temperature to 0� C to reach > 427 (4.0 h, 44% conv.), which is a satisfactory and practical level. 4.3. Immobilization of lipase on porous ceramic support (Toyonite) for acceleration2d As described above, the temperature effect is useful for enhancing the enantiose lectivity; however, one problem is the decrease in the reaction rate. For example, although in a lipase AK-catalyzed resolution of solketal, the E value (9 at 30� C, Table 1, entry 1) is increased up to 55 by lowering the temperature to −40� C, 10 times the amount of lipase and 8-fold the reaction time are required as com pared with those at 30� C.2b Thus, the rate of acceleration is an important subject especially to make the low-temperature reaction practical. Acceleration of the reaction rate was attained by using an immobilized lipase on the porous ceramic support (Toyonite).23 The immobilized lipase PS is commercially available as lipase PS-C “Amano” II, which has (methacryloy loxy)propylsilanetrioxyl bridges on the ceramic surface, and lipases are immobi lized on the bridges.23 Immobilization of an enzyme is known to affect the enzyme conformation, rigidity, and aggregation state to alter the enantioselectivity and reactivity.24 As shown in Table 3, the use of the Toyonite-immobilized lipase AK accelerates the reaction from 11 000 (TTN/h, total turnover number per hour) for Celite-immobilized one to 53 000 at 30� C. Observed maximal acceleration is 80 times at −40� C in the case of entry 4 compared with that of entry 3. The great acceleration ability is significant for practical use,25−27 especially at low tempera tures. In an organic solvent, lipase molecules usually form aggregation structures, even on Celite, which reduce the activity, while on Toyonite lipases may be highly dispersed by immobilization with organic bridges on the porous ceramic to exert the inherent high activity.
Table 3
Toyonite-immobilized lipase-catalyzed resolution of solketal (±)-3 (vinyl butylate)
Entry
1 2 3 4
Lipase
AK AK PS PS
Organic bridge
Celite Toyonite Celite Toyonite
E
TTN/h
30� C
−40� C
30� C
−40� C
90 32 68 68
55 21 15 15
11 000 53 000 6400 110 000
110 1400 22 1700
32
Takashi Sakai
4.4. Structural optimization of organic bridges on Toyonite2d Structure of organic bridges attached on the support is also crucial for the conformational engineering of enzymes. The ability of organic bridges in the low-temperature reaction was then examined by using the substrate of 2-hydroxymethyl-1,4-benzodioxane 4 as shown in Table 4 and Fig. 10.2d Figure 10 shows that choice of organic bridges is crucially important both to accelerate the reaction and to enhance the enantioselectivity. As far as examined for 9a–i, termi nal olefin is not necessary, and carbonyl function is requisite. A small structural change of the bridges remarkably affects the temperature effect probably by the difference in a manner of hydrogen bonding between the bridge and functions of Table 4 Effect of organic bridges on the Toyonite-immobilized lipase-catalyzed resolution of (±)-4
Entry
1 2 3 4 5 6 7 8 9 10 11 a
Organic bridge
Nonea Noneb 9a 9b 9c 9d 9e 9f 9g 9h 9ic
E
TTN/h
30� C
−30� C
30� C
−30� C
18 19 8.6 10 6.6 7.9 4.8 11 6.8 5.9 –
33 31 18 17 9.3 .28 21 28 12 6.8 –
3100 5300 7300 14 000 14 000 8700 27 000 12 000 57 000 7200 –
26 52 130 280 230 280 840 100 940 61 –
Commercially available lipase PS immobilized on Celite.
Toyonite without organic bridges.
c Lipase could not be immobilized.
b
Temperature control of enantioselectivity 30
0
–20
3.5
–30
°C
9f 9d 9e 9a 9b
3.0
Ln E
33
2.5
9g 9c
2.0
9h
1.5 3.5
4.0 1/T (× 10–3, K–1)
Figure 10: Temperature effect on the Toyonite-immobilized lipase-catalyzed resolution of (±)-4 by varying the organic bridges.
lipase molecules. The bridge 9d was the best choice from the points of reaction efficiency and availability. 4.5. Practical resolution of azirine 1 by the “low-temperature method” combined with Toyonite-immobilized lipase and optimized acylating agent2e In the first attempt of the low-temperature method for azirine-2-methanol 1 using the Celite-immobilized lipase (Scheme 1), the E value was increased from 17 (30� C) up to 99 (−40� C); however, the TTN/h was decreased from 4700 to 210. On the other hand, use of Toyonite D-M-immobilized lipase28 in the reaction remarkably raised the TTN/h to 4200 at −40� C. In contrast, it lowered the E value to 33. Therefore, adjustment of the two conflicting features, the reaction rate and the enantioselectivity, is essential for the practical use of the low-temperature method. For this purpose, the acylating agents29 were screened and found to be highly effective on the E values. The results of the reactions carried out at −40� C are shown in Table 5.2e Elongation of the acyl chain to vinyl butanoate dramatically increased the E value up to 96, a comparable value in the Celite-immobilized lipase, together with a sufficient TTN/h of 3200. Further improvement was attained by using Toyonite 200M-immobilized lipase, which gave the highest E value (130) and TTN/h (7800) with vinyl butanoate at −40� C. These results indicate that the low-temperature method increases the enantio selectivity, at least above inversion temperature, and the enantioselectivity and reaction rate can be optimized by the use of Toyonite-immobilized lipase and a suitable acylating agent.
34
Takashi Sakai
Table 5 Toyonite-immoblized lipase-catalyzed resolution of ±-1 at −40� C
Entry
Acylating agents
Lipasea
E
TTN/h
A B B B B B B B B B C C D
99 34 96 54 102 35 40 44 71 7 130 77 68
210 4200 3200 1600 2000 1500 1500 1800 3600 5300 7800 8600 1500
R 1 2 3 4 5 6 7 8 9 10 11 12 13
CH3 CH3 CH3 CH2 2 CH3 CH2 4 CH3 CH2 4 CH3 CH2 6 CH3 CH2 8 CH3 CH2 10 PhCH2 CH2 CH2 Cl CH3 CH2 2 CH3 CH2 4 CH3 CH2 2
3a (1)b 3a (1) 3b (1) 3c (1) 3c (2) 3d (2) 3e (2) 3f (2) 3g (2) 3h (1) 3b (1) 3c (2) 3b (2)
a
A: Lipase PS on Celite; B: lipase PS immobilized on Toyonite D-M with 3 (methacryloyloxy)propylsilanetrioxy bridges; C: lipase PS immobilized on Toyonite 200M with 3-(methacryloyloxy)propylsilanetrioxy bridges; D: lipase PS immobilized on Toyonite 200 with 3-(propanoyloxy)hexylsilanetrioxy bridges. b Equivalent of acylation agent.
4.6. Resolution of (2R∗ 3S∗ )- and (2R∗ 3R∗ )-3-methyl-3-phenyl-2-aziridinemethanols2h The lipase-catalyzed resolution of (2R∗ ,3S ∗ )-3-methyl-3-phenyl-2-aziridine methanol (±)-11 by using the “low-temperature method” gave synthetically useful (2R,3S)-11 and its acetate (2S,3R)-11a with (2S)-selectivity (E = 55 at −40� C), while a similar reaction of (2R∗ ,3R∗ )-3-methyl-3-phenyl-2-aziridinemethanol (±) 12 gave (2S,3S)-12 and its acetate (2R,3R)-12a with (2R)-selectivity (E = 73 at −20� C) (Scheme 2). Compound (±)-11 was prepared conveniently via diastereos elective addition of MeMgBr to t-butyl 3-phenyl-2H-azirine-2-carboxylate, which was successfully prepared by the Neber reaction of oxime tosylate of t-butyl
Temperature control of enantioselectivity
1) CH3MgBr 2) LiAlH4
N Ph
OH (2S)selective (±)-11 (2R*,3S*)
(±)-10a
CO2t-Bu
CH3
Lipase PS-C ll
H
CH3
CO2t-Bu
N
H N
Ph
1) PhMgBr 2) LiAlH4
H N
CH3
OH
Ph
(±)-10b
Lipase PS-C ll
H
(2S)selective
(±)-12 (2R*,3S*)
35
H N
CH3
S
Ph
OAc + H
(2S,3R)-11a
H N
CH3 Ph
H
Ph CH3
H N
H
R
OH
(2R,3S)-11
OAc +
R
Ph CH3
H N OH S
H
(2S,3S)-12
(2R,3R)-12a
Scheme 2: Resolution of (2R∗ ,3S ∗ )- and (2R ,3R∗ )-3-methyl-3-phenyl-2-aziridinemethanols. ∗
benzoylacetate. As far as we know, a few examples of the lipase-catalyzed reac tion for such 2-aziridinemethanols having two stereogenic centers at - and carbons are known,30 and none of the reaction with aziridine derivatives without N -protection have been reported. As shown in Fig. 11, the reaction of 11 in ace tone gave higher enantioselectivity, and the best result (E = 55) was obtained at −40� C. However, further lowering the temperature to −50� C did not increase the E value. In contrast, the temperature modulation in THF increased the E value continuously to −60� C. The temperature effect for compound 12 in acetone is shown in Fig. 12. The inversion temperatures (Tinv ) for 11 and 12 are different in acetone.
25
0
–20 –30
–40
–50
–60 °C
E
Ln E
4
50 30
3
20 10
2
3.7
4.1 1/T (× 10–3, K–1)
4.5
Figure 11: Temperature effect in the lipase-catalyzed resolution of ±-11 (�: in acetone; •: in THF; �: in Et2 O).
36
Takashi Sakai 25
0
–20
–40
–50
°C
Ln E
4.5
E 73 67 61 54
4.0
3.5
30
3.6
4.0 1/T (× 10–3, K–1)
4.4
Figure 12: Temperature effect in the lipase-catalyzed resolution of (±)-12 in acetone.
4.7. Resolution of 5-(hydroxymethyl)-3-phenyl-2-isoxazoline2g Optically active 5-(hydroxymethyl)-3-phenyl-2-isoxazoline 13 is a versatile key intermediate for the syntheses of -hydroxy ketones,31 -amino alcohols,32 and -amino acids.33 However, the lipase-catalyzed kinetic resolution of isoxazoline (±)-13 has not been reported so far probably because of the low enantioselectivity expected for primary alcohols (Scheme 3). The enantioselectivity was found to be very low (E value = 4–5 in i-Pr 2 O) at room temperature; however, it could be markedly improved up to an E value of 249 at −60� C by using lipase PS-C II in acetone, which was the best solvent among those tested (THF, i-Pr 2 O) (Fig. 13). The temperature effect involving Tinv was markedly influenced by the solvent, acylating agent, and support. Tinv was not observed in the case with vinyl acetate below to −60� C. Lipase PS-C ll Organic solvent
N O OH
Ph
OCOR
N O Ph
(±)-13 30°C: E = 5 (i-Pr2O) –60°C: E = 249 (acetone)
H
N O O
R
+ Ph
H
OH
O (S)-13 (R)-14a: R = CH3 (R)-14b: R = (CH2)2CH3 (R)-14c: R = (CH2)2Ph
Scheme 3: Resolution of (±)-5-(hydroxymethyl)-3-phenyl-2-isoxazoline
((±)-13).
Temperature control of enantioselectivity
Ln E
0
–20
–40
–60
°C E
6.0
37
5.0
148
4.0
54
3.0
20
2.0
7.4
1.0 3.5
4.0
4.5 1/T (× 10–3, K–1)
5.0
Figure 13: Temperature effect in lipase PS-C II-catalyzed resolution of (±)-13 with vinyl acetate (•), vinyl butyrate (�), and vinyl 3-phenylpropanoate (�) in acetone. 4.8. Application of temperature control to asymmetric protonation8 The low-temperature method is effective not only in the kinetic resolution of alcohols but also in the enantioface-selective asymmetric protonation of enol acetate of 2-methylcyclohexanone (15) giving (R)-2-methylcyclohexanone (16).8 The reaction in H2 O at 30� C gave 28% ee (98% conv.), which was improved up to 77% ee (82% conv.) by the reaction using lipase PS-C II in i-Pr 2 O and ethanol at 0� C. Acceleration of the reaction with lipase PS-C II made this reaction possible because this reaction required a long reaction time. The temperature effect is shown in Fig. 14. The regular temperature effect was not observed. The protons may be supplied from H2 O, methanol, or ethanol, whose bulkiness is important. 4.9. Lipase-catalyzed resolutions at high temperatures up to 120� C Lipase Amano PS-C II was also found to be useful for a high-temperature reaction in the resolution of a bulky substrate, 1,1-diphenyl-2-propanol, which showed no reactivity under usual conditions with lipase PS.7 An enantiopure product was obtained at 40–120� C, and the highest conversion (39%) was obtained at 80–90� C. It is very interesting that a single enzyme is usable in the reaction at a very wide range of temperatures from −80� C to 120� C. 5. LOW-TEMPERATURE REACTIONS IN LITERATURES Recently, temperature control of enantioselectivity is actively studied,34−62 and many examples for the low-temperature reactions have been published. The typical examples for the synthetic purpose are summarized in Fig. 15. The E values of these are generally increased by lowering the temperature. Compound 29 is used
38
Takashi Sakai O
O
Lipase PS-C ll
O
ROH (10 equiv.), i-Pr2O R = H, Me, Et (R)-16
15 60
Ln E
2.5
0 –10 °C
30
%ee
2.0
76
1.5
64
1.0
46
0.5
24
0.0 2.5
3.5 3 1/T (× 10–3, K –1)
EtoH MeOH
4
Figure 14: Lipase-catalyzed enantioface-selective asymmetric protonation. in a media of supercritical CO2 . Compounds 36 are used for the kinetic resolution in the hydrolysis of nitrile and amide, and compound 37 is for the reaction in the hydrolytic ring opening of epoxide. Interestingly, some examples show rather negative temperature effect as shown in Fig. 16. The latter examples may be due to the entropy-driven reactions,6 and are also interesting. F BnO OH
H
H3C C
OTBS
H3C 1835
RT: E = 106 –5°C: E = 307
N 30°C: E = 88 CH3 15°C: E = 127
OH
2138
NH2 39
(In E–1/T graph)
22 40°C: E = 13 –20°C: E = 84
Ph
O
ONO2
1936
2037
40°C: E = 2 4°C: E = 100
22°C: E = 57 –18°C: E = 96
CO2Me O
OH CH3
H
OH
1734
OH
C C
OH O
OCOC3H7
N3 OH 40
23 70°C: E = 18 4°C: E = 72
2441 15°C: E = 18 –13°C: E = 26
Figure 15: Examples of the “low-temperature method.”
Temperature control of enantioselectivity
OH
OH
39
CH3 N O
OH
OH
OH
CO16H33O
N
2542
2643
2744
30°C: E = 40 0°C: E > 750
22°C: E = 17 4°C: E = 32
30°C: E = 18 10°C: E = 31
2845 40°C: E = 6.8 –15°C: E = 33.6
O
OH
Cl 2946 (In E–1/T graph in supercritical CO2)
H3C
OH
HO
OH
F3C
H3C Si H3C Ph
OH 3047
3148
RT: 35% ee 0°C: 49% ee
RT: 93% ee 4°C: >99% ee
OH O
CO2i-Bu
H3C
CO2H O
NH2
3350 25°C: E = 49 0°C: E = 66
3249
25°C: E = 118 0°C: E = 240
H3C
H3C
OH O
C2H5
3451 25°C: E = 14 0°C: E = 78
with LiCl
50°C: E = 12
10°C: E = 1300
3552
O
3653
X
X = CN, CONH2 (Rhodococcus sp. AJ270)
Cl
3754
27°C: E < 40
0°C: E < 100
(A. niger )
30°C: E = 23 20°C: E = 32
Figure 15: Continued.
OAc
CH2OH NHCO2tBu
H N
Bn
Ph O O
3855 60°C: E = 26 22°C: E = 2
3956 RT: E = 127 0°C: E = 13
4057 55°C: E = 130 28°C: E = 24
Ph
O O 4158 30°C: E = 107 4°C: E = 5.8
Figure 16: Temperature effect where lowering the temperature decreases the
enantioselectivity.
40
Takashi Sakai
6. LIPASE-CATALYZED RESOLUTION OF PRIMARY ALCOHOLS: PROMISING CANDIDATES FOR THE “LOW-TEMPERATURE METHOD” Examples of the lipase-catalyzed resolution of primary alcohols are listed in Fig. 17.63−126 They usually give low enantioselectivity because of mechanistic reasons, and no effective method for improving the enantioselectivity is avail able. One of the purposes of this book is to create new ideas and possibilities in this field. The “low-temperature method” is a promising one to improve the enantioselectivity of these alcohols.
Figure 17: Example of lipase-catalyzed resolution of primary alcohols [lit.].
Temperature control of enantioselectivity
Figure 17: Continued.
41
42
Takashi Sakai
Figure 17: Continued.
Temperature control of enantioselectivity
Figure 17: Continued.
43
44
Takashi Sakai
Figure 17: Continued.
Temperature control of enantioselectivity
45
Figure 17: Continued.
7. CONCLUSION Here, the temperature effect is discussed from the aspect of synthetic utility. Temperature control of enantioselectivity, i.e., the “low-temperature method”, is simple and now practically acceptable method. The phenomenon is based on the theory of physical organic chemistry and will be studied further for understanding the enzymatic reaction as organic reaction.
REFERENCES 1. (a) Drauz, K.; Waldmann, H. (Eds) Enzyme Catalysis in Organic Synthesis; Wiley-VCH: Weinheim, 2002. (b) Borncheuer, U. T.; Kazlauskas, R. J. Hydrolases in Organic Synthesis; Wiley-VCH: Weinheim, 2000 (1st edn) and 2006 (2nd edn). (c) Itoh, T.; Han, S.; Matsushita, Y.; Hayase, S. Green Chem. 2004, 6, 437–439. (d) Tsukada, Y.; Iwamoto, K.; Furutani, H.; Matsushita, Y.; Abe, Y.; Matsumoto, K.; Monda, K.; Hayase, S.; Kawatsura, M.; Itoh, T. Tetrahedron Lett. 2006, 47, 1801–1804 and the literatures cited therein. (e) Matsuda, T.; Harada, T.; Nakamura, K. Green Chem. 2004, 6, 440–444. (f) Matsuda, T.; Harada, T.; Nakamura, K. Curr. Org. Chem. 2005, 9, 299–315. (g) Matsuda, T.; Harada, T.; Nakamura, K.; Ikariya, T. Tetrahedron Asymm. 2005, 16, 909–915. Effect of temperature on hydrolytic enzyme in supercritical CO2 is also discussed. 2. (a) Sakai, T.; Kawabata, I.; Kishimoto, T.; Ema, T.; Utaka, M. J. Org. Chem. 1997, 62, 4906– 4907. (b) Sakai, T.; Kishimoto, I.; Ema, T.; Utaka, M. Tetrahedron Lett. 1998, 39, 7881–7884. (c) Sakai, T.; Miki, Y.; Tsuboi, M.; Takeuchi, H.; Ema, T.; Uneyama, K.; Utaka, M. J. Org. Chem. 2000, 65, 2740–2747. (d) Sakai, T.; Hayashi, K.; Yano, F.; Takami, M.; Ino, M.; Korenaga, T.; Ema, T. Bull. Chem. Soc. Jpn 2003, 76, 1441–1446. (e) Sakai, T.; Matsuda, A.; Korenaga, T.; Ema, T. Bull. Chem. Soc. Jpn 2003, 76, 1819–1821. (f) Mini Review: Sakai, T. Tetrahedron Asymm. 2004, 15, 2749–2756. (g) Sakai, T.; Mitsutomi, H.; Korenaga, T.; Ema, T. Tetrahedron Asymm. 2005, 16, 1535–1539. (h) Sakai, T.; Liu, Y.; Ohta, H.; Korenaga, T.; Ema, T. J. Org. Chem. 2005, 70, 1369–1375. 3. Talsky, G. Angew. Chem. Int. Ed. 1971, 10, 548. 4. (a) Lam, L. K. P.; Hui, R. A. H.; Jones, J. B. J. Org. Chem. 1986, 51, 2047–2050. (b) Keinan, E.; Hafeli, E. K.; Seth, K. K.; Lamed, R. J. Am. Chem. Soc. 1986, 108, 162–169. (c) Willaert, J. J.; Lemière, G. L.; Joris, L. A.; Lepoivre, J. A.; Alderweireldt, F. C. Bioorg. Chem. 1988, 16,
46
Takashi Sakai
5. 6.
7.
8.
9. 10.
11. 12. 13. 14. 15. 16. 17. 18. 19.
20. 21.
22.
223–231. (d) Parmar, V. S.; Prasad, A. K.; Singh, P. K.; Gupta, S. Tetrahedron Asymm. 1992, 3, 1395–1398. (e) Secundo, F.; Riva, S. R.; Carrea, G. Tetrahedron Asymm. 1992, 3, 267–280. (f) Yasufuku, Y.; Ueji, S. Biotechnol. Lett. 1995, 17, 1311–1316. (g) Kasche, V.; Galunsky, B.; Nurk, E.; Piotraschke, E.; Rieks, A. Biotech. Lett. 1996, 18, 455–460. (h) Galunsky, B.; Ignatova, S.; Kasche, V. Biochem. Biophys. Acta 1997, 1343, 130–138. (i) Miyazawa, T.; Minowa, H.; Miyamoto, T.; Imagawa, K.; Yanagihara, R.; Yamada, T. Tetrahedron Asymm. 1997, 8, 367–370. Holmberg, E.; Hult, K. Biotech. Lett. 1991, 13, 323–326. (a) Pham, V. T.; Phillips, R. S.; Ljungdahl, L. G. J. Am. Chem. Soc. 1989, 111, 1935–1936. (b) Pham, V. T.; Philips, R. S. J. Am. Chem. Soc. 1990, 112, 3629–3632. (c) Pig liver esterase: Andrade, M. A. C.; Andrade, F. A. C.; Phillip, R. S. Bioorg. Med. Chem. Lett. 1991, 1, 373– 376. (d) Phillip, R. S. Enzyme Microb. Technol. 1992, 14, 417–419. (e) Zheng, C.; Pham, V. T.; Phillips, R. S. Catal. Today 1994,22, 607–620. (f) Phillips, R. S. TIBTECH 1996, 14, 13–16. Lipase PS-C II-catalyzed resolution of a bulky substrate at high temperatures up to 120� C in organic solvent: (a) Ema, T.; Kageyama, M.; Korenaga, T.; Sakai, T. Tetrahedron Asymm. 2003, 14, 3943–3947. (b) Ema, T. Tetrahedron Asymm. 2004, 15, 2765–2770. (a) Review: Ema, T. Curr. Org. Chem. 2004, 8, 1009-1-25. (b) Rational design of lipase by site-directed mutagenesis on the basis of stereo-sensing mechanism for secondary alcohol: Ema, T.; Fujii, T.; Ozaki, M.; Korenaga, T.; Sakai, T. Chem. Commun. 2005, 4650–4651. Lipase PS-C II-catalyzed asymmetric protonation: Sakai, T.; Matsuda, A.; Korenaga, T.; Ema, T. Tetrahedron Asymm. 2004, 15, 1929–1932. Review: Padwa, A.; Woolhouse, A. D. In Comprehensive Heterocyclic Chemistry; Lowowski, W. (Ed.); Pergamon Press: Oxford; Vol. 7, Chapter 5, 1984, p. 47. Recent papers cited in Ref. 2a. Weissfloch, A. N. E.; Kazlauskas, R. J. J. Org. Chem. 1995, 60, 6959–6969. Chen, C.-S.; Fujimoto, Y.; Girdaukas, G.; Sih, C. J. J. Am. Chem. Soc. 1982,104, 7294–7299. Carrea, G.; Riva, S. Angew. Chem. Int. Ed. 2000, 39, 2226–2254. Overbeeke, P. L. A.; Jongejan, J. A.; Heijnen, J. J. Biotechnol. Bioeng. 2000, 70, 278–290. Theil, F. Tetrahedron 2000, 56, 2905–2919. Loughlin, W. A. Biores. Tech. 2000, 49–62. Sugai, T. Curr. Org. Chem. 1999, 3, 393–406. Cainelli, G.; de Matteis, V.; Galletti, P.; Giacomini, D. Chem. Commun. 2000, 2351–2352. Cainelli, G.; Galletti, P.; Giacomini, D.; Gualandi, A.; Quintavalla, A. Helv. Chim. Acta 2003, 86, 3548–3559. Variable-temperature 13 C NMR experiments show that the solute–solvent clustering effect manages the chemical and enzymatic enantioselectivity. Cainelli, G.; Galletti, P.; Pieraccini, S.; Quintavalla, A.; Giacomini, D.; Spada, G. P. Chirality 2004, 16, 50–56. (a) Vanttinen, E.; Kanerva, L. T. Tetrahedron Asymm. 1997, 6, 923–933. (b) Krief, A.; Provins, L.; Froidbise, A. Tetrahedron Lett. 1998, 39, 1437–1440. (c) Bianchi, D.; Bosetti, A.; Golini, P.; Cesti, P.; Pina, C. Tetrahedron Asymm. 1997, 8, 817–819. (d) Chenault, H. K.; Chafin, L. F.; Liehr, S. J. Org. Chem. 1998, 63, 4039–4045. Synthesis of optically pure 2-amino-1-alcohol,18a–c 1,2-diol,2c and 1,2-diamine2d involving pentafluorophenyl groups: (a) Sakai, T.; Kubo, K.; Kashino, S.; Uneyama, K. Tetrahedron Asymm. 1996, 7, 1883–1886. (b) Sakai, T.; Takayama, T.; Ohkawa, T.; Yoshio, O.; Ema, T.; Utaka, M. Tetrahedron Lett. 1997, 38, 1987–1990. (c) Sakai, T.; Miki, Y.; Nakatani, M.; Ema, T.; Uneyama, K.; Utaka, M. Tetrahedron Lett. 1998, 39, 5233–5236. (d) Korenaga, T.; Tanaka, H.; Ema, T.; Sakai, T. J. Fluorine Chem. 2003, 122, 201–205. (e) Sakai, T.; Korenaga, T.; Washio, N.; Nishio, Y.; Minami, S.; Ema, T. Bull. Chem. Soc. Jpn 2004, 77, 1001–1008. See also Ref. 2c.
Temperature control of enantioselectivity
F
F
F
F
F
F F
FF
F
F
F H2N
F F
F
F
F
F F
FF F
F HO OH (S,S)
F
F
F
F F
F
H2N
OH
OH
(1R,2S)
(1R,2S) chiral 2-amino alcohols F
F
F
F
FF F H 2N
OH
(1S,2R)
F
F
47
F
F F
FF F
F HO OH (R,R)
chiral 1,2-diols
23. Toyonite type 200 without organic bridges on the surface: a new type of spherical porous ceram ics support having 155 ± 5 m average diameter and 60 nm average sized pores. Yamashita, Y.; Kamori, M.; Takenaka, H.; Takahashi, J. Jpn. Kokai Tokkyo Koho, JP 09313179, 1997; US Patent 6004786. Commercially available Toyonite 200M is Toyonite 200 with 3-(2 methylpropenoyloxy)propylsilanetrioxyl groups attached on it. Lipase PS immobilized on Toy onite 200M is also available from Amano Pharmaceutical Co., Ltd, or Wako Pure Chemical Industries, Ltd, as Lipase PS-C “Amano” II. See also Ref.2c. 24. For current examples: (a) Palomo, J. M.; Fernández-Lorente, G.; Mateo, C.; Fuentes, M.; Fernández-Lorente, R.; Guisan, J. M. Tetrahedron Asymm. 2002, 13, 1337–1345. (b) Terreni, M.; Mateo, C.; Bastida, A.; Dalmases, P.; Hugust, L.; Guisan, J. M. Enzyme Microb. Technol. 2001, 28, 389. 25. Kamori, M.; Hori, T.; Yamashita, Y.; Hirose, Y.; Naoshima, Y. J. Mol. Catal. B Enzym. 2000, 9, 269–274. 26. Kato, K.; Gong, Y.; Saito, T.; Kimoto, H. J. Biosci. Bioeng. 2000, 90, 332. 27. Suzuki, M.; Nagasawa, C.; Sugai, T. Tetrahedron 2001, 57, 4841. 28. Toyonite D-M (porous ceramic support, Toyo Denka Kogyo Co. Ltd.) has 120 nm of mean pore size having 3-(2-methylpropenoyloxy)propylsilanetrioxyl bridges on the surface. 29. Recent reports for the enzymatic resolution with various acylating reagents: (a) Kawasaki, M.; Goto, M.; Kawabata,S.; Kodama, T.; Kometani, T. Tetrahedron Lett. 1999, 40, 5223–5226. (b) Hirose, K.; Naka, H.; Yano, M.; Ohashi, S.; Naemura, K.; Tobe, Y. Tetrahedron Asymm. 2000, 11, 1199–1215. (c) Kita, Y.; Takebe, Y.; Murata, K.; Naka, T.; Akai, S. J. Org. Chem. 2000, 65, 83–88. (d) Ottosson, J.; Hult, K. J. Mol. Catal. B Enzym. 2001, 11, 1025. (e) Reaction in ionic solvent: Itoh, T.; Akasaki, E.; Nishimura, Y. Chem. Lett. 2002, 154–155. (f) Akai, S.; Naka, T.; Fujita, T.; Takebe, Y.; Tsujino, T.; Kita, Y. J. Org. Chem. 2002, 67, 411–419. 30. (a) Fuji, K.; Kawabata, T.; Kiryu, Y.; Sugiura, Y. Tetrahedron Lett. 1990, 31, 6663–6666. (b) Davoli, P.; Prati, F. Heterocycles 2000, 53, 2379–2389. (c) Davoli, P.; Caselli, E.; Bucciarelli, M.; Forni, A.; Torre, G.; Prati, F. J. Chem. Soc. Perkin Trans. I 2002, 1948–1953. 31. Lee, J. Y.; Kim, B. H. Tetrahedron Lett. 1992, 33, 2557–2560. 32. Jaëger, V.; Buss, V.; Schwab, W. Tetrahedron Lett. 1978, 19, 3133–3136. 33. Minter, A. R.; Fuller, A. A.; Mapp, A. K. J. Am. Chem. Soc. 2003, 125, 6846–6847. 34. Aoyagi, Y.; Saitoh, Y.; Ueno, T.; Horiguchi, M.; Takeya, K. J. Org. Chem. 2003, 68, 6899–6904.
48
Takashi Sakai
35. de Gonzalo, G.; Brieva, R.; Sánchez, V. M.; Bayod, M.; Gotor, V. J. Org. Chem. 2001, 66, 8947–8953. 36. Cipiciani, A.; Bellezza, F. J. Mol. Catal. B Enzym. 2002, 17, 261–266. 37. Pchelka, B. K.; Loupy, A.; Plenkiewicz, J.; Petit, A.; Blanco, L. Tetrahedron Asymm. 2001, 12, 2109–2119. 38. Miyazawa, T.; Yukawa, T.; Koshiba, T.; Sakamoto, H.; Ueji, S.; Yanagihara, R.; Yamada, T. Tetrahedron Asymm. 2001, 12, 1595–1602. 39. López-Serrano, P.; Wegman, M. A.; van Rantwijk, F.; Sheladon, R. A. Tetrahedron Asymm. 2001, 12, 235–240. 40. Pchelka, B. K.; Loupy, A.; Plenkiewicz, J.; Blanco, L. Tetrahedron Asymm. 2000, 11, 2719–2732. 41. Secundo, F.; Oppizzi, M. L.; Carrea, G.; De Amici, M.; Dallanoce, C. Biocatal. Biotrans. 1999, 17, 241–250. 42. Baczko, K.; Larpent, C. J. Chem. Soc. Perkin Trans. II 2000, 521–526. 43. Haraldsson, G. G.; Thordarson, P.; Halldorsson, A.; Kristinsson, B. Tetrahedron Asymm. 1999, 10, 3671–3674. 44. Kawasaki, M.; Goto, M.; Kawabata, S.; Kodama, T.; Kometani, T. Tetrahedron Lett. 1999, 40, 5223–5226. 45. Avdagi´ c, A.; Lazac, A.; Majer, Z.; Hollòsi, M.; Šunji´c, V. Helv. Chem. Acta 1998, 81, 1567–1583. 46. Matsuda, T.; Kanamaru, R.; Watanabe, K.; Kamitanaka, T.; Harada, T.; Nakamura, K. Tetra hedron Asymm. 2003, 14, 2087–2091. 47. Arai, N.; Chikaraishi, N.; Ikawa, M.; Omura, S.; Kuwajima, I. Tetrahedron Asymm. 2004, 15, 733–741. 48. Ghorpade, S. R.; Kharul, R. K.; Joshi, R. R.; Kalkote, U. R.; Ravindranathan, T. Tetrahedron Asymm. 2004, 15, 733–741. 49. Kawamnami, Y.; Itoh, K. Chem. Lett. 2005, 34, 682–683. 50. Miyazawa, T.; Kaito, E.; Yukawa, T.; Murashima, T.; Yamada, T. J. Mol. Catal. B Enzym. 2005, 37, 63–67. 51. Miyazawa, T.; Imagawa, K.; Minowa, H.; Miyamoto, T.; Yamada, T. Tetrahedron 2005, 61, 10254–10261. 52. Okamoto, T.; Yasuhito, E.; Ueji, S. Org. Biomol. Chem. 2006, 4, 1147–1153. 53. Wang, M.-X.; Feng, G.-Q. J. Mol. Catal. B Enzym. 2002, 18, 267–272. 54. Manoj, K. M.; Archelas, A.; Baratti, J.; Furstoss, R. Tetrahedron 2001, 57, 695–701. 55. Cipiciani, A.; Bellezza, F.; Fringuelli, F.; Silvestrini, M. G. Tetrahedron Asymm. 2001, 12, 2277–2281. 56. Cainelli, G.; Marreis, V. D.; Galletti, P.; Orioli, P. Chem. Commun. 2000, 2351–2352. 57. Kaman, J.; Van der Eycken, J.; Peter, A.; Fulop, F. Tetrahedron Asymm. 2001, 12, 625–631. 58. Goto, M.; Kawasaki, M.; Kometani, T. J. Mol. Catal. B Enzym. 2000, 9, 245–250. 59. Galunsky, B.; Ignatova, S.; Kasche, V. Biochim. Biophys. Acta 1997, 1434, 130–138. 60. Overbeeke, A.; Ottosson, J.; Hult, K.; Jongejan, J. A.; Duine, J. A. Biocatal. Biotrans. 1999, 17, 61–79. 61. Ljubovi´ c, E.; Elenkov, M.; Avdagic, A.; Šunji´c, V. Food Technol. Biotechnol. 1999, 37, 215–224. 62. Persson, M.; Costes, D.; Wehtje, E.; Adlercreutz, P. Enzyme Microb. Technol. 2002, 30, 916–923. 63. Fernández, S.; Brieva, R.; Rebolledo, F.; Gotor, V. J. Chem. Soc. Perkin Trans. I 1992, 2885–2890. 64. Ferraboschi, P.; Grisenti, P.; Manzocchi, A.; Santaniello, E. J. Org. Chem. 1990, 55, 6214–6216. 65. Cambou, B.; Klibanov, A. M. J. Am. Chem. Soc. 1984, 106, 2687–2692.
Temperature control of enantioselectivity
49
66. Francalanci, F.; Cesti, P.; Cabri, W.; Bianchi, D.; Martinengo, T.; Foà, M. J. Org. Chem. 1987, 52, 5079–5082. 67. Terao, Y.; Tsuji, K.; Murata, M.; Achiwa, K.; Nishio, T.; Watanabe, N.; Seto, K. Chem. Pharm. Bull. 1989,37, 1653. 68. Bianchi, D.; Cesti, P.; Battistel, E. J. Org. Chem. 1988, 53, 5531–5534. 69. (a) Bianchi, D.; Cabri, W.; Cesti, P.; Francalanci, F.; Rama, F. Tetrahedron Lett. 1988, 29, 2455–2458. (b) Kanerva, L. T.; Vänttinen, E. Tetrahedron Asymm. 1993, 4, 85–90. 70. (a) Ferraboschi, P.; Brembilla, D.; Grisenti, P.; Santaniello, E. J. Org. Chem. 1991, 56, 5478– 5480. (b) Ferraboschi, P.; Casati, S.; Grisenti, P.; Santaniello, E. Tetrahedron Asymm. 1993, 4, 9–12. 71. Bevinakatti, H. S.; Newadkar, R. V. Tetrahedron Asymm. 1993, 4, 773–776. 72. Egri, G.; Baitz-Gásc, E.; Poppe, L. Tetrahedron Asymm. 1996, 7, 1437–1448. 73. (a) Hof, R. P.; Kellogg, R. M. Tetrahedron Asymm. 1994, 5, 565–568; (b) Hof, R. P.; Kellogg, R. M. J. Chem. Soc. Perkin Trans. I 1996, 2051–2060. 74. Chen, S.-T.; Fang, J.-M. J. Org. Chem. 1997, 62, 4349–4357. 75. Peter, M.; Van der Eycken, J.; Bernáth, G.; Fülöp, F. Tetrahedron Asymm. 1998, 9, 2339–2347. 76. Pallavicini, M.; Valoti, E.; Villa, L.; Piccolo, O. J. Org. Chem. 1994, 59, 1751–1754. 77. (a) Antus, S.; Gottsegen, A.; Kajtár, J.; Kovács, T.; Tóth, T. S.; Wagner, H. Tetrahedron Asymm. 1993, 4, 339–344. (b) Ennis, M. D.; Old, D. W. Tetrahedron Lett. 1992, 33, 6283–6286. 78. Akita, H.; Umezawa, I.; Nozawa, M.; Nagumo, S. Tetrahedron Asymm. 1993, 4, 757–760. 79. Yokomatsu, T.; Nakabayashi, N.; Matsumoto, K.; Shibuya, S. Tetrahedron Asymm. 1995, 6, 3055–3062. 80. Herradón, B.; Cueto, S.; Morcuende, A.; Valverde, S. Tetrahedron Asymm. 1993, 4, 845–864. 81. Weidner, J.; Theil, F.; Kunath, A.; Schick, H. Liebigs Ann. Chem. 1991, 1301. 82. Khlebnikov, V.; Mori, K.; Terashima, K.; Tanaka, Y.; Sato, M. Chem. Pharm. Bull. 1995, 43, 1659–1662. 83. Tanimoto, H.; Oritani, T. Tetrahedron Asymm. 1996, 7, 1695–1704. 84. Johnson, C. R.; Xu, Y.; Nicolao, K. C.; Yang, Z.; Guy, R. K.; Dong, J. G.; Berova, N. Tetrahedron Lett. 1995, 36, 3291–3294. 85. (a) Laval, G.; Audran, G.; Sanchez, S.; Monti, H. Tetrahedron Asymm. 1999, 10, 1927–1933. (b) Laval, G.; Cadillio, G.; Monti, H.; Tolomelli, A.; Audran, G.; Galano, J.-M. Tetrahedron Asymm. 2000, 11, 1289–1294. 86. Hyatt, J. A.; Skelton, C. Tetrahedron Asymm. 1997, 8, 523–526. 87. Mizuguti, E.; Suzuki, T.; Achiwa, K. Synlett 1994, 929–930. 88. Kámán, J.; Forró, E.; Fülöp, F. Tetrahedron Asymm. 2000, 11, 1593–1600. 89. Miyazawa, K.; Yufit, D. S.; Howard, J. A. K.; de Meijere, A. Eur. J. Org. Chem. 2000, 24, 4109–4117. 90. Wakamatsu, H.; Terao, Y. Chem. Pharm. Bull. 1996, 44, 261–263. 91. Nakano, H.; Okuyama, Y.; Iwasa, K.; Hongo, H. Tetrahedron Asymm. 1994, 5, 1155–1156. 92. Ayers, T. A.; Schnettler, R. A.; Marciniak, G.; Stewart, K. T.; Mishra, R. K.; Krysan, D. J.; Bernas, B. R.; Bhardwaj, P.; Fevig, T. L. Tetrahedron Asymm. 1997, 8, 45–55. 93. Mizuno, K.; Sakuda, S.; Nihira, T.; Yamada, Y. Tetrahedron 1994, 50, 10849–10858. 94. (a) Bracher, F.; Papke, T. Tetrahedron Asymm. 1994, 5, 1653–1656. (b) Nordin, O.; Heden ström, E.; Hgberg, H.-E. Tetrahedron Asymm. 1994, 5, 785–788. 95. Schieweck, F.; Altenbach, H.-J. Tetrahedron Asymm. 1998, 9, 403–406. 96. Lemaire, M.; Bolte, J. Tetrahedron Asymm. 1999, 10, 4755–4762. 97. Gais, H.-J.; von der Weiden, I. Tetrahedron Asymm. 1996, 7, 1253–1216. 98. Goj, O.; Burchardt, A.; Haufe, G. Tetrahedron Asymm. 1997, 8, 399–408. 99. Jiménez, O.; Bosch, M. P.; Guerrero, A. J. Org. Chem. 1997, 62, 3496–3499. 100. Kiełbasi´nski, P.; Omela´nczuk, J.; Mikolajczyk, M. Tetrahedron Asymm. 2000, 11, 1313–1321. 101. Forró, E.; Árva, J.; Fülöp, F. Tetrahedron Asymm. 2001, 12, 643–649.
50
Takashi Sakai
102. Nodin, O.; Nguyen, B.-V.; Vörde, C.; Hedenström, E.; Högberg, H.-E. J. Chem. Soc. Perkin Trans. I 2000, 367–376. 103. Hof, R. P.; Kellogg, R. M. J. Org. Chem. 1996, 61, 3423–3427. 104. Rigby, J. H.; Sugathapala, P. Tetrahedron Lett. 1996, 37, 5293–5296. 105. Itoh, T.; Kawai, K.; Hayase, S.; Ohara, H. Tetrahedron Lett. 2003, 44, 4081–4084. 106. Kurokawa, M.; Shindo, T.; Suzuki, M.; Nakajima, N.; Ishihara, K.; Sugai, T. Tetrahedron Asymm. 2003, 14, 1323–1333. 107. Murakami, M.; Kamaya, H.; Kaneko, C.; Sato, M. Tetrahedron Asymm. 2003, 14, 201–215. 108. de Gonzalo, G.; Brieva, R.; Sánchez, V. M.; Bayod, M.; Gotor, V. J. Org. Chem. 2003, 68, 3333–3336. 109. Angoli, M.; Barilli, A.; Lesma, G. D.; Riva, S.; Silvani, A.; Danieli, B. J. Org. Chem. 2003, 68, 9525–9527. 110. Kiełbasi´nski, P.; Albrycht, M.; Luczak, J.; Mikolajczyk, M. Tetrahedron Asymm. 2002, 13, 735–738. 111. Bierstedt, A.; Stölting, J.; Fröhlich, R.; Metz, P. Tetrahedron Asymm. 2001, 12, 3399–3407. 112. de Gonzalo, G.; Brieva, R.; Sánchez, V. M.; Bayod, M.; Gotor, V. J. Org. Chem. 2001, 66, 8947–8953. 113. Forro, E.; Fulop, F. Tetrahedron Asymm. 2001, 12, 2351–2358. 114. Miyazawa, T.; Yukawa, T.; Koshiba, T.; Sakamoto, H.; Ueji, S.; Yanagihara, R.; Yamada, T. Tetrahedron Asymm. 2001, 12, 1595–1602. 115. Ferorelli, S.; Franchini, C.; Loiodice, F.; Perrone, M. G.; Scilimati, A.; Sinicropi, M. S.; Tortorella, P. Tetrahedron Asymm. 2001, 12, 853–862. 116. Olivo, H. F.; Velazquez, F.; Trevisan, H. C. Org. Lett. 2000, 2, 4055–4058. 117. Kawasaki, M.; Goto, M.; Kawabata, S.; Kometani, T. Tetrahedron Asymm. 2001, 12, 585–596. 118. Hamersak, Z.; Ljubovic, E.; Mercep, M.; Mesic, M.; Sunjic, V. Synthesis 2001, 1989–1992. 119. Akita, H.; Nozawa, M.; Mitsuda, A.; Ohsawa, H. Tetrahedron Asymm. 2000, 11, 1375–1388. 120. Ramadas, S.; Krupadanam, G. L. D. Tetrahedron Asymm. 2000, 11, 3375–3393. 121. Kawasaki, M.; Goto, M.; Kawabata, S.; Kodama, T.; Kometani, T. Tetrahedron Lett. 1999, 40, 5223–5226. 122. Majeri´c, M.; Šunji´c, V. Tetrahedron Asymm. 1996, 7, 815–824. 123. Nair, M. S. Anilkumar, A. T. Tetrahedron Asymm. 1996, 7, 511–514. 124. Naemura, K.; Fukuda, R.; Murata, M.; Konishi, M.; Hirose, K.; Tobe, Y. Tetrahedron Asymm. 1995, 6, 2385–2394. 125. Sankaranarayanan, S.; Sharma, A.; Kulkarni, B. A.; Chattopadhyay, S. J. Org. Chem. 1995, 60, 4251–4254. 126. Asensio, G.; Andreu, C.; Marco, J. A. Tetrahedron Lett. 1991, 32, 4197–4198.
Future Directions in Biocatalysis Edited by Tomoko Matsuda © 2007 Elsevier B.V. All rights reserved.
51
Chapter 3
Future directions in photosynthetic organisms-catalyzed reactions Kaoru Nakamura Institute for Chemical Research, Kyoto University, Uji, Kyoto, Japan
Abstract Present states and future directions of the use of photosynthetic microorganisms, especially microalgae, for biotransformation are discussed.
1. INTRODUCTION Heterotrophs such as fungus, bacteria, and yeasts have been used as biocatalysts for biotransformation of organic compounds to afford useful compounds such as chiral intermediates for medicines. On the contrary, autotrophs such as plant cell and microalgae are rare to be utilized for biotransformations, and investigation is necessary because they are environment-friendly catalysts: they absorb carbon dioxide to generate oxygen using solar energy. Among photosynthetic organisms, microalgae are expected to form a new group of biocatalysts because of the high growth rates compared to plant cells. In this chapter, reduction, oxidation, and hydroxylation using algae are introduced. Environmental remediation using algae is also explained.
2. REDUCTION REACTION The reduction of ketones, aldehydes, and olefins has been extensively explored using chemical and biological methods. As the latter method, reduction by heterotrophic microbes has been widely used for the synthesis of chiral alcohols. On the contrary, the use of autotrophic photosynthetic organisms such as plant cell and algae is relatively rare and has not been explored because the method for culti vation is different from that of heterotrophic microbes. Therefore, the investigation using photosynthetic organisms may lead to novel biotransformations. Indeed, recent research on the use of a cyanobacterium as a biocatalyst has opened up this area: asymmetric reduction of ketones by a cyanobacteria, Syne chococcus elongates PCC 7942, with the aid of light energy proceeded smoothly
52
Kaoru Nakamura
Figure 1: Reduction of ketones by cyanobacteria.
and afforded the corresponding (S-alcohols in excellent enantioselectivities1−3 (Fig. 1). Characteristics of the reduction reaction using cyanobacteria are as follows: (a) Biocatalyst/substrate (b/s) ratios are low: A large amount of biocatalyst is usually required to reduce a considerable amount of substrate (the b/s for baker’s yeast is about 50–350). On the contrary, a low b/s ratio (2.6–0.5) could be achieved using the cyanobacteria. The improvement in the b/s ratio is caused by the fact that the cyanobacterium can utilize the power of light effectively to reduce the substrate. (b) The reaction afforded high selectivity and wide substrate specificity: Ketones used in this report are reduced by the cyanobacterium with excellent enan tioselectivities (> 96% ee). An enzyme exhibiting high enantioselectivity usually shows a relatively strict substrate specificity; hence, there scarcely is a catalyst that reacts with many kinds of substrates and also shows high selectivities. This alga can reduce a wide variety of aryl methyl ketones and afford the corresponding alcohols with high enantioselectivities. (c) Light energy can be used for reduction: Reduction of substrates usually requires a large input of energy, and in microbial reductions, carbohydrates such as sugars have been used as the energy source. These carbohydrates are generated through photosynthesis with sunlight energy. In other words, we have been indirectly using light energy for asymmetric reduction in the heterotrophic organism-catalyzed reduction. However, in the bioreduction using microalgae, the reaction was promoted by the direct use of light energy. For the majority of redox enzymes, nicotinamide adenine dinucleotide [NAD(H)] and its respective phosphate [NADP(H)] are required. These cofactors are prohibitively expensive if used in stoichiometric amounts. Since it is only the oxidation state of the cofactor that changes during the reaction, it may be regen erated in situ by using a second redox reaction to allow it to re-enter the reaction cycle. Usually in the heterotrophic organism-catalyzed reduction, formate, glu cose, and simple alcohols such as ethanol and 2-propanol are used to transform the
Future directions in photosynthetic organisms-catalyzed reactions
53
oxidized form of the coenzyme to the reduced form. These reductants originally stem from bio-products of CO2 with phototrophs with the aid of sunlight. Phototrophs such as algae and plants capture light energy to generate NADPH from NADP+ through photosynthetic electron-transfer reactions. Sub sequently, CO2 is converted into sugar, generally using NADPH. The reducing power of NADPH generated through photosynthesis can also be used in the reduc tion of exogenous substrates such as unnatural ketones to yield useful optically active alcohols. Thus, cofactor-recycling is no problem when photosynthetic living cells are used as biocatalysts for reduction. Accordingly, we can use solar energy directly for bioconversion of artificial substrates.2 (d) The stereochemical course of the reduction is possibly changed by light con ditions: The reduction of ,-difluoroacetophenone by a cyanobacterium proceeded both under light and in the dark, and the poor enantioselectivities (20–30% ee) observed in the dark were improved by irradiation. Thus, the enantioselectivities increased according to the lightness (70% ee under light (1000 lux)). The use of DCMU, a photosynthetic inhibitor, decreased the enantioselectivity of the reduction even under light conditions. The stereochemical course of the reduction is controlled by illumination or by adding DCMU.3 (e) The microalgae is easily manipulated and has high growth rate: Photosynthetic plant cell cultures typically grow quite slowly. However, cyanobac teria grow much faster than plant cell cultures in spite of the fact that the algae are types of phototrophs. Thus, contamination with microbes during the cultivation of algae can be prevented, and sufficient amount for biotransformation can be obtained easily. (f) Ecological system: Algae have the ability to directly utilize sunlight and carbon dioxide for photosyn thesis. Due to this activity, cyanobacteria may help to solve a global environmental problem, the greenhouse effect, which increasingly threatens mankind at the begin ning of the 21st century. Other examples of microalgae-catalyzed reductions of carbonyl groups are summarized below and shown in Fig. 2: • Reduction of carbonyl groups: Terpene4 and aromatic56 aldehydes (100 ppm) were reduced by microalgae. In a series of chlorinated benzaldehyde, m- or p chlorobenzaldehyde reacted faster than the o-derivative.5 Due to toxicity, the substrate concentrations are difficult to increase. Asymmetric reductions of ketones by microalgae were reported. Thus, aliphatic7−9 and aromatic1−31011 ketones were reduced.
Figure 2: Examples of reduction and oxidation reactions.
Future directions in photosynthetic organisms-catalyzed reactions
55
• Reduction of carbon–carbon double bond: Microalgae easily reduce carbon– carbon double bonds in enone.12 Usually, the reduction of carbonyl group and carbon–carbon double bond proceeds concomitantly to afford the mixture of corresponding saturated ketone, saturated alcohol, and unsaturated alcohol because a whole cell of microalgae has two types of reductases to reduce carbonyl and olefinic groups. The use of isolated reductase, which reduces carbon–carbon double bond chemoselectively, can produce saturated ketones selectively. The future direction of reduction of carbonyl compounds is as follows: 1. Development of new reduction systems that reduce sterically hindered compounds: The reported examples of reduction of carbonyl compounds are usually for the substrates that can be easily reduced such as methyl ketones. Since the demand for reduction of various types of com pounds is increasing, investigation of new biocatalytic reductions is required. Photosynthetic organisms are not investigated yet, and they may have new type of enzymes, which can reduce sterically hindered compounds. 2. Development of a new system for biocatalysis by photosynthetic organ isms: Since most of the present reactors of biocatalysis are for heterotrophic microorganisms, their systems are not usable for the reaction by photosyn thetic organisms. Since they require light for growing, it is necessary to develop a new type of photobioreactor to utilize the light energy as reduction power efficiently. 3. Development of new methods for controlling reactions: Although many methods are already known in microbial reactions using heterotroph to control the reaction,13 little is known about the methods using photosynthetic organisms. In usual microbial reactions, three methods, screening of suitable microbes, screening of suitable substrates, and modifying the reaction conditions, have been used for controlling the reaction. These methods have to be modified to use for the reaction by photosynthetic organisms. For example, for the efficient screening of photosynthetic organisms, the formation of large culture stock is necessary.
3. OXIDATION AND HYDROXYLATION Microalgae were used for oxidation and hydroxylation of organic compounds (Fig. 3). For example, hydroxylation of (S)-limonene affords a mixture of cis and trans carveols.14 By hydroxylation and oxidation using Chlorella,15
56
Kaoru Nakamura
Figure 3: Oxidation, hydroxylation and degradation.
valencene, cheaply obtained from Valencia orange, was converted to the product nootkatone, which is the aroma of grapefruit and is used for cos metic and fiber manufactures. Bioconversion of hydrocortisone by Nostoc afforded the degradated ketone16 via oxidation. Oxidation of sulfur atom in thiaoleic acid was done by Chlorella.17 This reaction was catalyzed by oleoyl desaturase. However, in these reactions, over-degradated product is also formed, and it is necessary to develop methods to inhibit the unnecessary reaction to afford a single product in high chemical yield. Stereo- and regioselective reactions are also desired.
4. REMOVAL OF ORGANIC AND INORGANIC SUBSTANCES IN WASTEWATER The prudent disposal of large quantities of agricultural and domestic wastewaters is a major concern in our modern society. Raw wastewaters most often contain significant amounts of bioavailable organic substances such as phenols, endocrine
Future directions in photosynthetic organisms-catalyzed reactions
57
disrupters, and inorganic substances such as ammoniate, nitrate, and phosphate. To remove these substances, algae and microalgae were used.18 For example, inorganic substances such as ammonium,19 phosphorous,18 and arsenate20 compounds and organic substances such as nitro compounds,21 phenols including bisphenol-A,2223 and endocrine-disrupting chemicals24 were removed by using algae or microalgae. The problem of the investigation for removal of haz ardous compounds from wastewater is that the removal and degradation abilities are insufficient for practical use. The easiness of harvest of the biomass is also problematic. Future direction of this field is to develop a novel system for remedia tion: screening of powerful biocatalysts that degrade hazardous compounds rapidly and that can be easily harvested after degradation. The latter is necessary for removal of inorganic substances. Microalgae immobilized in a polymeric matrix or as attached algal communities (biofilm/periphyton) growing in shallow,25 artificial streams or on the surfaces of rotating biological contactors (RBC/biodiscs)26 are expected to be developed.
5. CONCLUSION At present, photosynthetic organisms are not generally used as biocatalysts for bioconversion of organic compounds except for bioremediation of pollutants in the environment, although they are environment-friendly catalysts, and they may contain unusual type of enzymes to establish new reactions. Development of bioreactors specially developed for photosynthetic organism-catalyzed reaction as well as finding effective photosynthetic organisms as a biocatalyst are required in the future.
REFERENCES 1. 2. 3. 4. 5. 6. 7. 8.
Nakamura, K.; Yamanaka, R.; Tohi, K.; Hamada, H. Tetrahedron Lett. 2000, 41, 6799–6802. Nakamura, K.; Yamanaka, R. J. Chem. Soc. Chem. Commun. 2002, 1782–1783. Nakamura, K.; Yamanaka, R. Tetrahedron Asymm. 2002, 13, 2529–2533. Noma, Y.; Takahashi, H.; Asakawa, Y. Phytochemistry 1991, 30, 1147. Hook, I. L.; Ryan, S.; Sheridan, H. Phytochemistry 1999, 51, 621–627. Noma, Y.; Okajima, Y.; Takahashi, H.; Asakawa, Y. Phytochemistry 1991, 30, 2969–2972. Fiorentino, A.; Pinto, G.; Pollio, A.; Previtera, L. Bioorg. Med. Chem. Lett. 1991, 1, 673–674. Utsukihara ,T.; Chai, W.; Kato, N.; Nakamura, K.; Horiuchi, C. A. J. Mol. Catal. B Enzym. 2004, 31, 19–24. 9. Yoshizako, F.; Kuramoto, T.; Nishimura, A.; Chubachi, M. J. Ferment. Bioeng. 1998, 85, 439–442. 10. Utsukihara, T.; Misumi, O.; Kato, N.; Kuroiwa, T.; Horiuchi, C. A. Tetrahedron Asymm. 2006, 17, 1179–1185. 11. Itoh, K.; Sakamaki, H.; Nakamura, K.; Horiuchi, C. A. Tetrahedron Asymm. 2005, 16, 1403–1408.
58
Kaoru Nakamura
12. Shimoda, K.; Hirata, T. J. Mol. Catal. B Enzym. 2000, 8, 255–264. 13. Nakamura, K.; Yamanaka, R.; Matsuda, T.; Harada, T. Tetrahedron Asymm. 2003, 14(18), 2659–2681. 14. Hamada, H.; Kondo, Y.; Ishihara, K.; Nakajima, N.; Hamada, H.; Kurihara, R.; Hirata, T. J Biosci. Bioeng. 2003, 96, 581–584. 15. Furusawa, M.; Hashimoto, T.; Noma, Y.; Asakawa, Y. Chem. Pharm. Bull. 2005, 53, 1513–1514. 16. Yazdi, M. T.; Arabi, H.; Faramarzi, M. A.; Ghasemi, Y.; Amini, M.; Shokravi, S.; Mohseni, F. A. Phytochemistry 2004, 65, 2205–2209. 17. Nugier-Chauvin, C.; Fauconnot, L.; Noiret, N.; Poulain, S.; Patin, H.; J. Mol. Catal. B Enzym. 1998, 5, 133–135. 18. Hoffmann, J. P. J. Phycol. 1998, 34, 757–763. 19. Talbot, P.; de la Noue, J. Water Res. 1993, 27, 153–159. 20. Murray, L. A.; Raab, A.; Marr, I. L.; Feldmann, J. Appl. Organometal. Chem. 2003, 17, 669–674. 21. Pavlostathis, S. G.; Jackson, G. H. Water Res. 2002, 36, 1699–1706. 22. Yang, S.; Wu, R. S. S.; Kong, R. Y. C. Aquatic Toxicol. 2002, 59, 191–200. 23. Hirooka, T.; Akiyama, Y.; Tsuji, N.; Nakamura, T.; Nagase, H.; Hirata, K.; Miyamoto, K. J. Biosci. Bioeng. 2003, 95, 200–203. 24. Sethunathan, N.; Megharaj, M.; Chen, Z. L.; Williams, B. D.; Lewis, G.; Naidu, R. J. Agric. Food Chem. 2004, 52, 3030–3035. 25. Li, X. Z.; Webb, J. S.; Kjelleberg, S.; Rosche, B. Appl. Environ. Microbiol. 2006, 72, 1639–1644. 26. Kargi, F.; Eker, S. Process Biochem. 2002, 37, 1201–1206.
Future Directions in Biocatalysis Edited by Tomoko Matsuda © 2007 Published by Elsevier B.V.
59
Chapter 4
Catalysis by enzyme–metal combinations Mahn-Joo Kim1 , Jaiwook Park1 , Yangsoo Ahn1 , Palakodety R. Krishna2 1
Department of Chemistry, Pohang University of Science and Technology, Pohang, Gyeongbuk, Korea 2 Discovery Laboratory, Organic Chemistry Division III, Indian Institute of Chemical Technology, Hyderabad, India
Abstract Catalytic transformation based on combined enzyme and metal catalysis is described as a new class of methodology for the synthesis of enantiopure compounds. This approach is particularly useful for dynamic kinetic resolution in which enzymatic resolution is coupled with metal-catalyzed racemization for the conversion of a racemic substrate to a single enantiomeric product.
1. INTRODUCTION The search for new and efficient methods for the synthesis of optically pure compounds has been an active area of research.1 The ever-growing market for the “chiral drugs,” especially after the understanding of the causes of Thalidomide Tragedy in 1960s, has put tremendous burden on chemists in discovering new methods and transforming these methods into technologies for the synthesis of single enantiomer drugs by economically viable processes. Traditionally, kinetic resolution (KR) of a racemate is still one of the major methods adopted for the production of the required enantiomer on the industrial front.23 However, this practice is often associated with the problem of either discarding unwanted isomer or recycling it at high costs. Reverting to asymmetric processes in which achiral starting materials are converted to chiral non-racemic products is still an attractive proposition. Consequently, efforts have been directed at discovering such asymmetric reactions/methods or catalytic reagents ideally suited for the production of single enantiomers in good yields and purities. The novel phenomenon of converting racemic substrates into a single enan tiomer of the product by dynamic kinetic resolution (DKR) via racemization of the substrates has been a formidable challenge in asymmetric synthesis.4 Recently, DKR has been receiving increasing attention since it can overcome the limitations
60
Mahn-Joo Kim et al.
of the conventional KR. Particularly, the maximum yield of one stereoisomer of the product in DKR can reach 100% whereas the maximum yield of one stereoiso mer in KR cannot exceed 50%. Accordingly, DKR has been intensively studied as a better alternative for asymmetric synthesis. Attempts are being made to develop efficient catalysts for DKR. This chapter deals with recent developments in this area, in particular DKR by enzyme–metal combinations. Each successful DKR is exemplified with sev eral substrates and novel metal catalyst. Asymmetric transformations of achiral substrates via DKR of racemic intermediates also are described.
2. DYNAMIC KINETIC RESOLUTIONS BY ENZYME–METAL COMBINATIONS DKR requires two catalysts: one for resolution and one for racemization. We and others have developed a novel strategy using enzyme as the resolution catalyst and metal as the racemization catalyst as shown in Scheme 1.5 The R-selective DKR can be achieved by combining a R-selective enzyme with a proper metal catalyst and its counterpart by the combination of the metal catalyst with a S-selective enzyme. This strategy has been demonstrated to be applicable to the DKR of secondary alcohols, allylic esters, and primary amines. Among them, the DKR of secondary alcohols has been the most successful. 2.1. DKR of secondary alcohols The KR of secondary alcohols by some hydrolytic enzymes has been well known. The combinations of these hydrolytic enzymes with racemization catalysts have been explored as the catalysts for the efficient DKR of the secondary alcohols. Up to now, lipase and subtilisin have been employed, respectively, as the R- and S-selective resolution enzymes in combination with metal catalysts (Scheme 2).
X R1
R
EnzR
R2
Y R1
R R2
Metal X S R1
R2
Y
EnzS
S R1
R2
Scheme 1: DKR by enzyme–metal combination.
Catalysis by enzyme–metal combinations OH R1
R
R2
61
OCOR
Lipase RCO2R'
R1
R
R2
Metal OH S R1
R2
OCOR
Subtilisin
S
RCO2R'
R1
R2
Scheme 2: DKR of secondary alcohol. 2.1.1. (R)-selective DKR of secondary alcohols The use of metal catalysts with the hydrolytic enzymes in the DKR of simple secondary alcohols was investigated by several groups including our, Williams, and Bäckvall groups. In 1996, Williams et al. reported for the first time the use of a metal catalyst in the DKR of secondary alcohols.7 The DKR was performed on 1-phenylethanol with the combination of a lipase and a rhodium complex to result in the product albeit in low enantiomeric excess (80% ee). Later, Bäckvall et al. reported a significant improvement of the enantiomeric output by using a diruthenium complex 1 along with an immobilized and thermally stable lipase (Candida antarctica lipase B (CALB); trade name Novozym-435).10 A notable modification in this method was the use of p-chlorophenyl acetate (PCPA), which was found to be more compatible with the racemization catalyst than popular acyl donors such as vinyl and isopropenyl acetate. Thus, the DKR of 1-phenylethanol by this procedure resulted in optically pure (R--phenylethyl acetate in high yield (Table 1).10b However, the procedure has some drawbacks. First, it requires
Table 1 DKR of 1-phenylethanol with diruthenium complex 1 OH Ph
Acyl donor
Cl
CALB 1 Acyl donor
acetophenone
t-BuOH, 70°C
OAc Ph
ee (%)
Yield (%)
OAc
>99
50
OAc
>99
72
>99
100
OAc
62
Mahn-Joo Kim et al.
an elevated temperature (70 C) for the activation of the diruthenium catalyst. The high temperature is unacceptable for thermally less-stable enzymes. Second, a stoichiometric amount of acetophenone should be added as hydrogen mediator for inducing racemization and thus achieving high conversion yield. The absence of acetophenone usually costs 10–15% lowering in yield. Third, unreacted PCPA is often difficult to remove from the acylated products during work-up. To overcome these limitations, more efficient racemization catalyst should be developed, which is highly active at room temperature, compatible with readily available acyl donors such as vinyl and isopropenyl acetate, and does not require a hydrogen mediator for racemization.
Ph Ph
O
O H Ph Ph
Ph
Ph Ph Ru H Ru Ph CO OC CO CO
Cl Cl Ru Ru X Cl
Ru PPh 3 Cl PPh3
1
2
3: X = Cl 4: X = H
Later, in a modification to the above system, we reported the use of an indenylruthenium complex 2 as a racemization catalyst for the DKR of secondary alcohols, which does not require ketones but a weak base like triethylamine and molecular oxygen to be activated.11 The DKR with 2 in combination with immobilized Pseudomonas cepacia lipase (PCL, trade name, Lipase PS-C® ) was carried out at a lower temperature (60 C) and provided good yields and high optical purities (Table 2). This paved the way for the omission of ketones as
Table 2 DKR of secondary alcohols with indenyl ruthenium complex 2 OH R
R′
OAc
PCL 2 PCPA, Et3N, O2 60°C, 43 h
R
R′
R
R
ee (%)
Yield (%)
Ph 4-MeO-Ph 4-Br-Ph 1-Indanyl PhCH2
Me Me Me
96 99 99 82 97
86 82 98 88 60
Me
Catalysis by enzyme–metal combinations
63
Table 3 DKR of secondary alcohols with cymene-ruthenium catalyst 3 OH R
R Ph 4-MeO-Ph 4-Cl-Ph PhCH2
OAc
PCL 3 PCPA, Et3N
CH2Cl2, 40°C
R
ee (%)
Yield (%)
94 99 99 >99
95 93 93 85
hydrogen mediators for the racemization. However, we wanted that ideally the reaction should be carried out at ambient temperature. Towards that goal, soon after, we discovered a remarkable cymene-ruthenium catalyst 3 and its hydride form 4 as effective catalyst systems for a facile DKR of secondary alcohols at 40 C (Table 3). A noticeable feature of this catalyst system was that allylic alco hols12 also underwent facile DKR at room temperature to provide high yields of corresponding chiral acetates with excellent optical purities (Table 4). Addi tionally, even in ionic liquids such as [EMIm]BF4 and [BMIm]PF6 ([EMIm] = 1-ethyl-3-methylimidazolium, [BMIm] = 1-butyl-3-methylimidazolium),13 the
Table 4 DKR of allylic alcohols with cymene-ruthenium catalyst 4 OH R
R Ph 4-Cl-Ph 4-MeO-Ph 2-Furyl c-C6 H11 (CH3 3 C
OAc
PCL 4 PCPA, Et3N CH2Cl2, r.t.
R
ee (%)
Yield (%)
>99 99 99 99 95 >99
84 91 85 92 90 85
64
Mahn-Joo Kim et al.
Table 5 DKR of alcohols with cymene-ruthenium catalyst 3 in [BMIm]PF6 OH R
R′
OAc
PCL 3 R
CH3CO2CH2CF3, Et3N [BMIm]PF6, r.t.
R′
R
R
ee (%)
Yield (%)
Ph PhCHCH2 3-Me-Ph 4-Me-Ph 4-MeO-Ph 4-Cl-Ph 4-Br-Ph 1-Indanyl
Me Me Me Me Me Me Me
85 85 87 87 85 87 92 85
4-[CH3 CH(OH)]Ph
Me
3-[CH3 CH(OH)]Ph
Me
99 99 98 99 99 99 99 99 99 (de 99%) 99 (de 97%)
87 86
same efficacious DKR was retained for benzylic alcohols at room temperature. It was observed that the Ru-catalyzed racemization occurred more rapidly in ionic liquids compared to organic solvents. The added advantage of the use of ionic liquids has been the reusability of both the catalyst and the enzyme by a simple extraction of the products by ether (Table 5).14
Ph Y Ph Ph Ph Ru OC Cl OC
5: Y = NHCH(CH3)2 6: Y = Ph
In an effort directed at developing a racemization catalyst which works uniformly for all the substrates at room temperature, we designed and synthe sized a novel aminocyclopentadienyl ruthenium chloride complex 5.9 The DKR of aromatic as well as aliphatic alcohols could be conducted at room tempera ture. In case of aromatic alcohols, the substituent effects were found insignificant in the DKR; however, aromatic alcohols have comparatively faster conversion rates than their aliphatic counterparts. This is the first ever report of a catalyst
Catalysis by enzyme–metal combinations
65
Table 6 DKR of alcohols with aminocyclopentadienyl ruthenium complex OH R
CALB 5 or 6 Isopropenyl acetate tBuOK, Na2CO3 toluene, 25°C
R′
OAc R
R′
R
R
Catalyst
ee (%)
Yield (%)
Ph
Me
4-Cl-Ph
Me
4-MeO-Ph
Me
1-Indanyl 4-NO2 -Ph 4-CN-Ph c-C6 H11
Me Me Me
CH3 (CH2 4 CH2 =CH PhCH= (Ph)3 COCH2 Ph c-C6 H11
Me Me Me =CH2 CH= =CH2 CH=
5 6 5 6 5 6 5 6 6 5 6 5 5 5 5 5
>99 >99 >99 >99 >99 >99 95 >99 >99 >99 >99 91 98 99 81 >99
95 92 94 91 90 94 89 97 95 86c 98 89c 93 97 62 90
system that works efficiently at room temperature for the successful DKR of secondary alcohols. The resulting acylated products were obtained in high yields and high enantiomeric excess (Table 6). An additional feature is the use of iso propenyl acetate, which is readily available, more active than PCPA, and easily separable from the DKR mixtures.15 Although the mechanism of catalytic racem ization is not yet clear, according to our interpretation, it can be deduced that the amino group in 5 seems to play a crucial role in the racemization, though Bäckvall suggests a different pathway16 for a similar yet modified complex 6 that has no amino functionality. At the same time, Sheldon et al. reported a new catalyst system of [TosN(CH2 2 NH2 ]RuCl(p-cymene) and 2,2,6,6-tetramethyl-1 piperidinyloxy (TEMPO) for the DKR of alcohols17 but resulted in the conversion of 1-phenylethanol to its corresponding acetate with only 76% yield. The DKR of functionalized alcohols such as diols, hydroxy esters, hydroxy aldehydes, azido alcohols and hydroxy nitriles was also taken up as the synthetic utility of the products is very high; besides such a study will bring out the effect of multifunctional substrates under these reaction conditions to broaden the scope of DKR. Initially, the DKR of diols was achieved with diruthenium catalyst 1
66
Mahn-Joo Kim et al.
and CALB in the presence of PCPA to give the corresponding diacetates of (R R-configuration from the mixture of dl- and meso-isomers (Table 7).18 The DKRs of rigid benzylic diols with 1 gave better results in terms of diastereose lectivity compared to those of more flexible aliphatic diols, reflecting that lipase displays higher stereoselectivity towards benzylic diols than aliphatic diols. The DKRs of -, -, - and -hydroxy esters were also accomplished with PCL and 1 at 60–70 C.19 In the DKRs, the enantioselectivities were good in most cases though the yields were moderate. The use of H2 was necessary in the DKR of - and -hydroxy esters to suppress the formation of ketones (Tables 8–10). The DKRs of small functionalized alcohols such as 2-hydroxybutanoic acid, 2-hydroxypropanal, and 1,2-propanediol were carried out after the protection of the terminal groups with a bulky group (Tables 11 and 12) since the bulky pro tecting groups enhanced the enantioselectivity of the enzyme in the DKR.20 In the DKR of hydroxy acids, t-butyl group was found to be the best for carboxyl group protection. The trityl group was a proper choice for the protection of primary alcohols in diols such as 1,2-propanediol, 1,2-butanediol, and 1,3-butanediol.20 1,2-Benzenedimethanol was used for protecting the formyl groups of - and hydroxy aldehydes.20 High enantiomeric excesses (95% and higher) were obtained in the DKRs of the protected diols and hydroxy aldehydes. 2,6-Dimethyl-4 heptanol was used as a hydrogen source to suppress the formation of oxidized side products.
Table 7 DKR of diols with ruthenium complex CALB [Ru]
OH OH X
X CH2 CH2 CH2 CH2 CH2 CH2 =CH CH= 1,3-Ph 1,4-Ph 2,5-Pyr CH2 N(n-Bu)CH2
OAc OAc
OAc OAc +
X (R, R)
Acyl donor toluene
X meso
[Ru]
eea (%)
(R, R)/meso
Yield (%)
1 1 1 1 1 5 1 5 6 1 1
>99 >99 >97 >99 >99 >99 >99 >99 >99 >99 >96
86/14 38/62 90/10 74/26 98/2 99/1 98/2 98/2 99/1 100/0 89/11
63 90 63 43 76 95 77 94 90 78 64
Catalysis by enzyme–metal combinations
67
Table 8 DKR of -hydroxy esters PCL 1
OH R
OAc
PCPA cyclohexane, 60°C
CO2Me
R
CO2Me
R
ee (%)
Yield (%)
94 94 98 98 30 80
80 76 69 80 62 60
Ph 4-MeO-Ph 4-Br-Ph c-C6 H11 PhCH2 CH2 CH3 CH2 CH2 CH2
Table 9 DKR of -hydroxy esters PCL 1
OH R
CO2Me
OAc R
PCPA (CH3)3COCH3 60°C, 6 days
R Ph 4-MeO-Ph c-C6 H11 PhCH2
CO2Me
ee (%)
Yield (%)
95 99 70 96
76 74 82 80
Table 10 DKR of - and -hydroxy esters PCL 1
OH t-BuO2C
n
R
2 3 3
Me Me Et
n
R
OAc t-BuO2C
H2 PCPA, toluene
n
R
Equiv. of PCPA
Temp ( C)
eep (%)
Yield (%)
3.9 3 3
60 70 70
94 98 98
70 89 87
68
Mahn-Joo Kim et al.
Table 11 DKR of hydroxy acids, diols and hydroxy aldehydes O
PCL 1
OH
RO
O RO
PCPA toluene, 70°C
R Ph 4-MeO-Ph 4-Ph-Ph (CH3 3 C
OAc
ee (%)
Yield (%)
86 93 94 >99
88 91 92 88
Table 12 DKR of protected diols and hydroxy aldehydes by lipase-ruthenium combination PCL 1
OH R
n R′
OAc R
PCPA 2,6-dimethyl-4-heptanol toluene, 70°C
n
R′
R
n
R
eep (%)
(Ph)3 CO (Ph)3 CO (Ph)3 CO
1 1 2
Me Et Me
>99 99 95
96 91 97
0
Me
98
95
1
Me
96
90
O
Yield (%)
O O O
The DKRs of -azido alcohols19d and -hydroxy nitriles21a were also accom plished by employing 1 and CALB with PCPA as the acyl donor. The DKRs of -azido alcohols were performed at 60 C while those of -hydroxy nitriles required higher temperature (100 C) primarily to enhance the racemization rate. The optical purities of products were satisfactory in all cases. In the case of -hydroxy nitriles, dehydrogenation lowered the yield.
Catalysis by enzyme–metal combinations
69
2.1.2. (S)-Selective DKR of secondary alcohols The lipase-catalyzed DKRs provide only (R-products; to obtain (S-products, we needed a complementary (S-stereoselective enzyme. A survey of (S-selective enzymes compatible to use in DKR at room temperature revealed that subtilisin is a worthy candidate, but its commercial form was not applicable to DKR due to its low enzyme activity and instability. However, we succeeded in enhancing its activity by treating it with a surfactant before use. At room temperature DKR with subtilisin and ruthenium catalyst 5, trifluoroethyl butanoate was employed as an acylating agent and the (S-products were obtained in good yields and high optical purities (Table 13).22 The (S-selective DKR of alcohols with subtilisin was also possible in ionic liquid at room temperature (Table 14).14 In this case, the cymeneruthenium complex 3 was used as the racemization catalyst. In general, the optical purities of (S-esters were lower than those of (R-esters described in Table 5. 2.1.3. DKR of secondary alcohols by air-stable metal catalyst All the Ru-based racemization catalysts described earlier are air-sensitive and thus difficult to reuse. We found that a modified Ru complex 7 was air-stable and recyclable, in particular, in a polymer-supported form 8. The racemization of secondary alcohols with 7 took place equally well under both oxygen and argon atmospheres. The subsequent DKRs of several alcohols using 7 or 8 under aerobic
Table 13 DKR of secondary alcohols by subtilisin-ruthenium bicatalysisa OH R
R Ph 4-Cl-Ph 4-MeO-Ph c-C6 H11 PhCH2 PhCH2 CH2 CH3 (CH2 4 CH2 =CH PhCH= a
Isolated yields in parentheses.
Subtilisin 5 PrCO2CH2CF3
THF, 25°C
ee (%) 92 99 94 98 92 98 98 95
OCOPr R
Yielda (%) 95 92 93 80 77 80 77 90
(90) (91) (74) (76) (78) (67) (90)
70
Mahn-Joo Kim et al.
Table 14 DKR by subtilisin-ruthenium bicatalysis in [BMIm]PF6 Subtilisin-CLEC 3
OH R
R′
OCOPr R
n-PrCO2CH2CF3, Et3N [BMIm]PF6, r.t.
R′
R
R
ee (%)
Yield (%)
PhCH2 PhCH2 CH2 3-Me-Ph 4-Me-Ph 4-MeO-Ph 4-Cl-Ph 4-Br-Ph 1-Indanyl 4-[CH3 CH(OH)]Ph
Me Me Me Me Me Me Me
89 90 90 90 80 92 91 84 78
3-[CH3 CH(OH)]Ph
Me
97 97 85 85 99 87 82 86 86 (de 52%) 96 (de 63%)
Me
83
conditions at room temperature provided excellent yields with high optical purities (Table 15). Ph Y Ph Ph Ph Ru OC Cl OC
7: Y = OBn 8: Y = OCH2Ph-4-(CO2-Polymer)
2.1.4. DKR of esters The hydrolytic DKR of allyl esters has been studied as a DKR of esters. The first DKR was accomplished through Pd-catalyzed racemization and enzymatic hydrolysis of allylic acetates in a buffer solution.6 However, the DKR under these conditions was limited to cyclohexenyl acetates to give symmetrical palladiumallyl intermediates. Among them, 2-phenyl-2-cyclohexenyl acetate 9 was the only substrate to have been resolved with good results (81% yield, 96% ee). Ph AcO
Ps. fluorescence lipase PdCl2(MeCN)2 Phosphate buffer 37–40°C, 19d
9
Ph HO
Catalysis by enzyme–metal combinations
71
Table 15 DKR of secondary alcohols with air-stable ruthenium catalysts OH R
OAc
CALB 7 or 8
R′
R
Isopropenyl acetate, K3PO4 toluene, 25°C
R′
R
R
Catalyst
ee (%)
Yield (%)
Ph
Me
4-MeO-Ph
Me
4-Cl-Ph
Me
4-MeO-Ph 1-Indanyl 1-Naphthyl
Me
2-Naphthyl
Me
c-C6 H11
Me
CH3 (CH2 4 CH2
Me
7 8 7 8 7 8 7 7 7 8 7 8 7 8 7 8
>99 >99 >99 >99 >99 >99 >99 88 >99 >99 >99 >99 >99 >99 >99 >99
98 98 98 98 98 98 92 91 98 98 98 98 98 95 98 95
Me
We improved the DKR of allylic acetates significantly by replacing the enzymatic hydrolytic reaction with enzymatic transesterification reaction and employing Pd(0) as the racemizing catalyst in organic solvent (Scheme 3).23 Here, Pd-catalyzed racemization is usually accompanied by reductive elimination giving 1,3-dienes as byproducts. The side reaction was effectively suppressed by the addition of a chelating ligand 1,1 -bis(diphenylphosphino)ferrocene (dppf). The OAc R1
R R2
Lipase ROH
OH R1
Pd(0) OAc R1
S R2
Scheme 3: DKR of allylic acetates.
R2
72
Mahn-Joo Kim et al.
DKR reactions were performed with lipase and Pd(PPh3 4 in the presence of dppf and 2-propanol in THF. 2-Propanol was used as an acyl acceptor. Various acyclic allylic acetates were transformed to their corresponding allylic alcohols at room temperature in good yields and excellent optical purities (Table 16). 2.1.5. DKR of amines The DKR of amine is more challenging compared to that of secondary alcohol since no metal catalysts have been known for the efficient racemization of amine. Reetz et al. reported for the first time the DKR of amine, in which 1-phenylethylamine was resolved by the combination of lipase and palladium (Scheme 4). In this procedure, CALB and Pd/C were employed as the combo catalysts.8 However, the DKR required a very long reaction time (8 days) at 50–55 C and provided a poor isolated yield (60%). Recently, an improved procedure using Pd on alkaline earth salts as the racemization catalyst was reported by Jacobs et al.24 The DKR reactions were performed at 70 C for 24–72 h and 75–88% yields were obtained with 99% or greater enantiomeric excess.
Table 16 DKR of allylic acetates by lipase–palladium bicatalysis OAc R
CALB Pd(PPh3)4, dppf i-PrOH THF, r.t.
R
ee (%)
Ph 4-Cl-Ph 4-Me-Ph 2-Furyl 2-Naphthyl
98 97 98 >99 98
NH2 R1
R
R2
OH R
Yield (%) 83 77 81 87 70
NHCOR
Lipase RCO2R'
R1
R
R2
Pd NH2 R1
S
R2
Scheme 4: DKR of amine by lipase–Pd combinations.
Catalysis by enzyme–metal combinations NH2 R1
R
R2
NHCOR
Lipase RCO2R'
73
R1
R
R2
Ru NH2 R1
S
R2
Scheme 5: DKR of amine by lipase–Ru combinations. Recently, Bäckvall et al. reported that a p-methoxy derivative of diruthenium complex 1 racemizes benzyl amines at 90–100 C in toluene and the DKRs using it were achieved successfully (Scheme 5). More than ten benzylic amines were transformed to the corresponding amides with good yields and high ee.25
3. ASYMMETRIC TRANSFORMATIONS BY ENZYME–METAL COMBINATIONS The DKR processes for secondary alcohols and primary amines can be slightly modified for applications in the asymmetric transformations of ketones, enol esters, and ketoximes. The key point here is that racemization catalysts used in the DKR can also catalyze the hydrogenation of ketones, enol esters, and ketoximes. Thus, the DKR procedures need a reducing agent as additional additive to enable asymmetric transformations. 3.1. Asymmetric transformation of ketone The catalytic alcohol racemization with diruthenium catalyst 1 is based on the reversible transfer hydrogenation mechanism. Meanwhile, the problem of ketone formation in the DKR of secondary alcohols with 1 was identified due to the lib eration of molecular hydrogen. Then, we envisioned a novel asymmetric reductive acetylation of ketones to circumvent the problem of ketone formation (Scheme 6). A key factor of this process was the selection of hydrogen donors compatible with the DKR conditions. 2,6-Dimethyl-4-heptanol, which cannot be acylated by lipases, was chosen as a proper hydrogen donor.26 Asymmetric reductive acetylation of ketones was also possible under 1 atm hydrogen in ethyl acetate, which acted as acyl donor and solvent. Ethanol formation from ethyl acetate did not cause critical problem, and various ketones were successfully transformed into the corresponding chiral acetates (Table 17).26b However, reaction time (96 h) was unsatisfactory. Asymmetric reductive acetylation process was also applicable to acetox yaryl ketones.27 For example, m-acetoxyacetophenone 10 was transformed to
74
Mahn-Joo Kim et al.
OH R1 O R1
R2
R2
R
Ru
Lipase
[H]
AcOR
Ru
OAc R1
R2
OH R1
R2
S
Scheme 6: Asymmetric reductive acetylation of ketones. Table 17 Asymmetric reductive acetylation of ketones CALB 1
O R
R′
OAc R′
R
H2, EtOAc 70°C
R
R
ee (%)
Yield (%)
Ph 4-MeO-Ph 4-Cl-Ph 1-Indanyl -Tetralyl c-C6 H11 CH3 (CH2 4 CH2 PhCH2 CH2
Me Me Me
96 99 97 99 99 90 91 72
81 85 72 89 87 87 87 83
Me Me Me
(R-1-(3-hydroxyphenyl)ethyl acetate 11 under 1 atm H2 in 95% yield. The over all reaction seems to involve simple reduction and acyl migration reaction. In fact, however, it is the result of nine catalytic steps: two steps for rutheniumcatalyzed reductions, two steps for ruthenium-catalyzed racemization, two steps for ruthenium-catalyzed deacylations, and three steps for lipase-catalyzed acyla tions (Scheme 7). This process was applicable to a wide range of acyloxyphenyl ketones (Table 18). O OAc
Lipase 1
OAc OH
H2 10
11
Catalysis by enzyme–metal combinations
75
OH OAc
Ru O
OAc
OH OAc
OAc
OAc
H2 Ru
Ac-lipase Lipase
10 Lipase
Lipase
Lipase
Ac-lipase
Ac-lipase
Ac-lipase
O
OAc
OH OH
OH
OH
H2 Ru
Ac-lipase Lipase
11
Ru OH OH
Scheme 7: Multistep acyl transfer of m-acetoxyacetophenone. 3.2. Asymmetric transformation of enol ester After succeeding in the asymmetric reductive acylation of ketones, we ventured to see if enol acetates can be used as acyl donors and precursors of ketones at the same time through deacylation and keto–enol tautomerization (Scheme 8). The overall reaction thus corresponds to the asymmetric reduction of enol acetate. For example, 1-phenylvinyl acetate was transformed to (R-1-phenylethyl acetate by CALB and diruthenium complex 1 in the presence of 2,6-dimethyl-4-heptanol with 89% yield and 98% ee.26a Molecular hydrogen (1 atm) was almost equally effective for the transformation.26b A broad range of enol acetates were prepared from ketones and were successfully transformed into their corresponding (R-acetates under 1 atm H2 (Table 19). From unsymmetrical aliphatic ketones, enol acetates were obtained as the mixtures of regio- and geometrical isomers. Notably, however, the efficiency of the process was little affected by the isomeric composition of the enol acetates.
76
Mahn-Joo Kim et al.
Table 18 Asymmetric transformations of acyloxyphenyl ketones CALB 1
O RCOO
HO
H2 70°C
Substrate
Product
R OCOR
O
HO
RCOO
OCOR
O
ee (%)
Yield (%)
Me Pr
98 98
95 96
Me Pr
93 96
94 93
Me Pr
89 98
88 88
Me Pr
96 98
92 89
OH
RCOO
OCOR
O
RCOO
OH OCOR
O
RCOO
OCOR
HO
3.3. Asymmetric transformation of ketoxime The strategy for the asymmetric reductive acylation of ketones was extended to ketoximes (Scheme 9). The asymmetric reactions of ketoximes were performed with CALB and Pd/C in the presence of hydrogen, diisopropylethylamine, and ethyl acetate in toluene at 60 C for 5 days (Table 20).28 In comparison to the direct DKR of amines, the yields of chiral amides increased significantly. Diisopropy lethylamine was responsible for the increase in yields. However, the major factor would be the slow generation of amines, which maintains the amine concentration low enough to suppress side reactions including the reductive amination. Disap pointingly, this process is limited to benzylic amines. Additionally, low turnover frequencies also need to be overcome.
Catalysis by enzyme–metal combinations
77
OAc
OAc
R
R Lipase
Ac-lipase O
OH
Ru R
[H]
OH
Ru
R
R
Scheme 8: Asymmetric reduction of enol ester. Table 19 Asymmetric hydrogenation of enol acetates CALB 1
OAc R′
R
OAc
H2 or 2,6-dimethyl-4-heptanol
R
R′
R
R
ee (%)
Yield (%)
Ph 4-MeO-Ph 4-Cl-Ph 1-Indanyl c-C6 H11 PhCH2 PhCH2 CH2 CH3 (CH2 4 CH2
Me Me Me
98 98 97 99 99 79 94 91
89 80 91 87 94 90 92 95
Me Me Me Me
NH2 R1 NOH R1
R2
R1
R NHAc Lipase
Pd Pd
[H]
AcOR
NH2 R1
R1
S
Scheme 9: Asymmetric reductive acetylation of ketoxime.
R1
R2
78
Mahn-Joo Kim et al.
Table 20
Asymmetric reductive acetylation of ketoximes
N R
OH
CALB Pd/C
R′
NHAc R
H2, EtOAc (i-Pr)2NEt
toluene, 60°C
R′
R
R
ee (%)
Yield (%)
Ph 3-Me-Ph 4-Me-Ph 4-MeO-Ph Ph 1-Indanyl -Tetralyl 4-Chromanyl
Me Me Me Me Et
98 94 97 96 98 95 97 99
80 81 84 82 76 84 70 89
4. CONCLUSION This chapter dealt with catalysis by enzyme–metal combinations as the novel tool for the conversion of racemic substrates to single enantiomeric products. Despite the inherent complexity of enzyme–metal catalysis for ready access to enantiopure products, rapid progress has been made in the last few years. A wide range of substrates were converted into their respective enantiopure products under DKR and asymmetric transformation conditions. New metal catalyst systems compatible with enzymes were discovered and more importantly the transformations were achieved at ambient temperatures. The focus in future should be directed towards expanding the horizon of substrates and finding applications in the commercial manufacture of specific targets. New strategies for the development of recyclable catalyst systems are required for easy work-up procedures so that DKR becomes not only scalable but also an economically viable option and changes the way of manufacturing chiral molecules in future. It is heartening to note that a recent enantioselective synthesis of lamivudine (3TCTM , a known anti-HIV, was accom plished via DKR method.29
ACKNOWLEDGEMENTS We would like to thank Yoon Kyung Choi for her suggestions and corrections. Generous supports by KOSEF and KRF are also acknowledged.
Catalysis by enzyme–metal combinations
79
REFERENCES 1. Sheldon, R. A. Chirotechnology, Industrial Synthesis of Optically Active Compounds; Marcel Dekker: New York, 1993. 2. (a) Wong, C.-H.; Whitesides, G. M. Enzymes in Synthetic Organic Chemistry; Pergamon: Oxford, UK, 1994. (b) Koskinen, A. M. P.; Klibanov, A. M. Enzymatic Reactions in Organic Media; Blackie Academic & Professional: Glasgow, Scotland, 1996. (c) Faber, K. Biotransformations in Organic Chemistry, 3rd edn; Springer: Berlin, 1997. (d) Bornscheuer, U. T.; Kazlauskas, R. J. Hydrolases in Organic Synthesis; Wiley-VCH: Weilheim, 1999. (e) Deauz, K.; Waldmann, H. Enzyme Catalysis in Organic Synthesis: A Comprehensive Handbook, 2nd edn; Wiley-VCH: Weinheim; Vols I–III, 2002. 3. (a) Kim, M.-J.; Choi, G. –B.; Kim, H.-J. Tetrahedron Lett. 1995, 36, 6253. (b) Kim, M.-J.; Lim, I.-T. Synlett 1996, 2, 138. (c) Kim, M.-J.; Lim, I.-T.; Choi, G.-B.; Whang, S.-Y.; Ku, B.-C.; Choi, J.-Y. Bioorg. Med. Chem. Lett. 1996, 6, 71. (d) Kim, M.-J.; Lim, I.-T.; Kim, H.-J.; Wong, C.-H. Tetrahedron Asymm. 1997, 8, 1507. (e) Lee, D.; Kim, M.-J. Tetrahedron Lett. 1998, 39, 2163. (f) Chung, S.-K.; Chang, Y.-T.; Lee, E. J.; Shin, B.-G.; Kwon, Y.-U.; Kim, K.-C.; Lee, D.; Kim, M.-J. Bioorg. Med. Chem. Lett. 1998, 8, 1503. (g) Lee, D.; Kim, M.-J. Tetrahedron Lett. 1999, 39, 9039. (h) Lee, D.; Kim, M.-J. Org. Lett. 1999, 1, 925. (i) Im, A. S.; Cheong, C. S.; Lee, S. H. Bull. Korean Chem. Soc. 2003, 24, 1269. (j) Kang, H.-Y.; Ji, Y.; Yu, Y.-K.; Yu, J.-Y.; Lee, Y.; Lee, S.-J. Bull. Korean Chem. Soc. 2003, 24, 1819. 4. Ward, R. S. Tetrahedron Asymm. 1995, 6, 1475. 5. (a) Stürmer, R. Angew. Chem. Int. Ed. Engl. 1997, 36, 1173. (b) Azerad, R.; Buisson, D. Curr. Opin. Biotechnol. 2000, 11, 565. (c) Huerta, F. F.; Minidis, A. B. E.; Bäckvall, J.-E.Chem. Soc. Rev. 2001, 30, 321. (d) Kim, M.-J.; Ahn, Y.; Park, J. Curr. Opin. Biotechnol. 2002, 13, 578. (e) Pellissier, H.Tetrahedron 2004, 59, 8291. (f) Pámies, O.; Bäckvall, J.-E.Chem. Soc. Rev. 2003, 103, 3247. (g) Pámies, O.; Bäckvall, J.-E. Curr. Opin. Biotechnol. 2003, 14, 407. (h) Turner, N. J. Curr. Opin. Chem. Biol. 2004, 8, 114. 6. Allen, J. V.; Williams, J. M. J. Tetrahedron Lett. 1996, 37, 1859. 7. Dinh, P. M.; Howarth, J. A.; Hudnott, A. R.; Williams, J. M. J.; Harries, W. Tetrahedron Lett. 1996, 37, 7623. 8. Reetz, M. T.; Schimossek, K. Chimia 1996, 50, 668. 9. Choi, J. H.; Kim, Y. H.; Nam, S. H.; Shin, S. T.; Kim, M.-J.; Park, J. Angew. Chem. Int. Ed. Engl. 2002, 41, 2373. 10. (a) Larsson, A. L. E.; Persson, B. A.; Bäckvall, J.-E. Angew. Chem. Int. Ed. Engl. 1997, 36, 1211. (b) Persson, B. A.; Larsson, A. L. E.; Ray, M. L.; Bäckvall, J.-E. J. Am. Chem. Soc. 1999, 121, 1645. (c) Lee, H. K.; Ahn, Y. Bull. Korean Chem. Soc. 2004, 25, 1471. 11. Koh, J. H.; Jeong, H. M.; Kim, M.-J.; Park, J. Tetrahedron Lett. 1999, 40, 6281. 12. Lee, D.; Huh, E. A.; Kim, M.-J.; Jung, H. M.; Koh, J. H.; Park, J. Org. Lett. 2000, 2, 2377. 13. (a) Kim, K. W.; Song, B.; Choi, M. Y.; Kim, M.-J. Org. Lett. 2001, 3, 1507. (b) Lee, J. K.; Kim, M.-J. J. Org. Chem. 2002, 67, 6845. (c) Kim, M.-J.; Choi, M. Y.; Lee, J. K.; Ahn, Y. J. Mol. Catal. B Enzym. 2003, 26, 115. (d) Erbeldinger, M.; Mesiano, A. J.; Russel, A. Biotechnol. Prog. 2000, 16, 1129. (e) Lau, R. M.; van Rantwijk, F.; Seddon, K. R.; Sheldon, R. A. Org. Lett. 2000, 2, 4189. (f) Itoh, T.; Akasaki, E.; Kudo, K.; Shirakami, S. Chem. Lett. 2001, 262. (g) Schoefer, S. H.; Kraftzik, N.; Wasserscheid, P.; Kragl, U. Chem. Commun. 2001, 425. (h) Park, S.; Kazlauskas, R. J. Org. Chem. 2001, 66, 8395. 14. Kim, M.-J.; Kim, H. M.; Kim, D.; Ahn, Y.; Park, J. Green Chem. 2004, 6, 471. 15. Choi, J. H.; Choi, Y. K.; Kim, Y. H.; Park, E. S.; Kim, E. J.; Kim, M.-J.; Park, J. J. Org. Chem. 2004, 69, 1972. 16. (a) Csjernyik, G.; Bogár, K.; Bäckvall, J.-E. Tetrahedron Lett. 2004, 45, 6799. (b) Martin-Matute, B.; Edin, M.; Bogár, K.; Bäckvall, J.-E. Angew. Chem. Int. Ed. Engl.2004, 43, 6535.
80
Mahn-Joo Kim et al.
17. Dijksman, A.; Elzinga, J. M.; Li, Y. X.; Arends, W. C. E.; Sheldon, R. A. Tetrahedron Asymm. 2002, 13, 879. 18. Persson, B. A.; Huerta, F. F.; Bäckvall, J.-E. J. Org. Chem. 1999, 64, 5237. (b) Edin, M.; Bäckvall, J.-E. J. Org. Chem. 2003, 68, 2216. 19. (a) Huerta, F. F.; Laxmi, S. Y. R.; Bäckvall, J.-E. Org. Lett. 2002, 2, 1037. (b) Runmo, A. B. L.; Pámies, O.; Faber, K.; Bäckvall, J.-E. Tetrahedron Lett. 2002, 43, 2983. (c) Pámies, O.; Bäckvall, J.-E. J. Org. Chem. 2002, 67, 1261. (d) Pámies, O.; Bäckvall, J.-E. J. Org. Chem. 2001, 66, 4022. 20. Kim, M.-J.; Choi, Y. K.; Choi, M. Y.; Kim, M.; Park, J. J. Org. Chem. 2001, 66, 4736. 21. (a) Pámies, O.; Bäckvall, J.-E. Adv. Synth. Catal. 2001, 343, 726. (b) Pámies, O.; Bäckvall, J.-E. J. Org. Chem. 2002, 67, 9006. (c) Pámies, O.; Bäckvall, J.-E. J. Org. Chem. 2003, 68, 4815. 22. Kim, M.-J.; Chung, Y. I.; Choi, Y. K.; Lee, H. K.; Kim, D.; Park, J. J. Am. Chem. Soc. 2003, 125, 11494. 23. Choi, Y. K.; Suh, J. H.; Lee, D.; Lim, I.-T.; Jung, J. Y.; Kim, M.-J. J. Org. Chem. 1999, 64, 8423. 24. Parvulescu, A.; Vos, D. D.; Jacobs, P. Chem. Commun. 2005, 5307. 25. (a) Pámies, O.; Ell, A. H.; Samec, J. S. M.; Hermanns, N.; Bäckvall, J.-E. Tetrahedron Lett. 2002, 43, 4699. (b) Paetzold, J.; Bäckvall, J.-E. J. Am. Chem. Soc. 2005, 127, 17620. 26. (a) Jung, H. M.; Koh, J. H.; Kim, M.-J.; Park, J. Org. Lett. 2000, 2, 409. (b) Jung, H. M.; Koh, J. H.; Kim, M.-J.; Park, J. Org. Lett. 2000, 2, 2487. 27. Kim, M.-J.; Choi, M. Y.; Han, M. Y.; Choi, Y. K.; Lee, J. K.; Park, J. J. Org. Chem. 2002, 67, 9481. 28. Choi, Y. K.; Kim, M.; Ahn, Y.; Kim, M.-J. Org. Lett. 2001, 3, 4099. 29. Goodyear, M. D.; Hill, M. L.; West, J. P.; Whitehead, A. J. Tetrahedron Lett. 2005, 46, 8535.
Part Two Uncomon kind of biocatalytic reaction
This page intentionally left blank
Future Directions in Biocatalysis Edited by Tomoko Matsuda © 2007 Elsevier B.V. All rights reserved.
83
Chapter 5
Biological Kolbe–Schmitt carboxylation Possible use of enzymes for the direct carboxylation of organic substrates Toyokazu Yoshida, Toru Nagasawa Department of Biomolecular Science, Faculty of Engineering, Gifu University, Yanagido, Gifu, Japan
Abstract The occurrence of the enzymes catalyzing the Kolbe-Schmitt carboxylation has been shown, and the characterization of these enzymes has been reviewed. Among them, 2,6-dihydroxybenzoate decarboxylase and pyrrole-2-carboxylate decarboxylase efficiently catalyze the reverse carboxylation reaction and accumulate high concentration of 2,6 dihydroxybenzoate from 1,3-dihydroxybenzene and pyrrole-2-carboxylate from pyrrole, respectively, in the presence of 3 M KHCO3 . The possible application of biological Kolbe-Schmitt carboxylation has been discussed. Primary structure analysis of the decar boxylases suggests the latent distribution of various unidentified enzymes, probably cat alyzing the regioselective carboxylation of aromatic and heterocyclic compounds, in microorganisms.
1. INTRODUCTION Biocatalysis is now one of the most powerful and indispensable tools for organic synthesis due to its environment friendliness and excellent enantio-, regio-, and chemoselectivities. Due to the abundance of CO2 as the major greenhouse gas and C−C bond-forming properties, CO2 -fixing enzymes are of high interest. The quantitatively most important enzyme of this kind is ribulose-1,5-bisphosphate carboxylase catalyzing the central CO2 fixation in all photosynthetic organisms.1 Carboxylation reactions widely occur in nature by the direct use of CO2 or HCO3 − and are mediated by enzymes. Aryl carboxylases are less often described, and in microorganisms they are mainly found in the anaerobic degradation of pheno lic compounds via benzoic acids.2−11 C−C bond-forming enzymes are of inter est for preparative organic chemistry. There are only few applications of such direct enzymatic carboxylation reactions for synthetic purposes at industrial level.
84
Toyokazu Yoshida, Toru Nagasawa
The carboxylation reaction of alkali metal phenoxides with carbon diox ide to hydroxybenzoic acids is known as the Kolbe-Schmitt reaction.1213 The Kolbe-Schmitt reaction proceeds at high temperatures and pressures (100–200 C, 0.1–3 MPa) and has been used for the industrial production of aryl hydrox ycarboxylic acids such as salicylate, 4-hydroxybenzoic acid, 4-aminosalicylic acid, 3- or 6-hydroxy-2-naphthoic acid, etc., for a long time.14 These aryl hydroxycarboxylic acids have been widely used for the production of cosmet ics, pharmaceuticals, food additives, polymer liquid crystals, etc. Despite the fact that Kolbe-Schmitt reaction has been known and exploited for a very long time, the selectivity and yield are not yet completely mastered, and the production of either pure isomer is not easily achieved. In fact, purification process is needed after the synthesis, which is energy-consuming and wasteproducing. Owing to the value of the chemicals produced, it is highly wished to conduct a selective process working under mild conditions. For the devel opment of environment-friendly syntheses, the use of enzymes for the direct carboxylation of organic substrates needs more consideration. Aryl carboxy lases/decarboxylases, which catalyze the synthesis/degradation of aryl carboxylic acids, are characteristic of the region-specificity under mild conditions. In the present review, we have focused on aryl carboxylases/decarboxylases catalyzing CO2 -fixation reaction to explore the possible application of biological KolbeSchmitt carboxylation.
2. ENZYMES CATALYZING THE CARBOXYLATION OF PHENOLIC COMPOUNDS Phenol is an important intermediate in the anaerobic degradation of many complex and simple aromatic compounds. Tschech and Fuchs15 proposed that the carboxy lation of phenol to 4-hydroxybenzoate is the first step in the degradation of phenol under denitrifying conditions. However, 4-hydroxybenzoate is not detected in the cultures or cell extracts of the denitrifying Pseudomonas species in the presence of CO2 and phenol,8 but it is detected if phenol is replaced by phenolphosphate.16 In contrast, 4-hydroxybenzoate is readily detected as an intermediate of phenol degradation in the iron-reducing bacterium GS-15,17 and 4-hydroxybenzoate may prove to be a common intermediate in the anaerobic transformation. Thus, in anaer obic degradation of phenolic compounds, it has been postulated that carboxylation reactions may play important roles. Zhang et al. isolated Clostridium hydroxybenzoicum containing two inducible 4-hydroxybenzoate decarboxylase and 3,4-dihydroxybenzoate decar boxylase that form phenol and catechol (1,2-dihydroxybenzene), respectively.1819 The organism does not further metabolize phenol and catechol produced by these reactions. The carboxylation activities of the two purified decarboxylases are not
Biological Kolbe–Schmitt carboxylation
85
high in vitro, but these decarboxylases possibly play significant physiological roles in the anaerobic metabolism of phenol and catechol.2021 Pure cultures growing anaerobically with catechol and sulfate were iso lated,2223 and the carboxylation of catechol was proposed to be the initial reaction of anaerobic catechol degradation by Desulfobacterium sp. strain Cat2.24 Zhang and Young11 proposed that the initial key reaction for anaerobic degradation of naphthalene and phenanthrene was also carboxylation. Studies on 4-hydroxybenzoate decarboxylase and 3,4-hydroxybenzoate decarboxylase have been restricted to obligate anaerobic bacteria, C. hydroxy benzoicum.2021 Aside from the obligate anaerobic microorganism, C. hydroxy benzoicum, very recently facultative anaerobic bacteria, Enterobacter cloacae strains exhibiting high 4-hydroxybenzoate decarboxylase or 3,4-dihydroxybenzoate decarboxylase activity, have been isolated.2526 In this section, in addition to 4-hydroxybenzoate decarboxylase and 3,4-dihydroxybenzoate decarboxylase, three kinds of enzymes catalyzing the car boxylation of phenolic compounds are focused. 2.1. 4-Hydroxybenzoate decarboxylase (EC 4.1.1.61)
Scheme 1
4-Hydroxybenzoate decarboxylase (EC 4.1.1.61) of anaerobe C. hydroxyben zoicum was purified and characterized for the first time.20 It has an apparent molecular mass of 350 kDa and consists of six identical subunits of 57 kDa. The temperature optimum for the decarboxylation is approximately 50 C, the optimum pH being 5.6–6.2. The activation energy for decarboxylation of 4-hydroxybenzoate is 65 kJ mol−1 (20–37 C). The enzyme also catalyzes the decarboxylation of 3,4-dihydroxybenzoate. The apparent Km and kcat values for 4-hydroxybenzoate are 0.40 mM and 33 × 103 min−1 , and for 3,4-dihydroxybenzoate 1.2 mM and 11 × 103 min−1 , respectively, at pH 6.0 and 25 C. The enzyme activity was not influenced by the addition of biotin or avidin. Secondly, 4-hydroxybenzoate decar boxylase from an anaerobic co-culture, consisting of Clostridium-like strain and an unidentified strain, was purified and characterized.27 The occurrence of 4-hydroxybenzoate decarboxylase was also found in fac ultative anaerobic bacteria, E. cloacae P240, and the enzyme was purified and characterized.25 The activity of the cell-free extract of E. cloacae P240 was deter mined to be 137 mol min−1 (mg protein)−1 at 30 C, which was much higher than
86
Toyokazu Yoshida, Toru Nagasawa
that of C. hydroxybenzoicum, 033 mol min−1 (mg protein)−1 at 25 C.20 The puri fied enzyme of E. cloacae P240 is a homohexamer of identical 60 kDa subunits, which is in good agreement with that of C. hydroxybenzoicum. The properties of 4-hydroxybenzoate decarboxylase from E. cloacae P240 are similar to those of Clostridium strains in optimum temperature and pH, oxygen sensitivity, and substrate specificity. 4-Hydroxybenzoate decarboxylase catalyzes the reverse reactions, that is, the carboxylation of phenol to 4-hydroxybenzoate and of catechol to 3,4 dihydroxybenzoate.2025 Using the E. cloacae P240 purified enzyme, the carboxy lation reaction of phenol was investigated in a tightly sealed reaction vessel to avoid the leakage of CO2 gas. The reaction mixture contained 20 mM phenol, 3 M KHCO3 , 10 mM dithiothreitol, 100 mM potassium phosphate buffer (pH 7.0), and enzyme solution (or whole cells). The reaction was started by the addition of KHCO3 and incubated at 20 C. The decarboxylase catalyzed the reverse car boxylation reaction of 20 mM phenol to form 3.8 mM 4-hydroxybenzoate with a molar conversion yield of 19% (Fig. 1). The Km value for phenol was calcu lated to be 14.8 mM. The conversion ratio of phenol to 4-hydroxybezoate by C. hydroxybenzoicum decarboxylase was 0.5% in the presence of 3.3 mM phenol and 100 mM NaHCO3 by 2 h incubation; 17 M 4-hydroxybenzoate was formed.20 The difference in molar conversion ratios might be caused by the concentration of bicar bonate to the reaction mixture. The reversible conversion of 4-hydroxybenzoate and phenol was also observed by whole-cell suspensions. Assuming that HCO3 − is the co-substrate, the equilibrium constant calculated for the reaction 4 hydroxybenzoate− + H2 O � phenol + HCO−3 was 11.4 (± 0.5). The equilibrium constants explain the low conversion of phenol into 4-hydroxybenzoate.28
Concentration (mM)
20 15 10
5 0
0
50
100 150 Time (min)
200
Figure 1: Time course of carboxylation reaction of phenol. Closed circles,
4-hydroxybenzoate; open squares, phenol.
Biological Kolbe–Schmitt carboxylation
87
2.2. 3,4-Dihydroxybenzoate decarboxylase (EC 4.1.1.63)
Scheme 2 A 3,4-dihydroxybenzoate decarboxylase (EC 4.1.1.63) was purified from C. hydroxybenzoicum and characterized for the first time.21 The estimated molecular mass of the enzyme is 270 kDa. The subunit molecular mass is 57 kDa, sug gesting that the enzyme consists of five identical subunits. The temperature and pH optima are 50 C and pH 7.0, respectively. The Arrhenius energy for decar boxylation of 3,4-dihydroxybenzoate was 325 kJ mol−1 for the temperature range from 22 to 50 C. The Km and kcat for 3,4-dihydroxybenzoate were 0.6 mM and 54 × 103 min−1 , respectively, at pH 7.0 and 25 C. The enzyme catalyzes the reverse reaction, that is, the carboxylation of catechol to 3,4-dihydroxybenzoate, at pH 7.0. The enzyme does not decarboxylate 4-hydroxybenzoate. Although the equilibrium of the reaction is on the side of catechol, it is postulated that C. hydrox ybenzoicum uses the enzyme to convert catechol to 3,4-dihydroxybenzoate.21 The occurrence of 3,4-dihydroxybenzoate decarboxylase was also found widely in facultative anaerobes. Among them, Enterobacter cloacae P241 showed the highest activity of 3,4-hydroxybenzoate decarboxylase,26 and the activity of the cell-free extract of E. cloacae P241 was determined to be 0629 mol min−1 (mg protein)−1 at 30 C, which was more than that of C. hydroxybenzoicum, 011 mol min−1 (mg protein)−1 at 25 C.21 The E. cloacae P241 enzyme has a molecular mass of 334 kDa and consists of six identical 50 kDa subunits. The Km value for 3,4-dihydroxybenzoate was 177 M. The enzyme is also characteristic of its narrow substrate specificity and does not act on 4-hydroxybenzoate and other benzoate derivatives. The properties of E. cloacae P241 3,4-hydroxybenzoate decarboxylase were similar to those of C. hydroxybenzoicum in optimum temper ature and pH, oxygen sensitivity, and substrate specificity. The carboxylation reaction of catechol by E. cloacae P241 was investigated in a tightly sealed vessel to avoid the leakage of CO2 gas.26 The reaction mixture contained 25 mM catechol, 3 M KHCO3 , 10 mM dithiothreitol, 100 mM potassium phosphate buffer (pH 7.0), and enzyme solution. The reaction was started by the addition of KHCO3 , incubated at 20 C. The carboxylation for catechol was also observed using the purified enzyme and the whole-cell suspension of E. cloacae P241 in the presence of 25 mM catechol and 3 M KHCO3 , resulting in the formation of 5.49 mM 3,4-dihydroxybenzoate with a molar conversion ratio of 22% (Fig. 2).
88
Toyokazu Yoshida, Toru Nagasawa
Concentration (mM)
25 20 15 10 5 0
0
60 120 Time (min)
180
Figure 2: Time course of carboxylation reaction of catechol. Closed circles, 3,4-dihydroxybenzoate; open squares, catechol. The reaction product of the reserve carboxylation reaction was isolated and identified to be 3,4-dihydroxybenzoic acid by 1 H NMR and 13 C NMR with the authentic 3,4-dihydroxybenzoic acid as a reference. The carboxylation reaction of catechol to 3,4-dihydroxybenzoate was affected by the concentration of KHCO3 . The carboxylation activity of E. cloacae P241 3,4-dihydroxybenzoate decarboxy lase in the presence of 0.1 M KHCO3 was only 15% of that in the presence of 3 M KHCO3 .26 In the case of C. hydroxybenzoicum 3,4-dihydroxybenzote decarboxy lase, only 0.01 mM 3,4-dihydroxybenzoate was formed from 6 mM catechol in the presence of 50 mM NaHCO3 by 40 min incubation.21 The difference in molar conversion ratios might be caused by the concentration of bicarbonate added to the reaction mixture. 2.3. Phenolphosphate carboxylase (EC 4.1.1.-) in Thauera aromatica COO– CO2 + H2O
ATP + H2O
Pi
AMP + Pi OH
OPO3–
OH
Scheme 3 The anaerobic metabolism of phenol in T. aromatica is initiated by the ATP-
dependent conversion of phenol to phenylphosphate catalyzed by phenylphosphate
Biological Kolbe–Schmitt carboxylation
89
synthase (EC 2.7.9.-). The subsequent para carboxylation of phenylphosphate to 4-hydroxybenzoate is catalyzed by phenolphosphate carboxylase (EC 4.1.1.-).82930 Both enzyme activities are induced in cells grown anoxially on phenol and nitrate and not in cells grown on 4-hydroxybenzoate, the product of this process. Further metabolism of 4-hydroxybenzoate proceeds via benzoyl coenzyme A. Phenylphos phate synthase and phenylphosphate carboxylase were purified and characterized from T. aromatica.831−33 Phenylphosphate synthase consists of three subunits with molecular masses of 70, 40, and 24 kDa. Subunit 1 resembles the central part of classical phospho enolpyruvate synthase which contains a conserved histidine residue. It catalyzes the exchange of free [14 C] phenol and the phenol moiety of phenylphosphate but not the phosphorylation of phenol. Phosphorylation of phenol requires subunit 1, MgATP, and another protein, subunit 2 (40 kDa), which resembles the N-terminal part of phosphoenolpyruvate synthase. Subunit 1 and 2 catalyze the following reaction: phenol + MgATP + H2 O → phenylphosphate + MgAMP + orthophosphate The phosphoryl group in phenylphosphate is derived from the -phosphate group of ATP. The free energy of ATP hydrolysis obviously favors the trapping of phe nol (Km , 0.04 mM), even at a low ambient substrate concentration. The reaction is stimulated several fold by another protein, subunit 3 (24 kDa). The molecular and catalytic features of phenylphosphate synthase resemble those of phospho enolpyruvate synthase, albeit with interesting modifications.33 Phenylphosphate is converted into 4-hydroxybenzoate by phenylphosphate carboxylase. This enzyme consists of four proteins with molecular masses of 54, 53, 18, and 10 kDa. Three of the subunits ( 54, 53, and 10 kDa) were sufficient to catalyze the exchange of 14 CO2 and the carboxyl group of 4-hydroxybenzoate but not phenylphosphate carboxylation. Phenylphosphate carboxylation was restored when the 18 kDa subunit was added. As shown in the reaction model of Fig. 3, the 14 CO2 exchange reaction catalyzed by the three subunits of the core enzyme requires the fully reversible release of CO2 from 4-hydroxybenzoate with formation of a tightly enzyme-bound phenolate intermediate. Carboxylation of phenylphos phate requires the addition of subunit, which is thought to form the same enzyme-bound energized phenolate intermediate from phenylphosphate with vir tually irreversible release of phosphate. Then , , and subunits catalyze the carboxylation of the enzyme-bound energized phenolate intermediate to produce 4-hydroxybenzoate. Phenylphosphate carboxylase acts on phenolic compounds, uses CO2 as a substrate, does not contain biotin or thiamine diphosphate, requires K+ and a divalent metal cation (Mg2+ or Mn2+ ) for activity, and are strongly inhibited by oxygen. The purified E. cloacae P240 4-hydroxybenzoate decarboxylase did not catalyze the carboxylation of phenylphosphate,25 indicating phenolphosphate
90
Toyokazu Yoshida, Toru Nagasawa
COO– Phenol exchange reaction (Subunit 1)
+
Subunit 1
H2O
PO32–
Pi OPO3– Phenylphosphate O– hydrolase
OH Pi
+ H2O
δ -Subunit
ATP H –
Subunit 1
OH
PO3
–
2–
Subunit 1
PO2
AMP Subunit 2 Phosphorylation of subunit 1
H CO2
COO–
CO2 CO2 exchange reaction
α β γ - Subunit Phenylphosphate synthase
Phenylphosphate carboxylase
Figure 3: Possible reaction mechanism of carboxylation of phenol via phenylphosphate.
carboxylase (EC 4.1.1.-) was distinguishable from 4-hydroxybenzoate decarboxy lases (EC 4.1.1.61). Based on the anaerobic metabolism of phenol by T. aromatica, Aresta et al. studied the production of 4-hydroxybenzoic acid from the technological aspect.3435 The crude extract was partially purified by using membranes with a given molecular weight cut-off (MWCO). The enzyme was supported on a solid matrix (agar) to stabilize its activity. The best solid support was revealed to be low-melting agar on which the enzyme had a life of several days to week. In the membrane reactor, as shown in Fig. 4, phenylphosphate was incubated with the enzyme under CO2 atmosphere and the 4-hydroxybenzoic acid accumulated.35 Once all the phosphorylated phenol has been converted, the solution is recovered, and more substrate was added. Membrane was used for the separation of the reaction space where the enzyme is kept, from the space where the reaction product is extracted. The enzyme does not cross the membrane that has a MWCO of 100 kDa. The 4-hydroxybenzoic acid produced in the central reactor, space B, crossed the membrane and was collected in the external part C from where it can be withdrawn with a syringe or downloaded through the stopcock. The lifetime of the enzyme is of several days at room temperature under atmospheric pressure of carbon dioxide that can be used as reaction gas. The process is clean and good results are obtained with a turnover number of approximately 16 000.
Biological Kolbe–Schmitt carboxylation
91
Reagent + cosubstrate
A
B C
Product
Figure 4: Membrane reactor for 4-hydroxybenzoate production using phenolphosphate carboxylase. A membrane (A) separates the reaction space containing the enzyme (B) from water phase where the product is collected (C).
2.4. 2,6-Dihydroxybenzoate decarboxylase OH
OH
COOH
+
OH
CO2
OH
Scheme 4
A novel decarboxylase, 2,6-dihydroxybenzoate decarboxylase, was found in Agrobacterium tumefaciens IAM 12048 at first.36 Thereafter, the same activity was found in Rhizobium species by two groups independently.3738 Furthermore, Pandoraea sp. 12B-2, the most powerful producer of 2,6-dihydroxybenzoate decar boxylase, was isolated.39 These enzymes have been purified and characterized. 2,6-Dihydroxybenzoate decarboxylase activity of these bacteria was induced specifically by 2,6-dihydroxybenzoate. The enzyme activity in a cell-free extract of A. tumefaciens IAM 12048 was stable during storage at 4 C for 7 days in potassium phosphate buffer (pH 7.0) containing 1 mM dithiothreitol. Dif ferent from 4-hydroxybenzoate decarboxylase and 3,4-dihydroxybenzoate decar boxylase, 2,6-dihydroxybenzoate decarboxylase was much less labile and barely
92
Toyokazu Yoshida, Toru Nagasawa
exhibited the sensitivity to oxygen. Therefore, the enzyme purification was per formed with relatively high yield. The purified enzyme of A. tumefaciens IAM 12048 was a homotetramer of identical 38 kDa subunits. The enzyme showed no characteristic absorption maximum other than 280 nm, indicating the absence of a prosthetic group such as pyridoxal 5 -phosphate and thiamine pyrophos phate. The enzyme activity was not diminished after the incubation at 50 C for 30 min. Treatment at 60 and 70 C caused 18 and 100% losses of initial activ ity, respectively. The enzyme was stable on incubation at 30 C for 20 min in the pH range of 5.0–11.0. When the decarboxylation reaction was carried out for 20 min at various temperatures, the activity was maximal at 60 C. The high est activity was observed at pH 8.5 (10 mM Tris–HCl buffer) and the activities under pH 5.0–10.0 were over 80% of that at pH 8.5. 2,6-Dihydroxybenzoate decarboxylases of A. tumefaciens IAM 12048 and Rhizobium species had similar properties. The purified enzyme of A. tumefaciens IAM 12048 catalyzed the regiose lective carboxylation of 1,3-dihydroxybenzene into 2,6-dihydroxybenzoate in the presence of 15 mM 1,3-dihydroxybenzene and 3 M KHCO3 , with a molar conver sion yield of 30%. The Rhizobium enzymes were also confirmed to catalyze the reverse carboxylation. The regioselective carboxylation of 1,3-dihydroxybenzene was optimized using the whole cells of Pandoraea sp. 12B-2. The carboxyla tion reaction was carried out at 30 C in a tightly sealed reaction vessel to avoid the leakage of CO2 gas. The standard reaction mixture contained 12.5 mM 1,3 dihydroxybenzene, 3 M KHCO3 , 100 mM potassium phosphate buffer (pH 7.0), and whole cells (22.0 mg dry weight per 1 ml of reaction mixture). The effect of the KHCO3 concentration on the production of 2,6 dihydroxybenzene was investigated.39 In the presence of 0.1 M KHCO3 , 0.5 mM 2,6-dihydroxybenzoate was formed from 12.5 mM 1,3-dihydroxybenzene. The addition of 1–3 M KHCO3 in the reaction mixture significantly promoted the formation of 2,6-dihydroxybenzoate (Fig. 5a). With 3 M KHCO3 , the molar conversion ratio of 1,3-dihydroxybenzene reached its highest value (48%). The effect of temperature on 2,6-dihydroxybenzoate formation was exam ined (Fig. 5b). When the reaction was carried out for 6 h at 40 or 50 C, the initial velocity of 2,6-dihydroxybenzoate formation was accelerated. How ever, the prolonged incubation over 40 C resulted in the degradation of 2,6 dihydroxybenzoate. To enhance the productivity of 2,6-dihydroxybenzoate, the addition of various kinds of organic solvent was tested. Among them, the addition of 10–20% (v/v) acetone accelerated the initial velocity of 2,6 dihydroxybenzoate formation (Fig. 5c); however, when the equilibrium was achieved, the final molar conversion yield of 1,3-hydroxybenzene reached the same level as in the case without adding acetone. The addition of acetone decreased the viscosity of the whole cells of Pandoraea sp. 12B-2 in the reaction mixture.
2,6-Dihydroxybenzoate (mM)
2,6-Dihydroxybenzoate (mM)
Biological Kolbe–Schmitt carboxylation
6 5 4 3 2 1 0
0
10
20
30
50 40 30 20 10 0
0
20
Time (h)
2,6-Dihydroxybenzoate (mM)
93
40
60
80
Time (h)
100 80 60 40 20 0
0
20
40
60
80
Time (h)
Figure 5: Effect of KHCO3 concentraion (a), temperature (b), and acetone (c) on the carboxylation of 1,3-dihydroxybenzene. (a) The following concentrations of KHCO3 were added in the reaction mixture: open triangles, 0.1 M; closed diamonds, 1 M; open squares, 2 M; closed circles, 3 M. (b) Reactions were carried out using 100 mM 1,3-dihydroxybenzene at 20 C open triangles; 30 C closed circles; 35 C closed diamonds; 40 C open squares. (c) Reactions were carried out using 200 mM 1,3-dihydroxybenzene. Acetone was added at the following concentrations: open squares, 0% (v/v); closed circles 10% (v/v); closed diamonds 20% (v/v).
When the whole-cell reaction was carried out in the presence of 0.1–3 M 1,3-dihydroxybenzene and 3 M KHCO3 , the molar conversion ratio of 1,3-dihydroxybenzene always reached 45–50% (Fig. 6). The high concentration of 1,3-dihydroxybenzene was not inhibitory on 2,6-dihydroxybenzoate decar boxylase. When 3 M 1,3-dihydroxybenzene was incubated with the whole cells of Pandoraea sp. 12B-2 (43.9 mg as dry cell weight) in the presence of 3 M KHCO3 , 220 mg ml−1 of 2,6-dihydroxybenzoate (1.42 M) accumulated after 120 h incubation, with a conversion ratio of 48%. During the carboxylation of 1,3 dihydroxybenzene, no other product except for 2,6-dihydroxybenzoate was formed.
Toyokazu Yoshida, Toru Nagasawa
2,6-Dihydroxybenzoate (mM)
94
1500 1200 900 600 300 0
0
50
100 150 Time (h)
200
250
Figure 6: 2,6-Dihydroxybenzoate production using whole cells of Pandoraea sp. 12B-2. Reactions were carried out in the reaction mixture containing the following concentrations of 1,3-dihydroxybenzne: closed circles, 3 M; open squares, 2 M; closed diamonds, 1 M; open triangles, 0.1 M.
2,3-Dihydroxybenzoate (mM)
The product was isolated and identified by 1 H NMR and 13 C NMR analyses comparing with the authentic 2,6-dihydroxybenzoic acid as a reference. Carboxylation of 20–300 mM 1,2-dihydroxybenzene was carried out using 36.9 mg (as dry cell weight) of whole cells in the presence of 3 M KHCO3 in 1 ml of the reaction mixture. The molar conversion yields were almost the same using 20, 100, and 200 mM 1,2-dihydroxybenzene (approximately 25%) as shown in Fig. 7.
50 40 30 20 10 0
0
6
12 18 Time (min)
24
Figure 7: Time course of carboxylation of 1,2-dihydroxybenzene using whole
cells of Pandoraea sp. 12B-2. Reactions were carried out in the reaction mixture
containing the following concentration of 1,2-dihydroxybenzene: closed circles,
300 mM; open squares, 200 mM; closed diamonds, 100 mM; open triangles,
20 mM.
Biological Kolbe–Schmitt carboxylation
95
2.5. 2,3-Dihydroxybenzoate decarboxylase
HO
OH
HO
COOH
OH
+
CO2
Scheme 5 2,3-Dihydroxybenzoate decarboxylase has been reported to be involved in the metabolism of indole, tryptophan, and anthranilic acid.4041 The primary struc ture of 2,3-dihydroxybenzoate decaroboxylase of Aspergillus niger has been revealed by gene analysis, which exhibits significant homology with those of 2,6-dihydroxybenzoate decarboxylases (unpublished data). This suggests that 2,3 dihydroxybenzoate decarboxylase also catalyzes the regioselective carboxylation of catechol to 2,3-dihydroxybenzoate, although the carboxylation activity has not been examined. 2,3-Dihydroxybenzoate decarboxylase purified from Aspergillus niger has a molecular mass of 120 kDa and consists of four identical 28 kDa sub units. 2,3-Dihydroxybenzoate has a Km value of 340 M and does not act on salicylate, anthranilate, 2,3-dihydroxybenzaldehyde, 2,4-dihydroxybenzoate, 3-hydroxyanthranilate, 3-hydroxybenzoate, 2,3-dihydroxybenzoate, benzoate, or 4-hydroxybenzoate.42 The enzyme of Trichosporon cutaneum is a homodimer of identical 36.5 kDa subunits, which also catalyzes the decarboxylation of 2,3,5-trihydroxybenzoate and 2,3,6-trihydroxybenzoate.41 2,3-Dihdroxybenzoate decarboxylase can be purified, without the addition of sulfhydryl-protecting reagents to the purification buffer, indicating that the decarboxylases are insensi tive to O2 . Recently, the distribution of 2,3-dihydroxybenzoate decarboxylase has been found in a variety of fungal strains (unpublished data), and the carboxylation activ ity for catechol is confirmed by the reaction using resting cells (or cell-free extract) in the presence of 3 M KHCO3 . The detailed comparative studies of enzyme structures and catalytic properties between 2,3-dihydroxybenzoate decarboxylase and 3,4-dihyroxybenzoate decarboxylase might explain how the decarboxylases catalyze the regioselective carboxylation of catechol.
3. ENZYMES CATALYZING THE DIRECT CARBOXYLATION OF HETEROCYCLIC COMPOUNDS Non-oxidative novel aromatic acid decarboxylases, pyrrole-2-carboxylate decar boxylase and indole-3-carboxylate decarboxylase, were found in Bacillus
96
Toyokazu Yoshida, Toru Nagasawa
megaterium PYR291043 and Arthrobacter nicotianae F11612,44 respectively. These enzymes also catalyze the reverse reaction, the regiospecific carboxylation of heterocyclic compound, pyrrole, or indole. 3.1. Pyrrole-2-carboxylate decarboxylase
+ N H
COOH
CO2
N H
Scheme 6
B. megaterium PYR2910, isolated from soil for its ability to grown on pyrrole-2 carboxylate as the sole source of carbon and energy, produces a novel enzyme, pyrrole-2-carboxylate decarboxylase, to catalyze the decarboxylation of pyrrole 2-carboxylate into pyrrole and CO2 .43 Thiophene-2-carboxylate and l-thioproline (each 0.2%, w/v), which are analogous to the substrate pyrrole-2-carboxylate but not converted by the enzyme, were found to be the most effective enzyme inducers, leading to 3-fold higher specific enzyme activity than the substrate inducer pyrrole 2-carboxylate.45 The enzyme was purified from B. megaterium PYR2910. The enzyme has a molecular mass of approximately 98 kDa and consists of two identical subunits. The Vmax and Km values for decarboxylation were determined to be 989 units mg−1 and 24 mM, respectively. The purified enzyme was stable between pH 6 and 9 and at temperature below 50 C. The pH and temperature optima were 6.5 and 45 C, respectively. A unique feature of this enzyme is its requirement of an organic acid, such as acetate, propionate, butyrate, or pimelate, for the activity. The highest activity was found with pimelate (1750 mol min−1 mg−1 , Km 1.8 mM), followed by butyrate (76% relative activity, 45 mM), propionate (74%, 42 mM), and acetate (56%, 43 mM). These acids might reflect the steric dimensions of the enzyme site, where the organic acid affects the catalysis. Throughout the reaction, stoichiometric amounts of pyrrole and CO2 were formed from pyrrole-2-carboxylate. During the reaction, the concentrations of added organic acid, such as acetate, stayed constant.43 Pyrrole-2-carboxylate decarboxylase attains equilibrium in the course of either decarboxylation or carboxylation (Fig. 8). The decarboxylation of 100 mM pyrrole-2-carboxylate was in equilibrium after 1 h, resulting in an equilibrium constant of 0.3 M.45 Due to this “balanced” equilibrium, the enzyme also catalyzed the reverse carboxylation of pyrrole after the addition of HCO3 − , leading to a similar equilibrium constant of 0.4 M and a shift of the [pyrrole]/[pyrrole-2 carboxylate] ratio toward the acid.
Concentration (mM)
Biological Kolbe–Schmitt carboxylation
100
97
100 Pyrrole-2-carboxylate
Pyrrole
80
80 60
60
40
40 Pyrrole-2-carboxylate
20
20 Pyrrole
0
0 0
2
4
6
8
0
2
4
6
8 10 12
Time (min) (a)
(b)
Figure 8: Decarboxylation of pyrrole-2-carboxylate (a) and carboxylation of pyrrole (b) by pyrrole-2-carboxylate decarboxylase.
The reverse CO2 fixation depended on a CO2 source (CO2 or HCO3 − ), which was an additional limiting factor for the reverse reaction. Due to high water solubilities, the best CO2 sources were bicarbonates (HCO3 − with KHCO3 leading to 82 mM pyrrole-2-carboxylate from 100 mM pyrrole, followed by NH4 HCO3 (94% relative activity), NaHCO3 (81%), BaCO3 (17%), and CaCO3 (16%). Other carbonates (CO3 2− ), CO2 gas, or dry ice were with low or without effect due to a low water solubility of CO3 2− and CO2 at neutral pH.46 The reverse reaction showed a substrate saturation dependence, with optimal HCO3 − concentrations above 2.5 M. For the highest carboxylation yield, saturating amounts of 3 M KHCO3 were used, leading to a shift of the reaction equilibrium toward the carboxylate. HCO3 − addition was accompanied by CO2 gas evolution resulting in an increased pressure in the tightly closed reaction vessel of 1.38 atm, which supported the reverse reaction productivity 2.5-fold compared to atmospheric pressure. High pressures are also known to be applied in organic chemical carboxylations.47 As biocatalyst, either concentrated cells with an optical density at 610 nm of 40, previously grown under inducing conditions, or the purified enzyme, both in a concentration corresponding to 100 units enzyme activity ml−1 , were employed. Additionally, acetate as an enzyme cofactor and l-ascorbate as an anti-oxidizing and enzyme-protecting agent were added to the reaction mixture. For maximal CO2 fixation rates, 300 mM pyrrole was optimal. Higher pyrrole concentrations inhib ited the enzyme. In a batch reaction, 255 g l−1 (230 mM) pyrrole-2-carboxylate was formed from 207 g l−1 (300 mM) pyrrole (Fig. 9a). The productivity was increased to 325 mM (361 g l−1 ) by feeding 150 mM pyrrole after 3 h, with initially 250 mM pyrrole (Fig. 9b). The yield after bioconversion was 80%, limited by the equilibrium.
98
Toyokazu Yoshida, Toru Nagasawa
Concentration (mM)
400 Pyrrole-2-carboxylate 300 Pyrrole-2-carboxylate 200 100 Pyrrole
Pyrrole
0 0
2
4
6
8
10
0
2
4
6
8 10 12
Time (min) (a)
(b)
Figure 9: Time course of enzymatic carboxylation of pyrrole. (a) In the batch reaction, initially 300 mM pyrrole was added. (b) The batch-fed reaction was started with 250 mM pyrrole, followed by a second addition of 150 mM after 3 h.
An enzyme mechanism including a cofactor role of organic acid was pro posed. Analogous to the decarboxylation of pyrrole-2-carboxylate by heat, an electrophilic substitution at C2 pyrrole with a C2 protonated intermediate is prob able. The negatively charged organic acid might attack the only positive ring position at N1 attracting its proton. This eases the electron delocalization in the ring, thus increasing the electron density at C2. The C2 proton, therefore, can be substituted by the electrophilic carbon of CO2 (rather than by the less electrophilic carbon of HCO3 − ). The electrophilic substitution also allows the reverse decar boxylation with a protonated intermediate stabilized by the organic acid. Support for the presumed catalytic function of the pyrrole N1-proton might be deduced from the fact that N -methylpyrrole is not converted by the enzyme. The development of CO2 fixation reactions in supercritical CO2 attracts increasing attention due to its gas-like low viscosities and high diffusivities and its liquid-like solubilizing power. Matsuda et al.48 attempted to carry out the conO H
C N
H
O
O N
H
O
C
N
C
O–
H
O–
H O–
O R
O
O R
Scheme 7
O–
O R
Biological Kolbe–Schmitt carboxylation
99
version of pyrrole into pyrrole-2-carboxylate in supercritical CO2 using cells of B. megaterium PYR2910. The reaction was conducted by adding CO2 to 10 MPa to the mixture of pyrrole, the cells, KHCO3 , and NH4 OAc in potassium phos phate buffer at 40 C. The reaction reached an equilibrium position within a few hours and did not proceed further. The yield of the carboxylation reaction in supercritical CO2 (7.6 MPa) was 12 times higher than that under atmospheric pres sure. The effect of pressure on the carboxylation of pyrrole was also investigated, and the maximum yield was between 4 and 7 MPa. This finding suggested the potentiality for biocatalysis in supercritical CO2 in developing synthetic methods utilizing CO2 . Pyrrole-2-carboxylate is employed in the synthesis of various pharmaceu ticals4950 and a potential herbicide.51 A number of organic syntheses have been described52−54 However, they require multiple steps and result in low yields. Furthermore, the chemical carbonation of pyrrole with K2 CO3 depends on high pressure and temperature.55 The one-step enzymatic conversion has advantages with regard to regiospecificity, yield, and mild reaction conditions. 3.2. Indole-3-carboxylate decarboxylase COOH + N H
CO2
N H
Scheme 8 The highest indole-3-carboxylate decarboxylase activity was found in A. nico tianae F11612 isolated from the soil sample through conventional enrichment culture using indole-3-carboxylate as a sole carbon source.44 The occurrence of the enzyme was also found in Fusarium oxysporum IAM5009 and Gibberella fujikuroi IFO6605 from culture collections. The enzyme of A. nicotianae FI1612 was inducibly formed by the addition of 0.05% (w/v) indole-3-carboxylic acid, and 3-cyanoindole and l-tryptophan also induced the enzyme activity slightly. No activity was found without the addition of inducers. In the screening for indole-3-carboxylate decarboxylase, its weak activity was frequently lost during aerobic cultivation. However, after the optimization of culture conditions of A. nicotianae FI1612, increased activity of whole cells was found even under aerobic conditions. The highest total activity of about 500 nmol ml−1 min−1 was observed after 32 h at 28 C. When a cell extract prepared from A. nicotianae FI1612 cells was stored without the addition of sulfhydryl-protecting reagents, 80% of the initial activity was lost after storage at 4 C for 4 days. The enzyme activity was stabilized
100
Toyokazu Yoshida, Toru Nagasawa
by the addition of a mixture of 1 mM dithiothreitol, 50 mM Na2 S2 O3 , and 20% (v/v) glycerol to the purification buffer. However, much loss of activity seemed inevitable during enzyme purification. Due to its lability, the enzyme could not be purified to be homogeneous; however, the molecular mass of the enzyme was estimated to be 258 kDa by gel permeation. The decarboxylation activity was maximal at 50 C and pH 7.0. The A. nicotianae FI1612 enzyme did not require any cofactor for its activity, although the pyrrole-2-carboxylate decarboxylase activity of B. megaterium PYR2910 was completely dependent on an organic acid such as acetic acid.43 The carboxylation of indole into indole-3-carboxylate was observed by the purified indole-3-carboxylate decarboxylase as well as by the whole cells. For the carboxylation reaction, temperatures over 30 C were not appropriate. The activi ties at 10, 20, and 30 C were about the same. The activity was maximal at pH 8.0 (Tris–HCl buffer, 100 mM). As shown in Fig. 10, the resting cells of A. nicotianae FI1612 also catalyzed the carboxylation of indole efficiently in the reaction mix ture containing 20 mM indole, 3 M KHCO3 , 100 mM potassium phosphate buffer (pH 6.0) in a tightly closed reaction vessel. By 6 h, 6.81 mM indole-3-carboxylic acid accumulated in the reaction mixture with a molar conversion yield of 34%. Compared to the carboxylation of pyrrole by pyrrole-2-carboxylate decarboxylase, the lower value compared might derive from the lower solubility of indole in the reaction mixture. Resting cells of A. nicotianae FI1612 also catalyzed the carboxylation of 2-methylindole and quinoxaline. The activities toward 2-methylindole and quinoxaline were 37 and < 1% of the activity toward indole, respectively. The reaction products of the reverse carboxylation, indole-3-carboxylic acid and 2-methylindole-3-carboxylic acid, were isolated and identified through physico chemical analyses with the authentic compounds as reference.
Indole-3-carboxylate (mM)
25 20 15 10 5 0
0
2
4 Time (h)
6
Figure 10: Carboxylation of indole by whole cells of Arthrobacter nicotianae
FI1612.
Biological Kolbe–Schmitt carboxylation
101
4. STRUCTURE ANALYSIS OF DECARBOXYLASES CATALYZING CO2 FIXATION Up to now, primary structures of the following enzymes catalyzing CO2 fixation have been revealed from nucleotide sequencing of their genes: 4-hydroxybenzoate decarboxylase,2556 3,4-dihydroxybenzoate decarboxylase,26 pyrrole-2-carboxylate decarboxylase (unpublished data), indole-3-carboxylate decarboxylase (unpublished data), and 2,6-dihydroxybenzoate decarboxylase.3738 As for 2,3-dihydroxybenzoate decarboxylase, the carboxylation activity for cat echol has not been reported. However, we presume that 2,3-dihydroxybenzoate decarboxylase also catalyzes the reverse carboxylation reaction, since the primary structure is homologous to that of 2,6-dihydroxybenzoate decar boxylase. These decarboxylases can be divided into two enzyme groups as shown in Table 1, according to similarity of their primary structures. Class I contains oxygen-sensitive decarboxylases, their subunit molecular mass being 52–60 kDa. 4-Hydroxybenzoate decarboxylase, 3,4-dihydroxybenzoate
Table 1 Classification of decarboxylases catalyzing CO2 fixation Sub. MWa (kDa)
Enzyme
Source
Class I 4-Hydroxybenzoate
Chyd
57
3-Octaprenyl-4-hydroxybenzoate decarboxylase
Eclo240 Eclo241
60 59
YclC VdcC (vanillate decarboxylase) Unidentified hypothetical proteins
Bmeg
52
Anic
60
Atum Rrad Rsp Anig
38 34 38 28
decarboxylase 3,4-Dihydroxybenzoate decarbnoxylase Pyrrole-2-carboxylate decarboxylase Indole-3-carboxylate decarboxylase Class II 2,6-Dihydroxybenzoate decarboxylase 2,3-Dihydroxybenzoate decarboxylase
Homologous proteins
5-Carboxyvanillate decarboxyolate 2-Amino-3-carboxyymuconate-6 semialdehyde decarboxylase Unidentified hypothetical proteins
Chyd, Clostridium hydroxybenzoicum; Eclo240, Enterobacter cloacae P240; Eclo241, Enterobacter cloacae P241; Bmeg, Bacillus megaterium PYR2910; Anic, Arthrobacter nicotiacae FI1612; Atum, Agrobacterium tumefaciens IAM12048; Rrad, Rhizobium radiobacter WU0108; Rsp, Rhizobium sp. strain MTP-10005.
102
Toyokazu Yoshida, Toru Nagasawa
decarboxylase, pyrrole-2-carboxylate decarboxylase, and indole-3-carboxylate decarboxylase belong to this enzyme group. The decarboxylases in class II are insensitive to oxygen with subunit molecular mass of 28–38 kDa, such as 2,6 dihydroxybenzoate decarboxylase and 2,3-dihydroxybenzoate decarboxylase. The members of class I show no significant homology with class II enzymes. The structural and evolutionary relationships between class I and II enzymes have not been elucidated yet, because no tertiary structure has so far been presented.
4.1. Class I decarboxylases In the aligned primary structures of class I decarboxylases, the conserved amino acid residues are scattered over their primary structures. There have been few reports to identify the amino acid residues essential for catalytic activity or sub strate binding. Huang et al.56 reported the E-X-P motif in the alignment analysis for 4-hydroxybenzoate decarboxylase of C. hydroxybenzoicum and its homologous unidentified proteins. The E-X-P motif is also conserved in pyrrole-2-carboxylate decarboxylase and indole-3-carboxylate decarboxylase (unpublished data). How ever, the corresponding motif sequence is not observed in the primary structures of 3,4-dihydroxybenzoate decarboxylase of E. cloacae P241.26 Recent homology search using 4-hydroxybenzoate decarboxylase of E. cloacae P240 has shown that its primary structure exhibits 53, 72, and 28% identities to 4-hydroxybenzoate decarboxylase of C. hydroxybenzoicum, VdcC protein (vanillate decarboxylase) of Streptomyces sp. strain D7, and 3 octaprenyl-4-hydroxybenzoate decarboxylase of Escherichia coli, respectively.25 On the database of protein primary structure, there are 11 unidentified pro teins showing over 50% identities with 4-hydroxybenzoate decarboxylase of E. cloacae P240. The homologous proteins are representatively named as probable 4-hydroxybenzoate decarboxylase, YclC protein, or 3-octaprenyl (or polyprenyl)-4-hydroxybenzoate decarboxylase. Hypothetical YclC of E. coli, puta tive 3-polyprenyl-4-hydroxybenzoate decarboxylase of Salmonella typhimurium, a hypothetical protein of S. enterica, YclC protein of Kluyvera citrophila, and putative 4-hydroxybenzoate decarboxylase of Shigella flexneri exhibited 96–97% identities to E. cloacae P240 4-hydroxybenzoate decarboxylase. These putative proteins might be 4-hydroxybenzoate decarboxylase, although the enzyme activity has not been reported in such bacteria. Although 4-hydroxybenzoate decarboxylase of E. cloacae P240 shows sim ilar properties to 3,4-dihydroxybenzoate decarboxylase of E. cloacae P241 with the exception of substrate specificity, the identity of primary structures was only 24%.26 Probably, two hydroxyl groups of 3,4-dihydroxybenzoate are strictly rec ognized by the substrate-binding region of 3,4-dihydroxybenzoate decarboxy lase. Pyrrole-2-carboxylate decarboxylase and indole-3-carboxylate decarboxylase exhibit reasonable homology (20–60%) with hypothetical proteins of various
Biological Kolbe–Schmitt carboxylation
103
microorganisms (unpublished data), suggesting the latent distribution of decar boxylases catalyzing the carboxylation of N -heterocyclic compounds. 4.2. Class II decarboxylases With respect to class II enzymes, the primary structure analysis and sitedirected mutagenesis study of 2,6-dihydroxybenzoate decarboxylase have been reported.3738 2,6-Dihydroxybenzoate decarboxylase shows 20–50% identi ties to 2,3-dihydroxybenzoate decarboxylase, 5-carboxyvanillate decarboxylase, 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase, and several hypo thetical proteins. The multiple alignment of 2,6-dihydroxybenzoate decarboxy lase of Rhizobium strains and the orthologous proteins including hypothetical proteins indicated that two histidine residues were conserved. A site-directed mutagenesis study revealed the histidine residues to be essential for the cat alytic activity.38 As for 2,3-dihydroxybenzoate decarboxylase, the presence of histidine, tryptophan, and cystein residues was suggested at the active site of the enzyme from Aspergillus niger.5758 To elucidate the reaction mechanism of decarboxylation/carboxylation reaction without the involvement of cofactor, further site-directed mutagenesis studies and X-ray crystallographic analysis are required. 4.3. Phenylphosphate carboxylase Primary structure analysis of phenylphosphate carboxylase of T. aromatica is performed in detail, to clarify the reaction mechanism involving four kinds of subunits.32 The subunits have molecular masses of 54, 53, 18, and 10 kDa, respectively, which make up the active phenylphosphate carboxylase. The primary structures of and subunits show homology with 3-octaprenyl 4-hydroxybenzoate decarboxylase, 4-hydroxybenzoate decarboxylase, and vanil late decarboxylase, whereas subunit is unique and not characterized. The 18 kDa subunit belongs to a hydratase/phosphatase protein family. Taking 4-hydroxybenzoate decarboxylase into consideration, Schühle and Fuchs postulate that the core enzyme catalyzes the reversible carboxylation.32
5. CONCLUSION The enzymes catalyzing the Kolbe–Schmitt carboxylation seem to occur ubiq uitously. Some of them, such as 2,6-dihydroxybenzoate decarboxylase and pyrrole-2-carboxylate decarboxylase, catalyze efficiently the reverse carboxyla tion reaction and accumulate high concentration of 2,6-dihydroxybenzoate from 1,3-dihydroxybenzene and pyrrole-2-carboxylate from pyrrole, respectively, in the
104
Toyokazu Yoshida, Toru Nagasawa
presence of 3 M KHCO3 . The facts rouse us to explore the possible applica tion of biological Kolbe–Schmitt carboxylation for the production of aromatic acids. The biological Kolbe–Schmitt carboxylation is a promising new tool for the regiospecific introduction of carboxy groups in precursors of pharmaceuti cals and agrochemicals in order to functionalize them and, thus, alter biological activities. Unfortunately, so far, aromatic acid decarboxylases are highly specific for each aromatic substrate, and a number of its analogs are not carboxylated. The gene resources of various aromatic decarboxylases have been gathered and preserved. Since there are various other valuable targets for regiospecific car boxylations, the finding of novel CO2 -fixing enzymes with a wider substrate spectrum is desirable. The screening for other reversible decarboxylases, showing wide substrate specificity and catalyzing regiospecific carboxylation, is signifi cant and potential. Further survey of microbial resources having aromatic decar boxylases will be continued. From now on, for the further application of the reverse carboxylation of decarboxylase, the most important thing is to develop new excellent techniques to shift the reaction equilibrium to the direction of carboxylation.
REFERENCES 1. Hartman, F. C.; Harpel, M. R. Annu. Rev. Biochem. 1994, 63, 197–234. 2. Bisaillon, J.-G.; Lèpine, F.; Beaudet, R.; Sylvestre, M. Appl. Environ. Microbiol. 1991, 57, 2131–2134. 3. Brackmann, R.; Fuchs, G. Eur. J. Biochem. 1993, 213, 563–571. 4. Gallert, C.; Winter, J. Appl. Microbiol. Biotechnol. 1992, 37, 119–124. 5. Gorny, N.; Schink, B. Appl. Environ. Microbiol. 1994, 60, 3396–3400. 6. Knoll, G.; Winter, J. Appl. Microbiol. Biotechnol. 1989, 30, 318–324. 7. Kuever, J.; Kulmer, J.; Jansen, S.; Fischer, U.; Blotevogel, K.-H. Arch. Microbiol. 1993, 159, 282–288. 8. Lack, A.; Fuchs, G. J. Bacteriol. 1992, 174, 3629–3636. 9. Ramanand, K.; Suflita, J. M. Appl. Environ. Microbiol. 1991, 49, 1689–1695. 10. Sharak-Genthner, B. R.; Townsend, G. T.; Chapman, P. J. FEMS Microbiol. Lett. 1991, 78, 265–270. 11. Zhang, X.; Young, L. Y. Appl. Environ. Microbiol. 1997, 63, 4759–4764. 12. Kolbe, H. Liebigs Ann. Chem. 1860, 113, 125–127. 13. Otta, K. Bull. Chem. Soc. Jpn 1974, 47, 2343–2344. 14. Dewar, M. S. J. The Electronic Theory of Organic Chemistry; Oxford University Press: London; 1949, pp. 1–324. 15. Tschech, A.; Fuchs, G. Arch. Microbiol. 1987, 148, 213–217. 16. Glockler, R. A.; Tschech, A.; Fuchs, G. FEBS Lett.1989, 251, 237–240. 17. Lovley, D. R.; Lonergan, D. J . Appl. Environ. Microbiol.1990, 56, 1858–1864. 18. Zhang, X.; Mandelco, L.; Wiegel, J. Int. J. Syst. Bacteriol. 1994, 44, 214–222. 19. Zhang, X.; Wiegel, J. Microb. Ecol. 1990, 20, 103–121. 20. He, Z.; Wiegel, J. Eur. J. Biochem. 1995, 229, 77–82. 21. He, Z.; Wiegel, J. J. Bacteriol. 1996, 178, 3539–3543. 22. Szewzyk, R.; Pfenning, N. Arch. Microbiol. 1987, 147, 163–168.
Biological Kolbe–Schmitt carboxylation 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. 42. 43. 44. 45. 46. 47. 48. 49. 50. 51. 52. 53. 54. 55. 56. 57. 58.
105
Schnell, S.; Bak, F.; Pfennig, N. Arch. Microbiol. 1989, 152, 556–563. Gorny, N.; Schink, B. Appl. Environ. Microbiol. 1994, 60, 3396–3400. Matsui, T.; Yoshida, T.; Hayashi, T.; Nagasawa, T. Arch. Microbiol. 2006, 186, 21–29. Matsui, T. Ph.D. Thesis, Gifu University, 2006. Li, T.; Juteau, P.; Beaudet, R.; Lépine, F.; Villemur, R.; Bisaillon, J. Can. J. Microbiol. 2000, 46, 856–859. Zhang, Z.; Wiegel, J. Appl. Environ. Microbiol, 1994, 60, 4182–4185. Lack, A.; Fuchs, G. Arch. Microbiol. 1994, 161, 132–139. Lack, A.; Fuchs, G. Eur. J. Biochem. 1991, 197, 473–479. Breining, S.; Schiltz, E.; Fuchs, G. J. Bacteriol. 2000, 182, 5849–5863. Schühle, K.; Fuchs, G. J. Bacteriol. 2004, 186, 4556–4567. Schmeling, S.; Narmandakh A.; Schmitt, O.; Gad’on, N.; Schühle, K.; Fuchs, G. J. Bacteriol, 2004, 186, 8044–8057. Aresta, M.; Quaranta, E.; Liberio, R.; Dileo, C.; Tommasi, I. Tetrahedron 1998, 54, 8841–8846. Aresta, M.; Dibenedetto, A. Rev. Mol. Biotechnol. 2002, 90, 113–128. Yoshida, T.; Hayakawa, Y.; Matsui, T.; Nagasawa, T. Arch. Microbiol. 2004, 181, 391–397. Yoshida, M.; Fukuhara, N.; Oikawa, T. J. Bacteriol. 2004, 186, 6855–6863. Ishii, Y.; Narimatsu, Y.; Iwasaki, Y.; Arai, N.; Kino, K.; Kirimura, K. Biochem. Biophys. Res. Commun. 2004, 324, 611–620. Matsui, T.; Yoshida, T.; Yoshimura, T.; Nagasawa, T. Appl. Microbiol. Biotechnol. 2006, 73, 95–102. Kamath, A. D.; Vaidyanathan, C. S. Appl. Environ. Microbiol. 1990, 56, 275–280. Anderson, J. J.; Dagley, S. J. Bacteriol. 1981, 146, 291–297. Kamath, A. D.; Dasgupta, D.; Vaidyanathan, C. S.Biochem. Biophys. Res. Commun. 1987, 145, 586–595. Omura, H.; Wieser, M.; Nagasawa, T. Eur. J. Biochem. 1998, 253, 480–484. Yoshida, T.; Fujita, K.; Nagasawa, T. Biosci. Biotechnol. Biochem. 2002, 66, 2388–2394. Wieser, M.; Fujii, N.; Yoshida, T.; Nagasawa, T. Eur. J. Biochem. 1998, 257, 495–499. Asada, K. In Organic and Bioorganic Chemistry of Carbon dioxide, Biological Carboxylation; Inoue, S.; Yamazaki, N. (Eds); Halsed: New York; 1982, pp. 185–251. Haruki, E. In Organic and Bioorganic Chemistry of Carbon dioxide, Organic Synthesis with Carbon Dioxide; Inoue, S.; Yamazaki, N. (Eds); Halsed: New York; 1982, pp. 5–78. Matsuda, T.; Ohashi, Y.; Harada, T.; Yanagihara, R.; Nagasawa, T.; Nakamura K. Chem. Commun. 2001, 2194–2195. Kerwin, J. F. Jr; Wagenaar, F.; Kopecka, H.; Lin, C. W.; Miller, T.; Witte, D.; Srashko, M.; Nadzan, A. M. J. Med. Chem. 1991, 34, 3550–3359. Kasum, B.; Prager, R. H.; Ksopelas, C. Aust. J. Chem. 1990, 43, 355–365 Peterson, M. L.; Corey, S. D., Fond, J. L.; Walker, M. C.; Sikorsky, J. A. Bioorg. Med. Chem. Lett. 1996, 6, 2853–2858. Doyle, F. P.; Mehta, M. D.; Sach, G. S.; Pearson, J. L. J. Chem. Soc. 1958, 4458–4466. Kreszu, G.; Firl, J. Angew. Chem. 1964, 76, 439. Terry, W. G.; Jackson, A. H.; Kenner, G. W.; Kornis, G. J. Chem. Soc. 1965, 4389–4393. Smissman, E. E.; Gaber, M. B.; Winzler, R. L. J. Am. Pharm. Assoc. 1956, 45, 509. Huang, Z.; He, Z.; Wiegel, J. J. Bacteriol. 1999, 181, 5119–5122. Kamath, A. V.; Rao, N. A.; Vaidyanathan, C. S. Biochem. Biophys. Res. Commun. 1989, 165, 20–26. Santha, R.; Savithri, H. S.; Rao, N. A.; Vaidyanathan, C. S. Eur. J. Biochem. 1995, 230, 104–110.
This page intentionally left blank
Future Directions in Biocatalysis Edited by Tomoko Matsuda © 2007 Elsevier B.V. All rights reserved.
107
Chapter 6
Discovery, redesign and applications of Baeyer–Villiger monooxygenases Daniel E. Torres Pazmiño, Marco W. Fraaije Laboratory of Biochemistry, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Nijenborgh, Groningen, The Netherlands
Abstract Baeyer–Villiger monooxygenases (BVMOs) represent valuable oxidative biocatalysts. A special feature of these atypical monooxygenases is that they catalyze not only Baeyer– Villiger oxidations but also sulfoxidations and a number of other oxidation reactions. Except for this promiscuity in reactivity, BVMOs are often very enantio-, regio- and/or chemoselective while accepting a broad range of substrates. This chapter provides an overview of recent developments concerning these special oxidative biocatalysts and sketches some future perspectives.
1. INTRODUCTION The Baeyer–Villiger oxidation reaction was discovered more than 100 years ago by Adolf von Baeyer and Victor Villiger.1 By this reaction, ketones are converted into the corresponding esters. In organic chemistry, peracids are commonly used as catalyst to perform this atypical oxidation reaction that results in oxygen insertion into a carbon−carbon bond (Fig. 1). Already in 1948 it was recognized that enzymes that catalyze Baeyer– Villiger reactions exist.2 This was concluded from the observation that a biological Baeyer–Villiger reaction occurred during the biotransformation of steroids by fungi. It took two decades for the first Baeyer–Villiger monooxygenases (BVMOs, EC 1.14.13.X), sometimes also referred to as Baeyer-Villigerases, to be isolated and characterized.34 From then on, a number of microbial BVMOs have been reported revealing several recurring biochemical characteristics (for a recent review see Ref. 5). All characterized BVMOs contain a flavin cofactor that is crucial for cataly sis while NADH or NADPH is needed as electron donor. An interesting observation is the fact that most reported BVMOs are soluble proteins. This is in contrast to many other monooxygenase systems that often are found to be membrane-bound or membrane-associated. In 1997, Willetts6 concluded from careful inspection of
108
Daniel E. Torres Pazmiño, Marco W. Fraaije O X1
O
Baeyer–Villiger oxidation
X2
X1
O
X2
Figure 1: The Baeyer–Villiger oxidation reaction. all available biochemical data on BVMOs that at least two classes of BVMOs exist. The type I BVMOs consist of only one polypeptide chain, contain FAD as tightly bound cofactor and are dependent on NADPH for activity. They contain two Rossmann sequence motifs, GxGxxG, indicating that these enzymes bind the two cofactors (FAD or NADPH) using separate dinucleotide-binding domains.7 The type II BVMOs use FMN as flavin cofactor and NADH as electron donor and are composed of two different subunits. At the time of the initial classification, the respective N-terminal sequences did not provide any clue concerning the struc ture of these two-component monooxygenases. However, recent sequence data suggest a sequence relationship with the flavin-dependent luciferases.8 Therefore, it is likely that type II BVMO oxygenase subunits will also have a TIM-barrel fold. Recent findings hint to at least two other BVMO classes of which one also represents a group of flavoproteins. It was found that the bacterial flavoprotein monooxygenase MtmOIV is involved in the biosynthetic pathway of the antitumor drug mithramycin.9 Sequence analysis indicates that it is related to flavoprotein monooxygenases that typically perform hydroxylation or epoxidation reactions.8 Crystals of this novel monooxygenase have recently been reported.10 A crystal structure would reveal what structural features separate this BVMO from the sequence-related hydroxylases and epoxidases. Also a heme-containing BVMO has recently been reported belonging to the cytochrome P450 superfamily.11 This plant enzyme was shown to convert a specific plant steroid. Earlier studies already suggested Baeyer–Villiger activity of other eukaryotic P450s.12 Future studies will reveal whether these novel oxidative enzymes can be of use for biocat alytic applications. However, the first results suggest that these newly identified BVMOs are dedicated to convert very specific and complex molecules suggesting a narrow substrate specificity. Nevertheless, the finding of these novel BVMO types indicates that during evolution several different enzymes have evolved into BVMOs. Therefore, more BVMO types may be discovered in the coming years. Most biochemical and biocatalytic studies have been performed with type I BVMOs.5 This is partly because of the fact that they represent relatively uncompli cated monooxygenase systems. These monooxygenases are typically soluble and composed of only one polypeptide chain. Expression systems have been devel oped for a number of type I BVMOs while no recombinant expression has been reported for a type II BVMO. Cyclohexanone monooxygenase (CHMO) from an Acinetobacter sp. NCIMB9871 was the only recombinant available BVMO
Discovery, redesign and applications of BVMOs R
R N
109
N
NADPH-binding flavin reduction
O
– N
N
NH
NH N H
N O
O
NADP+
Reaction with oxygen Formation of peroxyflavin
Release of NADP+ Release of water
R
R N
N
Baeyer–Villiger reaction
O
N
N
O NH
NH N H OH NADP+
O
Substrate-binding product release O
O
N HO NADP+
O–
O
O O
Figure 2: Scheme of the catalytic mechanism of type I BVMOs. Phenylacetone is taken as example substrate.
for a long time as it was cloned and overexpressed already in 1988.13 CHMO has been subjected to several sophisticated kinetic studies which have revealed that in BVMOs also, catalysis is achieved by formation of a peracid catalyst: a peroxyflavin (Fig. 2).1415 Upon reaction with NADPH and molecular oxygen, the flavin cofactor is able to form this peroxygenated flavin intermediate. This reactive intermediate is equivalent to the peracids used in organic chemistry and will react with a ketone to form an ester. In fact, it is the ability of BVMOs to form and stabilize a negatively charged peroxyflavin intermediate that enables these enzymes to perform Baeyer– Villiger reactions and other oxygenation reactions. The formation of the reactive oxygenated enzyme intermediate is not regulated by substrate binding which sets these BVMOs mechanistically apart from other well-studied monooxygenase sys tems. For example, cytochrome P450s and flavin-containing hydroxylases will only form the equivalent reactive enzyme intermediate after binding of a substrate. The peroxyflavin in CHMO is stabilized by active-site residues and the bound NADP+ coenzyme. Structural details concerning this enzyme complex are lacking as no CHMO structure is available. After its formation, the peroxyflavin enzyme interme diate waits until a suitable substrate enters the active site upon which oxygenation will take place. In the case that no suitable substrate is present, the peroxyflavin
110
Daniel E. Torres Pazmiño, Marco W. Fraaije
will decay to form hydrogen peroxide. However, this NADPH oxidase function of BVMOs is very inefficient (< 01 s−1 ) due to the effective stabilization of the peroxy intermediate. This prevents intracellular formation of toxic hydrogen per oxide. A striking feature of the catalytic mechanism of CHMO is the fact that the coenzyme NADPH/NADP+ remains bound to the enzyme throughout the catalytic cycle. Only when the oxygenation reaction and the decay of the hydroxyflavin into oxidized flavin have occurred, NADP+ is released (Fig. 2). This mechanistic feature was recently confirmed for another type I BVMO: 4-hydroxyacetophenone monooxygenase (HAPMO)16 . By kinetic inhibition studies and ESI-MS experi ments, it could be demonstrated that the coenzyme remains bound during the whole catalytic cycle. Also, with the newly identified phenylacetone monooxygenase (PAMO)17 we have found that NADP+ is a competitive inhibitor with respect to NADPH (M. W. Fraaije, personal communication), suggesting that NADP+ release is again the last step in the catalytic cycle. Another indirect proof for binding of NADP+ throughout the catalytic cycle came from a study where an artificial elec tron donor was tested.18 This revealed that NADP+ binding is essential to maintain the enantioselectivity of PAMO, indicating that the bound coenzyme forms parts of the active site determining the positioning of the substrate. It also indicates that, in vivo, BVMOs are virtually always occupied by NADP+ or NADPH. This is in line with the observation that BVMOs are highly stabilized when NADP+ is bound.16
2. BIOCATALYTIC PROPERTIES OF RECOMBINANT AVAILABLE BVMOS The list of heterologously expressed type I BVMOs has grown significantly in recent years (Table 1). Except for BVMOs primarily acting on small cyclic ketones (cyclopentanone and cyclohexanone)1920 , variants specific for larger cyclic ketones (cyclododecanone and cyclopentadecanone) have also been discovered.2122 Addi tionally, BVMOs that readily accept aromatic ketones (4-hydroxyacetophenone and phenylacetone derivatives) have been described.1723 Also, a BVMO acting on steroids has been reported.24 Substrate profiling studies suggest that BVMOs have a rather broad specificity and often display overlapping substrate speci ficities. For example, bicycloheptenone and aromatic sulfides have been shown to be converted by several BVMOs. Illustrative for the broad substrate speci ficity of BVMOs is the fact that in 2002 it was reported that for CHMO from Acinetobacter sp. over 100 different substrates had been reported.25 Since that time, a number of other ketones have been shown to be converted by this monooxygenase extending the impressive list of CHMO substrates even further.25−29 Except for exploring its catalytic potential, CHMO from Acinetobacter has also been used as a model system for upscaling BVMO-mediated biocatalysis.
Table 1 Recombinant available BVMOs Acronym
Cyclopentanone monooxygenase
CPMO
Cyclohexanone monooxygenase
CHMO
Primary substrate
Origin
O
Comamonas sp.
Year of cloning 20022041
Acinetobacter sp.
19881319
Rhodococcus ruber
200121
Pseudomonas sp.
200622
Pseudomonas fluorescens
200123
Thermobifida fusca
200417
O
Cyclododecanone monooxygenase
CDDMO
Cyclopentadecanone monooxygenase
CPDMO
O
O
4-Hydroxyacetophenone monooxygenase
HAPMO
Phenylacetone monooxygenase
PAMO
O HO
O
Ethionamide monooxygenase
EtaA
Steroid monooxygenase
STMO
Physiological substrates unidentified Mycobacterium tuberculosis Rhodococcus rhodochrous
200447
Discovery, redesign and applications of BVMOs
BVMO
199924
O
O
111
List of BVMOs that have been overexpressed in E. coli and of which the isolated enzyme has been characterized to some extend.
112
Daniel E. Torres Pazmiño, Marco W. Fraaije
In recent years, the main focus has been on using whole cells expressing CHMO as biocatalyst. By this, the problem of coenzyme usage by the enzyme can be circumvented, as NADPH will be regenerated by the cellular machinery. During the years, problems related to, e.g., product/substrate inhibition and oxygen sen sitivity have been tackled.3031 An efficient methodology has been developed that is applicable on kilogram scale.32 Using whole cells expressing CHMO in combi nation with resin-based in situ substrate feeding and product removal (SFPR) and a tuned oxygen supply, a highly productive process was developed yielding two nearly enantiopure (ee > 98%) regioisomeric lactones in good yield. This nicely illustrates that BVMOs can be applied on a scale that is relevant for synthesis of fine chemicals. While the substrate acceptance of a specific BVMO is often relaxed, cat alytic efficiencies and regio- and/or enantioselectivities can differ significantly when comparing BVMOs. A number of CHMO and CPMO homologs (>35% sequence identity) have recently been identified and explored concerning their biocatalytic potential. These comparative biocatalytic studies using highly sim ilar enzymes have revealed that, as expected, all studied CHMOs and CPMOs cover a similar substrate range.293334 However, regio- and/or enantioselectivi ties differ significantly. It was observed that CPMOs and CHMOs often dis play opposite enantioselectivities.34 This illustrates the need for a large library of BVMOs to meet the demand for enantio- and/or regioselective oxidative biocatalysts. Although BVMOs often display a broad substrate specificity, each BVMO has a certain preference for a specific type of substrate. While CHMO and CPMO are highly active with a range of (cyclic) aliphatic ketones, HAPMO and PAMO prefer aromatic substrates.172335−37 Figure 3 illustrates the overlapping substrate specificities for several well-studied BVMOs displaying several typical substrates for each BVMO. For several recombinant available BVMOs, no extensive substrate profiling studies have been performed. For steroid monooxygenase, only steroid substrates have been tested while cyclododecanone and cyclopentadecanone monooxyge nases have only been recently identified and await further exploration. Based on the first biocatalytic data obtained with cyclopentadecanone monooxygenase, it appears that this novel BVMO is attractive when relatively large compounds are targeted.22 The enzyme proved to be effective in enantioselective Baeyer–Villiger oxidations of a range of bulky cycloketones. By this, it complements the substrate range that is covered by other known BVMOs. 2.1. Discovery of novel BVMOs While the number of available recombinant BVMOs has grown significantly over the last few years, there is still a demand for other BVMOs to expand the biocat alytic diversity. Most BVMOs that have been described are dedicated to efficiently
Discovery, redesign and applications of BVMOs
CHMO
O
113
O
HAPMO R
R
R
X
O
O
O H
O N O
O
O H N
O
X
R R
H
HO
O
O
O S R
O O
O R R
O
O O
O
R
O
O MeO Me
nPr O
CPMO
PAMO O
Figure 3: Illustration of overlapping substrate specificities of four BVMOs. Cyclohexanone monooxygenase (CHMO), cyclopentanone monooxygenase (CPMO), 4-hydroxyacetophenone monooxygenase (HAPMO) and phenylacetone monooxygenase (PAMO). For each enzyme, several typical substrates are shown.
convert cyclohexanone and related cyclic aliphatic ketones. To cover a broader range of substrate types and enantio- and/or regioselectivities, new BVMOs have to be discovered. This can be done in a number of ways. In the past, it was com mon practice to isolate new microbes that were able to grow on a target substrate after which the respective enzyme/gene was retrieved. This approach has been successful in obtaining most of the presently available BVMOs (Table 1). Only PAMO and ethionamide monooxygenase have been discovered via other meth ods.1436 However, the classical approach of isolating a specific microorganism, enzyme purification and subsequently cloning is laborious, time consuming and often unsuccessful. Frequently, the enzyme responsible for the observed reaction is difficult to purify and hence the respective gene cannot be retrieved. Therefore, it is attractive to exploit other newly developed methods that circumvent these pitfalls.
114
Daniel E. Torres Pazmiño, Marco W. Fraaije
2.2. Exploring sequenced (meta)genomes for novel BVMOs Nowadays, the genomes of a wide variety of organisms have been sequenced and are publicly available, offering a new and efficient way of retrieving BVMO genes. Currently, as genome sequences of over 600 microbes are available (see http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi), it is attractive to look directly into this pool of genes in silico without growing and isolating any microor ganism. In addition to the database of partially and fully sequenced genomes, it is also informative to survey the database of sequenced environmental genomes. Especially, the ‘Sargasso sea’ metagenome database is rich in new sequences.38 Metagenomic databases contain a large number of unexplored genes (>1 million sequences in the Sargasso database!). However, in an in silico (meta)genome mining approach it is fundamental to have bioinformatic tools to identify, with some certainty, genes that encode BVMOs. By simply searching for sequences that show homology with known BVMOs, novel putative BVMO genes may be found. However, many sequence-related genes may represent flavoprotein monooxygenases that do not catalyze Baeyer–Villiger reactions. A more reliable identification of BVMO genes has become feasible since a type I BVMO-specific motif (FxGxxxHxxxWD /P was identified by comparing sequences of characterized BVMOs.39 This allows an effective survey of all (meta)genome databases concern ing the occurrence of type I BVMOs (Table 2: note that this table only includes completely sequenced genomes). The identification of new BVMO genes will obviously facilitate production of novel biocatalysts. Except for obtaining the new gene sequence of a specific BVMO, a thorough genome analysis may also provide more valuable information. As genes belonging to specific degradation pathways are often clustered on microbial genomes, analyzing the sequence regions flanking a BVMO gene may give hints concerning the physiological role of the enzyme and accordingly provide clues for the corresponding substrate specificity. In fact, we have found that many BVMO genes are flanked by an esterase/hydrolase gene. The corresponding esterase or lactonase activity would hydrolyze the ester or lactone formed by BVMO activity. Such a co-localization of BVMO with an esterase/lactonase has also been observed in sequenced genome fragments containing a BVMO gene, e.g., in the case of the CHMO, cyclopentanone monooxygenase, PAMO, HAPMO and cyclopentadecanone genes.17222340−42 This suggests that BVMOs often play a role in a specific catabolic pathway and is in agreement with the fact that most described BVMOs are part of a degradation pathway. A genomic trawl using the above-mentioned type I BVMO motif as filter currently yields 174 putative BVMO genes when searching for all finished micro bial genomes (Table 2). This indicates that type I BVMOs are not very rare but are frequently utilized by microbes. All identified BVMO genes originate from bacteria or fungi while none could be found in archaebacteria, plants, animals or the human genome. On average, roughly one out of two (174/348) micro bial genomes contain a BVMO gene. This suggests that at present ∼400 novel
Discovery, redesign and applications of BVMOs
115
Table 2 Genomic occurrence of BVMOs Source
Number of screened genomes
Number of putative BVMOsa
Bacteria
293
138
Archaea
Examples of genomes containing multiple BVMOsb Mycobacterium aviumc (12) Novosphingobium aromaticivorans (8) Rhodococcus RHA1 (20) –
27
0
d
Fungi
28
36
Other eukaryotese
22
0
–
Sargasso sea
–
32
–
370
206
–
Total
Aspergillus nidulans FGSC-4A (16) Gibberella zeae PH-1 (10) Magnaporthe grisea 70-15 (7)
a
Genomes were surveyed for the presence of putative type I BVMOs by: (1) searching for sequence homologs of phenylacetone monooxygenase and (2) filtering for sequences that contain the type I BVMO-sequence motif.39 b The number of BVMO genes for each genome is indicated in brackets.
c Mycobacterium avium subsp. paratuberculosis K-10.
d Sixteen yeast and 12 fungal genomes have been screened: 33 BVMOs discovered in fungi and
three in the yeast Candida albicans SC5314. e Other eukaryotes included Apis mellifera, Bombyx mori, Caenorhabditis elegans, Drosophila melanogaster, Homo sapiens, Mus musculus, Tetraodon nigroviridis.
type I BVMO genes are present in the genome sequence database (including the unfinished genomes). Strikingly, BVMO genes are unevenly distributed among microbial genomes with only a few microorganisms containing a large number of BVMOs while the majority of genomes are devoid of putative type I BVMOs (Fig. 4). In fact, the number of genomes containing only one BVMO is more or less equal to the number of genomes containing four or more BVMO genes. It is also worth noting that a relatively large number of bacterial BVMO genes (80) were found in actinomycetes. This may suggest a role of BVMOs in the synthesis of secondary metabolites. Also, the Sargasso metagenome database contains a sig nificant number of BVMO genes indicating that in the sea environment also many microbes employ BVMOs for specific but yet unknown metabolic routes (Table 2). These genes cannot simply be obtained using PCR techniques as the microbes from which the genes originate have not been isolated. However, by gene synthesis it is in principle feasible to explore these newly identified putative biocatalysts.
Daniel E. Torres Pazmiño, Marco W. Fraaije
Frequency (number of genomes screened)
116
260
260
250 Bacteria Fungi
24 20 14
11 6 3
2 0
0 0
1
1
0 2
3
>3
Number of BVMOs/genome
Figure 4: Distribution of putative type I BVMO genes among bacterial and fungal genomes (see Table 2).
In contrast to the type I BVMOs discussed above, type II BVMOs have been explored to a limited extent. In fact, an in silico search for type II BVMOs in the genome sequence database is hampered by the fact that only one type II BVMO sequence (limonene monooxygenase, gi47116765) has been deposited in the database. A BLAST search with the limonene monooxygenase sequence at NCBI (http://www.ncbi.nlm.nih.gov) reveals that only 12 bacterial sequences show a relatively high sequence homology (>40% sequence identity). Except for these sequence homologs, a large number of other sequences also show lim ited sequence homology and appear to belong to the luciferase class of flavindependent monooxygenases. This hints to an evolutionary relationship between type II BVMOs and luciferases. In the Sargasso sea database, only five sequences can be found that display high sequence identity (>40%) with limonene monooxy genase. These findings suggest that type II BVMOs are less widespread when compared with type I BVMOs explaining to some extent why these BVMOs have been reported in the literature less frequently. Recently, several BVMOs have been reported in the literature that had been found by genome mining. The first example concerned the discovery of a ther mostable BVMO. The well-studied BVMO, CHMO, is not a very robust biocata lyst. Often, conversions using this biocatalyst suffer from enzyme inactivation. To circumvent this problem, it was of interest to obtain a more (thermo)stable BVMO. As no BVMO genes have been identified in genomes of archaebacteria, genomes of (semi)thermophilic bacteria were surveyed. Using the above-mentioned BVMO sequence motif, it was found that the genome of Thermobifida fusca contains two
Discovery, redesign and applications of BVMOs
117
type I BVMO genes. This actinomycete typically grows at 55–60 C and there fore should yield thermostable biocatalysts. The two genes have been cloned and the corresponding enzymes have been overexpressed in Escherichia coli. Only one of the two expressed BVMOs could be purified and characterized and was shown to be primarily active on a range of aromatic ketones and sulfides. The highest catalytic efficiency has been obtained with phenylacetone and hence its name phenylacetone monooxygenase. The genes flanking the PAMO gene also suggest a role in the degradation of aromatic compounds like phenylacetone. Except for phenylacetone, a number of other ketones and sulfides are accepted by the enzyme.1736 With several aromatic prochiral ketones and sulfides, excellent enantioselectivity was observed. However, the enzyme is only marginally active with cyclic aliphatic ketones and therefore has only a limited overlap in substrate specificity when compared with CHMO (Fig. 3). The enzyme indeed proves to be of superior stability when compared with other known BVMOs as it is stable for days when stored at moderate temperatures (<40 C). The enzyme is also active in the presence of organic solvents and, interestingly, it was found that organic solvents can tune the enantioselectivity.43 More recently the group of Grogan reported on another genome mining project targeting BVMOs from Mycobacterium tuberculosis.44 The genome of M. tuberculosis harbors six putative type I BVMO genes. Also, other mycobac terial genomes are relatively rich in BVMO genes with M. marinum setting the record at present: 15 BVMO genes. All six type I BVMOs genes that are part of the genome of M. tuberculosis were cloned and four of them could be overexpressed in E. coli. Unfortunately, by using three test substrates, Baeyer– Villiger activity of only three mycobacterial BVMOs could be confirmed. One of them corresponds to ethionamide monooxygenase that has been shown to be involved in the activation of commonly used antitubercular drugs.4546 In a previous study, Baeyer–Villiger activity of this monooxygenase had already been verified with a large number of ketones.47 However, another overexpressed BVMO from M. tuberculosis exhibited exquisite enantioselectivity with racemic bicyclo[3.2.0]hept-2-en-6-one.44 This bicyclic aliphatic ketone is often used to probe the biocatalytic potential of BVMOs. This chiral ketone is of high value for the synthesis of fine chemicals when available in its enantiomerically pure form. Also, the chiral lactones formed from this ketone by Baeyer–Villiger oxidation are highly interesting for synthetic purposes. For this reason, CHMO has been exploited in several biocatalytic studies as mentioned above.3032 Using whole cells containing the novel mycobacterial biocatalyst, it was possible to perform a res olution of racemic bicyclo[3.2.0]hept-2-en-6-one yielding enantiomerically pure (1R,5S)-(+)-bicyclo[3.2.0]hept-2-en-6-one. This was not feasible with CHMO or any other available BVMO and demonstrates again the value of a genome mining approach. By exploring the catalytic properties of novel BVMOs identified only by sequence, new substrate specificities and regio- and/or enantioselectivities may be uncovered.
118
Daniel E. Torres Pazmiño, Marco W. Fraaije
2.3. Screening the metagenome for novel BVMOs Except for exploring sequenced genomes, yet other interesting approaches for discovering novel BVMOs exist. A recent development in the area of biocatalyst discovery is the exploitation of metagenomic DNA libraries. By this methodology, DNA is directly isolated from a certain sample that is expected to contain a variety of microbes (e.g., soil). Subsequently, the obtained DNA is randomly fragmented and cloned into a suitable vector and expression host. The resulting gene library, containing a huge number of randomly cloned genome fragments, can subsequently be screened for any desired biocatalytic activity. In this way, bacterial enzymes exhibiting specific activities can be found without the need of isolating or cultivating a specific bacterium. This culture-independent methodology has been shown to be very successful to uncover novel biocatalysts and has quickly become a standard approach at academic and industrial institutions. However, no BVMO discovered by metagenome screening has yet been reported. As shown above, BVMOs occur frequently in bacterial genomes and therefore metagenomic gene libraries should typically contain a multitude of BVMOs. However, it is not trivial to screen libraries for specific enzyme activities. Often screening methods rely on visualization of enzyme activity by color formation upon substrate conversion or growth that is triggered by the specifically desired enzyme activity. Several assays that can be used for screening cells for BVMO activity have been reported but none of them appears to be suited for generic screening of a massive number of clones.48−50 The most commonly used assay to detect BVMO activity in vitro is measuring the depletion of NADPH which absorbs light at 340 nm. This approach cannot be used when handling whole cells. Recently, several alternative methods have been reported to detect cells exhibiting BVMO activity. In one report, it was shown that the BVMO-associated ester/lactone product formation can be coupled to an esterase/lactonase which will result in a drop of pH. By using pH indicators, this change of pH could be visualized.51 A disadvantage of this approach is that it is limited by the substrate range of the hydrolytic partner enzyme and very sensitive to other activities that influence the pH. Another reported method for detecting BVMO activity is also dependent on hydrolysis of the formed product. It was shown that HAPMO readily catalyzes conversion of 3-acetylindole to indoxyl acetate. Chemical or enzymatic hydrolysis of this product yields indoxyl which spontaneously reacts with molecular oxygen forming the blue-colored compound, indigo (Fig. 5).52 Recently, two fluorogenic assays were also described that can be used for detecting BVMO activity.4849 However, these methods are biased toward specific chromogenic and fluorogenic substrates and will only yield enzymes that are active toward these and similar compounds. An effective and generic method of screening of BVMO activity is indis pensable for screening metagenome libraries as these libraries are often in the range of 100 000–1 000 000 clones. Therefore, it is a challenge to develop a novel way to efficiently detect BVMO activity in gene libraries. This would facilitate
Discovery, redesign and applications of BVMOs
O O BVMO N H
OH
O
3-Acetyl indole
O Oxidation
Esterase/KOH N H
119
N H
H N
N H
O Indigo blue
Figure 5: Chromogenic BVMO assay using 3-acetyl indole resulting in the formation of indigo blue.52
discovery of a new set of BVMOs displaying novel biocatalytic properties and may also disclose new types of BVMOs. 2.4. Redesign of BVMOs For enzyme redesign studies, structural information of a targeted biocatalyst is very valuable. However, at present, no structure of the well-studied BVMO, CHMO, is available. In order to obtain a predictive structural model of the active site of CHMO, a cubic space model has been built based on the substrate acceptance of this biocatalyst.53 While this model can predict to some extent the specificity and selectivity of CHMO, it is of little use for enzyme redesign studies. However, even if no structural information is available, it is still possible to exploit random mutagenesis methods in order to change specific biocatalytic properties of an enzyme. Such an approach of directed evolution has been performed with CHMO by the Reetz group.54 By error-prone PCR, a library of CHMO mutants was created. By using chiral GC analysis, a library of 10 000 mutants was screened for improved enantioselectivity using the prochiral substrate 4-hydroxycyclohexanone. Upon Baeyer–Villiger oxidation by wild-type CHMO, this ketone is converted into both corresponding lactone enantiomers (only 9% ee for the (R)-enantiomer). The same library was also used to find mutants that show an improved enantioselectivity with methyl-p-methylbenzyl thioether. This sulfide is readily oxidized by wildtype CHMO forming the (R-sulfoxide in low enantiomeric excess (ee = 14%). Although only a relatively small library of mutants was screened due to the limited screening efficiency (800 mutants per day), impressive results were obtained. For both reactions, multiple improved mutants were found that could be improved even further in a second round of mutagenesis. For the Baeyer–Villiger reaction, the enantioselectivity could be improved from 9 to 90% ee while mutants with the opposite enantioselectivity could also be retrieved. For the sulfoxidation reaction, several mutants were found that showed an excellent enantioselective behavior (>98% ee). Interestingly, both screens yielded mutants with improved biocatalytic properties in which only one specific residue was replaced: F432. Most other retrieved mutants contained multiple mutations suggesting that multiple mutations (additive effects) are needed to improve enantioselectivity.
120
Daniel E. Torres Pazmiño, Marco W. Fraaije
Except for the directed evolution study on CHMO, only a few other enzyme redesign studies on BVMOs have been reported. By sequence alignment of BVMO sequences, residues have been identified as targets to change the coenzyme speci ficity of CHMO and HAPMO.55 As mentioned above, most BVMOs are only active with the relatively expensive coenzyme NADPH, thereby compromising costeffective biocatalytic applications. It would be advantageous to engineer BVMOs which are active with NADH. By site-directed mutagenesis, it was found that one specific residue (K326 in CHMO) is crucially involved in recognizing the 2 -phosphate of NADPH. This lysine residue is conserved in all BVMO sequences which is in line with the observation that all type I BVMOs are NADPH-specific. However, while it was possible to change the selectivity of both CHMO and HAPMO toward NADH, all prepared mutants showed a modest to low activity with NADH. This indicates that a more thorough enzyme redesign strategy is needed in which the presently available structural information could be exploited (see below). Another site-directed mutagenesis study was performed by Cheesman et al.56 in which all histidine residues in CHMO were replaced to probe their respective function. This revealed that replacement of H59 prevented expression while the H163Q mutant exhibited only 10% activity. This latter observation is in line with the fact that H163 is part of the BVMO-specific motif mentioned above. Replacing the corresponding histidine in HAPMO also affected the activity of the respective enzyme strongly.39 Other sequence–function relationship data concerning a type I BVMO come from studies that focused on elucidating the genetic basis of drug resistance of M. tuberculosis isolates toward thioamides.4546 It was found that a range of point mutations in a specific gene, etaA, were associated with thioamide drug resistance. The resulting drug resistance can be ascribed to the inactivation of the corresponding enzyme: ethionamide monooxygenase. Future studies will reveal whether the reported mutations are fatal for expression or result in inactive enzyme. Ethionamide monooxygenase represents a type I BVMO and is able to convert a range of ketones into the corresponding esters.47 Except for catalyzing Baeyer– Villiger oxidations, the enzyme is also able to oxidize the sulfide moieties of several antitubercular thioamide drugs. The oxidized drugs appear to be highly toxic for mycobacteria. This indicates that ethionamide monooxygenase acts as a prodrug activator. In vitro, ethionamide monooxygenase only displays a very low activity with all tested substrates. This low activity may be due to the fact that all tested substrates are unrelated to the (unknown) physiological substrate of ethionamide monooxygenase. However, it might also indicate that ethionamide monooxygenase needs other components to be fully active. As mentioned above, the first BVMOs were already purified several decades ago. Subsequent biochemical studies have revealed that these enzymes are typi cally soluble and often easy to express at high levels in, e.g., E. coli. These features suggest that BVMOs are perfect candidates for X-ray crystallography studies. However, crystallization of several type I BVMOs has been attempted and proven
Discovery, redesign and applications of BVMOs
121
to be difficult. Several groups have tried to crystallize the prototype BVMO: CHMO from Acinetobacter. However, all attempts have been without success, which is probably caused by the relative instability of this specific monooxy genase. This is in line with the observation that CHMO is sensitive to cysteine oxidation leading to enzyme inactivation.57 Also, ethionamide monooxygenase has been subjected to crystallization trials. Unfortunately, the recombinant enzyme withstands crystallization as it tends to aggregate in its pure form (M. W. Fraaije, personal communication). We have successfully crystallized HAPMO resulting in large well-shaped yellow crystals. However, X-ray analysis of these crystals revealed that the diffracting power was very poor with a resolution limit of 6 Å on a synchrotron source. As flexibility in N-termini has been shown to introduce heterogeneity in protein crystals, truncation could be a solution for the diffraction problem as HAPMO contains an extended N-terminus when compared with other BVMOs.58 To test this, several truncated HAPMO mutants were also crystallized.52 However, no improvement in diffraction properties was found. Several BVMOs have been examined with respect to their stability. This has revealed that CHMO is not a very stable biocatalyst. The enzyme is rapidly degraded intracellularly when expressed in E. coli.59 In its isolated form, the enzyme is also quite unstable: t1/2 = 24 h at 25 C.60 Additives, e.g., kosmotropic salts, have a stabilizing effect but are not desirable for biocatalytic applications. It was also reported that immobilization on a solid carrier is a more effective way to stabilize CHMO. HAPMO was shown to inactivate rapidly at elevated temperatures: t1/2 = 80 min at 36 C.16 For this BVMO, it was shown that the lifetime could be increased 4-fold by adding the FAD cofactor. Addition of a NADPH coenzyme analog resulted in a more drastic effect as the enzyme remained fully active for 120 min at 36 C. While the addition of a coenzyme analog will inhibit efficient catalysis, it can be used as additive when a BVMO has to be stored. In order to obtain a more robust BVMO, we decided to search for a BVMO gene from a thermophilic microorganism. While no BVMO genes could be identified in hyperthermophilic archaea (Table 2), we discovered two genes in the genome of the semi-thermophile T. fusca (see above). One of the identified BVMOs was found to be overexpressed in E. coli as a soluble, fully flavinylated and active enzyme.17 As indicated above, the enzyme was found to be highly active on phenylacetone and is thermostable. Only at temperatures above 50 C, it tends to inactivate (t1/2 = 24 h at 52 C). Possibly due to its robustness, PAMO readily crystallizes yielding crystals with good diffraction properties (<2Å). This resulted in the elucidation of its crystal structure in 2004.61 The availability of the PAMO structure offers new possibilities for redesigning this or other BVMOs. One structure-inspired enzyme redesign study concerning PAMO has already been reported.62 By sequence alignment of CHMO and PAMO, it was deduced that PAMO contains an extended active site loop when compared with CHMO. It was probed whether, by deleting one or two loop residues, the substrate acceptance of PAMO could be altered. The designed mutants indeed brought about significant changes in substrate acceptance.
122
Daniel E. Torres Pazmiño, Marco W. Fraaije
While wild-type PAMO was unable to convert 2-phenylcyclohexanone efficiently, all deletion mutants readily accepted this ketone as substrate. All mutants also displayed a similar thermostability when compared with the parent enzyme. The most active mutant (deletion of S441 and A442) was used for examining its enantioselective properties. It was found that the mutant preferably formed the (R) enantiomer of the corresponding lactone (E = 100). While CHMO also shows a similar enantioselective behavior, this PAMO deletion mutant is a better candidate for future applications due to its superior stability. This clearly demonstrates that PAMO can be used as parent enzyme to design thermostable BVMO variants. It also illustrates that the available crystal structure of PAMO will be of great help for BVMO redesign efforts.5
3. CONCLUSIONS: FUTURE DIRECTIONS As each BVMO is limited in substrate specificity, it is crucial to have a large collection of these oxidative biocatalysts available. Except for expanding the scope of possible reactions, a large toolbox of BVMOs would also increase the chance of being able to perform any wanted specific chemo-, regio- and/or enantioselective reaction. This contrasts with the present situation as only a relatively small number of BVMOs can be exploited for biocatalytic purposes. Therefore, it is still crucial to discover or engineer BVMOs with novel biocatalytic properties. An obvious way to generate new BVMOs is by taking advantage of the genome sequence information: genome mining. Table 2 illustrates that many puta tive BVMO genes can be identified which can be explored for their catalytic potential. Two examples of such a genome mining approach have already been reported yielding two novel BVMOs with interesting biocatalytic properties (see earlier1744 ). However, it also shows the risks of such an approach. Of the six putative BVMO genes from M. tuberculosis that were cloned, only four resulted in significant expression of the corresponding protein.44 Of the four expressed pro teins, only one showed an interesting enzymatic activity. These are complications inherent to genome mining. It is still impossible to predict if a gene can be easily expressed in a certain host nor what specific activities it will exhibit. Nevertheless, as hundreds of unexplored putative BVMO genes can be identified in the genome database, it is attractive to delve into this wealth of sequence information. An effective way to clone novel BVMO genes from sequenced genomes is by using gene synthesis. This technology is becoming relatively inexpensive and allows, e.g., codon optimization for specific hosts. It also circumvents the need to obtain a specific organism or its genomic DNA. By this, obtaining novel BVMOs from sequenced genomes will become more efficient and will yield new BVMOs in the near future. The recently developed methodology for enzyme discovery that is based on “random” DNA isolation and subsequent screening (metagenome mining) is
Discovery, redesign and applications of BVMOs
123
not yet applicable for BVMO discovery. So far, no screening method has been described that is effective enough to allow screening of massive metagenomic gene libraries. As soon as this technological hurdle has been crossed, the number of available biocatalytically relevant BVMOs will grow. Another more sophisticated way of obtaining novel BVMOs is to redesign a specific BVMO in order to tune catalytic properties. Such an approach would ideally yield biocatalysts tailor-made to perform any wanted reaction. Random mutagenesis methods have been very popular in the last decade to obtain enzyme variants with improved biocatalytic properties. However, these directed evolution methods typically involve creation of huge libraries of enzyme mutants that have to be screened for a newly introduced characteristic. As a consequence, efficient screening techniques are required to fully screen these libraries. However, methods enabling ultra high-throughput screening are often unavailable and as a result only relatively small mutant libraries are screened. This limits the extent to which enzyme properties can be changed. One cannot expect that by introducing a few random mutations, enzymatic properties will fundamentally change.63 The recently reported directed evolution study on CHMO nicely exemplifies these limitations. As discussed above, screening of a CHMO mutant library for mutants that exhibit altered enantioselective behavior is currently feasible only at low throughput (800 clones per day). A relatively small library (10 000 clones) was screened for CHMO mutants with altered enantioselectivity when converting a ketone or a sulfide.54 The wild-type enzyme already showed some enantioselectivity on both test compounds and therefore the desired change in enzyme reactivity represent energetically seen a small change. Nevertheless, the approach was very successful as several dozens of mutants were found displaying improved enantioselectivity. Several mutants were sequenced and allowed identification of the replaced residues. The mutants represented single, double and triple mutants, indicating effective error-prone PCR. One residue was found in both screens and suggests that this is a hotspot in tuning enantioselective Baeyer–Villiger oxidations and sulfoxidations. As a structure of a sequence-related BVMO, PAMO (40% sequence identity), is available at present, it is now possible to build a homology model structure of CHMO and locate the observed random mutations. We have recently built such a CHMO model structure (unpublished results). Interestingly, inspection of the model reveals that most of the observed mutations are clustered in a specific part of the structure located at the re side of the flavin cofactor (Fig. 6). When disregarding mutations of surface residues in double or triple mutants, only one mutation was found in the NADPH-binding domain, three mutations were located in the helical domain while all other (10) mutations were part of the interior of the FAD-binding domain. All the observed mutations in the FADbinding domain are in loops and are close to the predicted substrate-binding pocket next to the flavin.61 Mutations in the same structural region in PAMO introduced by Bocola et al.62 confirmed that this is a hotspot for affecting sub strate specificity and enantioselectivity. These results attest to the effectiveness
124
Daniel E. Torres Pazmiño, Marco W. Fraaije
Figure 6: Model structure of CHMO. The FAD cofactor is shown as sticks. Mutations observed in a directed evolution study resulting in altered enantioselectivities are highlighted (spheres).54 Note that a number of mutations were found in double/triple mutants and cannot be linked with certainty to the altered catalytic properties. Mutations in double/triple mutants that are on the surface were omitted.
of directed evolution not only to generate valuable new biocatalysts but also to identify residues or structural regions that are important for enzyme functioning. By combining the information obtained by mutagenesis studies and the available structure of PAMO, more directed enzyme redesign studies can be performed in the near future. Such structure-inspired enzyme redesign efforts should effectively generate BVMO variants performing reactions that are yet inaccessible. As CHMO and CPMO homologs are closely related to PAMO at protein sequence level, it is feasible to build structural models of these biocatalysts. Except for tuning substrate specificity or regio- and/or enantioselectivity, it should also be possible to, e.g., engineer mutant enzymes that accept NADH as coenzyme. By solving the structure of PAMO, the residues interacting with the 2 -phosphate of NADPH have also been identified. This could fuel biocatalytic applications that involve usage of isolated enzymes. Generation of a BVMO that can both use NADH or NADPH might also be beneficial for biocatalysis based on whole cells. Except for extending the toolbox of type I BVMOs, it can also be worthwhile to explore other types of Baeyer–Villiger catalysts. As mentioned above, type II BVMOs have hardly been explored and new types of BVMOs have been discov ered in recent years. Furthermore, Baeyer–Villiger oxidation activity has also been introduced into enzymes that normally catalyze other (hydrolytic) reactions.64 This
Discovery, redesign and applications of BVMOs
125
indicates that the field of BVMO discovery and engineering is still expanding and it is expected that the number of biocatalytic applications based on these oxidative biocatalysts will grow accordingly.
REFERENCES 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30.
Baeyer, A.; Villiger, V. Ber. Dtsch. Chem. Ges. 1899, 32, 3625–3633. Turfitt, G. E. Biochem. J. 1948, 42, 376–383. Conrad, H. E.; DuBus, R.; Namtvedt, M. J.; Gunsalus, I. C. J. Biol. Chem. 1965, 240, 495–503. Forney, F. W.; Markovetz, A. J. Biochem. Biophys. Res. Commun. 1969, 37, 31–38. Kamerbeek, N. M.; Janssen, D. B.; van Berkel, W. J. H.; Fraaije, M. W. Adv. Synth. Catal. 2003, 345, 667–678. Willetts, A. TIBTECH 1997, 15, 55–62. Wierenga, R. K.; Terpstra, P.; Hol, W. G. J. J. Mol. Biol. 1986, 187, 101–107. van Berkel, W. J. H.; Kamerbeek, N. M.; Fraaije, M. W. J. Biotechnol. 2006, 124, 670–689. Rodríguez, D.; Quirós, L. M.; Braña, A. F.; Salas, J. A. J. Bacteriol. 2003, 185, 3962–3965. Wang, C.; Gibson, M.; Rohr, J.; Oliveira, M. A. Acta Crystallogr. 2005, 61, 1023–1026. Nomura, T.; Kushiro, T.; Yokota, T.; Kamiya, Y.; Bishop, G. J.; Yamaguchi, S. J. Biol. Chem. 2005, 280, 17873–17879. Fischer, R. T.; Trzaskos, J. M.; Magolda, R. L.; Ko, S. S.; Brosz, C. S.; Larsen, B. J. Biol. Chem. 1991, 266, 6124–6132. Chen, Y. C.; Peoples, O. P.; Walsh, C. T. J. Bacteriol. 1988, 170, 781–789. Ryerson, C. C.; Ballou, D. P.; Walsh, C. Biochemistry 1982, 21, 2644–2655. Sheng, D.; Ballou, D. P.; Massey, V. Biochemistry 2001, 40, 11156–11167. van den Heuvel, R. H. H.; Tahallah, N.; Kamerbeek, N. M.; Fraaije, M. W.; van Berkel, W. J. H.; Janssen, D. B.; Heck, A. J. R. J. Biol. Chem. 2005, 280, 32115–32121. Fraaije, M. W.; Wu, J.; Heuts, D. P. H. M.; van Hellemond, E. W.; Lutje Spelberg, J. H.; Janssen, D. B. Appl. Microbiol. Biotechnol. 2005, 66, 393–400. de Gonzalo, G.; Ottolina, G.; Carrea, G.; Fraaije, M. W. Chem. Commun. 2005, 29, 3724–3726. Donoghue, N. A.; Norris, D. B.; Trudgill, P. W. Eur. J. Biochem. 1976, 63, 175–192. Griffin, M.; Trudgill, P. W. Eur. J. Biochem. 1976, 63, 199–209. Kostichka, K.; Thomas, S. M.; Gibson, K. J.; Nagarajan, V.; Cheng, Q. J. Bacteriol. 2001, 183, 6478–6486. Iwaki, H.; Wang, S.; Grosse, S.; Bergeron, H.; Nagahashi, A.; Lertvorachon, J.; Yang, J.; Konishi, Y.; Hasegawa, Y.; Lau, P. C. K. Appl. Environ. Microbiol. 2006, 72, 2707–2720. Kamerbeek, N. M.; Moonen, M. J. H.; van Der Ven, J. G. M.; van Berkel, W. J. H.; Fraaije, M. W.; Janssen, D. B. Eur. J. Biochem. 2001, 268, 2547–2557. Morii, S.; Sawamoto, S.; Yamauchi, Y.; Miyamoto, M.; Iwami, M.; Itagaki, E. J. Biochem. 1999, 126, 624–631. Mihovilovic, M. D.; Müller, B.; Stanetty, P. Eur. J. Org. Chem. 2002, 22, 3711–3730. Wang, S.; Kayser, M. M.; Iwaki, H.; Lau, P. C. K. J. Mol. Catal. B Enzym. 2003, 22, 211–218. Mihovilovic, M. D.; Müller, B.; Schulze, A.; Stanetty, P.; Kayser, M. M. Eur. J. Org. Chem. 2003, 12, 2243–2249. Mihovilovic, M. D.; Rudroff, F.; Grötzl, B.; Stanetty, P. Eur. J. Org. Chem. 2005, 5, 809–816. Mihovilovic, M. D.; Snajdrova, R.; Grötzl, B. J. Mol. Catal. B Enzym. 2006, 39, 135–140. Hilker, I.; Baldwin, C.; Alphand, V.; Furstoss, R.; Woodley, J. M.; Wohlgemuth, R. Biotechnol. Bioeng. 2006, 93, 1138–1144.
126
Daniel E. Torres Pazmiño, Marco W. Fraaije
31. Alphand, V.; Carrea, G.; Wohlgemuth, R.; Furstoss, R.; Woodley, J. M. TIBTECH 2003, 21, 318–323. 32. Hilker, I.; Wohlgemuth, R.; Alphand, V.; Furstoss, R. Biotechnol. Bioeng. 2005, 92, 702–710. 33. Kyte, B. G.; Rouvière, P. E.; Cheng, Q.; Stewart, J. D. J. Org. Chem 2004, 69, 12–17. 34. Mihovilovic, M. D.; Rudroff, F.; Grötzl, B.; Kapitan, P.; Snajdrova, R.; Rydz, J.; Mach, R. Angew. Chem. Int. Ed. 2005, 44, 3609–3613. 35. de Gonzalo, G.; Torres Pazmiño, D. E.; Ottolina, G.; Fraaije, M. W.; Carrea, G. Tetrahedron Asymm. 2006, 17, 130–135. 36. de Gonzalo, G.; Torres Pazmiño, D. E.; Ottolina, G.; Fraaije, M. W.; Carrea, G. Tetrahedron Asymm. 2005, 16, 3077–3083. 37. Mihovilovic, M. D.; Kapitan, P.; Rydz, J.; Rudroff, F.; Ogink, F. H.; Fraaije, M. W. J. Mol. Catal. B Enzym. 2005, 32, 135–140. 38. Venter, J. C.; Remington, K.; Heidelberg, J. F.; Halpern, A. L.; Rusch, D.; Eisen, J. A.; Wu, D. Y.; Paulsen, I.; Nelson, K. E.; Nelson, W.; Fouts, D. E.; Levy, S.; Knap, A. H.; Lomas, M. W.; Nealson, K.; White, O.; Peterson, J.; Hoffman, J.; Parsons, R.; Baden-Tillson, H.; Pfannkoch, C.; Rogers, Y. H.; Smith, H. O. Science 2004, 304, 66–74. 39. Fraaije, M. W.; Kamerbeek, N. M.; van Berkel, W. J. H.; Janssen, D. B. FEBS Lett. 2002, 518, 43–47. 40. van Beilen, J. B.; Mourlane, F.; Seeger, M. A.; Kovac, J.; Li, Z.; Smits, T. H. M.; Fritsche, U.; Witholt, B. Environ. Microbiol. 2003, 5, 174–182. 41. Iwaki, H.; Hasegawa, Y.; Wang, S.; Kayser, M. M.; Lau, P. C. K. Appl. Environ. Microbiol. 2002, 68, 5671–5684. 42. Brzostowicz, P. C.; Blasko, M. S.; Rouvière, P. E. Appl. Microbiol. Biotechnol. 2004, 58, 781–789. 43. de Gonzalo, G.; Ottolina, G.; Zambianchi, F.; Fraaije, M. W.; Carrea, G. J. Mol. Catal. B Enzym. 2006, 39, 91–97. 44. Bonsor, D.; Butz, S. F.; Solomons, J.; Grant, S.; Fairlamb, I. J. S.; Fogg, M. J.; Grogan, G. Org. Biomol. Chem. 2006, 4, 1252–1260. 45. Baulard, A. R.; Betts, J. C.; Engohang-Ndong, J.; Quan, S.; McAdam, R. A.; Brennan, P. J.; Locht, C.; Besra, G. S. J. Biol. Chem. 2000, 275, 28326–28331. 46. DeBarber, A. E.; Mdluli, K.; Bosman, M.; Bekker, L. G.; Barry, C. E. Proc. Natl Acad. Sci. USA 2000, 97, 9677–9682. 47. Fraaije, M. W.; Kamerbeek, N. M.; Heidekamp, A. J.; Fortin, R.; Janssen, D. B. J. Biol. Chem. 2004, 279, 3354–3360. 48. Sicard, R.; Chen, L. S.; Marsaioli, A. J.; Reymond, J.-L. Adv. Synth. Catal. 2005, 347, 1041–1050. 49. Gutiérrez, M. C.; Sleegers, A.; Simpson, H. D.; Alphand, V.; Furstoss, R. Org. Biomol. Chem. 2003, 1, 3500–3506. 50. Bicalho, B.; Chen, L. S.; Grognux, J.; Reymond, J.-L.; Marsaioli, A. J. J. Braz. Chem. Soc. 2004, 15, 911–916. 51. Watts, A. B.; Beecher, J.; Whitcher, C. S.; Littlechild, J. A. Biocatal. Biotransform. 2002, 20, 209–214. 52. Kamerbeek, N. M. Ph.D.Thesis, University of Groningen, 2004. 53. Ottolina, G.; Carrea, G.; Colonna, S.; Rückemann, A. Tetrahedron Asymm. 1996, 7, 1123–1136. 54. Mihovilovic, M. D.; Rudroff, F.; Winninger, A.; Schneider, T.; Schulz, F.; Reetz, M. T. Org. Lett. 2006, 8, 1221–1224. 55. Kamerbeek, N. M.; Fraaije, M. W.; Janssen, D. B. Eur. J. Biochem. 2004, 271, 2107–2116. 56. Cheesman, M. J.; Kneller, M. B.; Rettie, A. E. ChemicoBiol. Interact. 2003, 146, 157–164. 57. Bennett, A. J. Undergr. Res. 2004, 6 (http://www.clas.ufl.edu/jur/200409/papers/paper_bennett. html). 58. Price, S. R.; Nagai, K. Curr. Opin. Biotech. 1995, 6, 425–430.
Discovery, redesign and applications of BVMOs
127
59. Walton, A. Z.; Stewart, J. D. Biotechnol. Prog. 2002, 18, 262–268. 60. Zambianchi, F.; Pasta, P.; Carrea, G.; Colonna, S.; Gaggero, N.; Woodley, J. M. Biotechnol. Bioeng. 2002, 78, 489–496. 61. Malito, E.; Alfieri, A.; Fraaije, M. W.; Mattevi, A. Proc. Natl Acad. Sci. USA 2004, 101, 13157–13162. 62. Bocola, M.; Schulz, F.; Leca, F.; Vogel, A.; Fraaije, M. W.; Reetz, M. T. Adv. Synth. Catal. 2005, 347, 979–986. 63. Morley, K. L.; Kazlauskas, R. J. TIBTECH 2005, 23, 231–237. 64. Carboni-Oerlemans, C.; Domínguez de María, P.; Tuin, B.; Bargeman, G.; Van der Meer, A.; Van Gemert, R. J. Biotech., 2006, 126, 140–151.
This page intentionally left blank
Future Directions in Biocatalysis Edited by Tomoko Matsuda © 2007 Elsevier B.V. All rights reserved.
129
Chapter 7
Enzymes in aldoxime–nitrile pathway: versatile tools in biocatalysis Yasuhisa Asano Biotechnology Research Center, and Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University, Imizu, Toyama, Japan
Abstract The discovery and exploitation of enzymes in aldoxime–nitrile pathway: nitrile hydratase, amidase, nitrilase, aldoxime dehydratase, etc., are shown along with the use of method ologies, such as organic chemistry, microbial screening by enrichment and acclimation culture techniques, enzyme purification, gene cloning, molecular screening by polymerase chain reaction (PCR).
1. INTRODUCTION The microbial and enzymatic production of useful materials has been successfully applied to several chemical processes1 and has become not only one of the most important research areas in synthetic organic chemistry, but also one of the most hot scientific topics in “Green Chemistry” in which materials are expected to be efficiently used, emissions and waste reduced and inherently safer processes sought.2 The recent success in microbial transformation has been based on the screen ing for microbial enzymes catalyzing new reactions or screening known enzymes for an unknown activity with synthetic substrates. Although the advantages of the use of enzymes in organic synthesis have been fully illustrated, not much attention has been paid to the systematic exploitation of microorganisms producing new enzymes.3 The isolation of microorganisms based on wide biological diversity is very important to initiate the study of the microbial transformation of chemicals and exploit new enzymes.
2. SCREENING FOR NEW MICROBIAL ENZYMES BY ENRICHMENT AND ACCLIMATION CULTURE TECHNIQUES Little is known about the substrate specificities of most of the enzymes as compared with common reagents used in organic synthesis. The velocity of the enzymatic
130
Yasuhisa Asano
reactions is much affected by the neighboring substituents: it cannot be predicted whether an unnatural chemical can be a substrate or not with most of the enzymes. Therefore, we screen microorganisms for an enzyme when (i) no information is available for the desirable reaction, (ii) nothing is known about the specific reaction but a homologous reaction is known to occur, (iii) an enzyme is known only in another biological source, (iv) insufficient amount of the enzyme is produced by a certain organism for a practical transformation, (v) increased stability of the enzyme for practical use is required, etc. Enrichment culture is a technique to isolate microorganisms having special growth characteristics.3 Some microorganisms grow faster than others in media with limited nutrients, high temperature, extreme pH values, etc. Microorgan isms that grow faster than other species become dominant after several transfers of the culture. The isolation method utilizing the difference of growth veloc ity gives us only limited group of microorganisms, since only a few kinds of fast-growing microorganisms usually appear on the plate containing a starting material in the successive transfer of microorganisms in the enrichment cul ture. The isolates are classified according to their biochemical and morphological characteristics. At the same time, microorganisms deposited among the culture collections are tested for the activity, dependent on or independent of the iso lation experiments. During such studies, there may be unexpected findings and discovery. An acclimation technique3 is applied when a toxic or unnatural compound is used as a substrate and usually run long term to isolate microorganisms which are not easily isolated by the enrichment culture. An adaptation to a syn thetic medium containing a target compound sometimes results in isolation of microorganisms having a desirable new enzyme. Genetic changes in the microor ganisms may be expected. Since fast-growing microorganisms do not always possess the desired enzyme activity and suppress the growth of other microor ganisms, one may look for microorganisms growing rather slowly on certain compounds by methods such as spreading diluted soil sample directly to the medium allowing an isolation of microorganisms having an ability to convert the compound. If the product is located in the downstream of the starting material in the metabolism, enzymes converting such compounds could be screened. In some cases, a new metabolic pathway of the compound may be discovered during the screening. Many industrial microorganisms have been isolated in such ways. How ever, when one wants to synthesize compounds located at the end of anabolism, such as polysaccharides, whose synthesis requires multistep enzyme reactions and energy, the strategy cannot be applied, since a compound with higher energy could be synthesized by coupling of an energy-yielding reaction. Oxidoreductases uti lizing NAD+ or NADP+ as cofactors are also useful in the oxidation or reduction reactions because of their reversible nature.
Enzymes in aldoxime–nitrile pathway
131
3. DEVELOPMENT OF NITRILE-DEGRADING ENZYMES4�5 Nitrile hydratase (NHase, EC 4.2.1.84) has become one of the most important industrial enzymes, although it was discovered during the studies on the microbial degradation of polyacrylonitrile. The properties of NHase and its nature to be able to accumulate extraordinarily high concentration of amides in a strikingly fast manner were discovered after a number of planning, experiments and assumptions. Although the details could be reported elsewhere, they are summarized as follows: (i) at first, polyacrylonitrile was a target of microbial degradation and there has been no description of an enzyme hydrating nitrile activity, although such reac tions have been well described in organic chemistry; (ii) equivalent transforming thinking was done, searching for degraders of oligomer or monomer rather than polyacrylonitrile degrader; (iii) an acclimation technique to isolate acrylonitrile, one of the most toxic nitriles, degrading microorganisms was used; (iv) purification of nitrile hydratase and its characterization were done for the first time, and a proof of involvement of amidase in nitrile hydrolysis to carboxylic acid was obtained; (v) equivalent transforming thinking was done to search for amide-accumulating microorganism among various nitrile-degrading microorganisms based on the dif ference in the substrate specificities of nitrile hydratase and amidase, since the only acrylonitrile degrader isolated was proved to have a nitrilase; (vi) discovery of amide-producing microorganisms in high amount, etc.4
4. SCREENING FOR HEAT-STABLE NHASE It goes without saying that not all microorganisms have been isolated by human beings. Once there is a report on a new enzyme produced by mesophiles, ther mostable enzymes catalyzing the same reaction could be sought from the environ ment. To seek for thermophilic microorganisms, volcano, hot springs, chimneys at the bottom of the sea, etc., are the sources of isolation of such microorganisms. With the increasing knowledge in genomic information, screening for new bio catalysts based on various aspects of similarities (primary, secondary and tertiary structures, motifs and domain structures of the proteins and their positions in the metabolism, etc.) from the database is also carried out. It is known that NHase used in industry has a lower optimum temperature,45 therefore many reports have been concerned with screening for thermostable NHase.6 Miyanaga et al. has succeeded to analyze the X-ray structure of such a thermostable NHase from Pseudomonas thermophila. Bacillus sp. BR449 pro ducing NHase with optimum temperature of 55 C has been isolated. Similarly, Bacillus sp. RAPc8 has a growth optimum at 65 C. Takashima et al. has isolated Bacillus smithii strain SC-J05-1, with optimum temperature at 40 C, and whose NHase has an optimum temperature and pH of 50 C and 10, respectively. Its crystal structure has also been elucidated. Bacillus pallidus strain Dac521 has
132
Yasuhisa Asano
an optimum growth temperature at 50 C. Pseudonocardia thermophila JCM3095 shows an optimum growth temperature at 60 C and NHase, whose higher structure is also solved, is stable at more than 60 C. It has been possible to use the wildtype strains of Pseudomonas chlororaphis B23 and Rhodococcus rhodochrous J-1, in the selective acrylamide production from acrylonitrile, although these recent isolates with higher optimum growth temperature would also metabolize amide produced by NHase quite fast; therefore, it would be necessary to produce amide by NHase expressed in heterologous hosts to block further metabolism of amide.
5. SCREENING FOR NHASE WITH PCR Recently, many studies have been concerned with the precise number of microor ganisms in the environment.7 The microorganisms isolated from paddy fields in Japan are less than 1% in number than those found under microscopic observa tions. It is reported that the number of culturable microorganisms isolated from the feces of human being has become almost the same in number by a microscopic result by the recent introduction of the anaerobic culture technology of microor ganisms. Previously, it was known that the number of culturable microoganisms from the feces was 0.01–0.1% of microscopic observations. It is reported that various unculturable microorganisms play important role in the removal of organic and inorganic chemicals in activated sludge. Contrary to the above-mentioned microbial screening for enzymes having unique properties, it has become possible to screen useful enzyme by PCR from the environment. It is reported that more than several micrograms of environ mental DNA is obtained from 1 g of soil. Many 16S rRNA sequences have been determined from environmental DNA. There are two possible reasons why the number of colonies is always lesser than that counted under microscopy: one is that microorganisms somehow give smaller number on the plates, the other is that there are many kinds of microorganisms which are unable to be cultivated. Evidences are appearing that the second one reflects the truth for the number of microorganisms in nature.8 Although there is difficulty in classifying the uncultur able microorganisms using the DNA database from the culturable microorganisms, many new gene clusters are discovered and characterized from environmental DNA. Therefore, it is expected that much fundamental and applied research will be carried out using the unculturable microorganisms and environmental DNA as sources of new DNA. Duran et al. recently reported a detection of new NHases using PCR.9 It is well known that there are Fe- and Co-requiring NHases. A PCR protocol was developed for the specific detection of genes coding NHase. The primer design was based on the highly conserved sequences found in the coding region of the -subunit gene of Rhodococcus erythropolis corresponding to the highly conserved sequence of the metal-binding site (326–352 amino acid of NHase gene). When
Enzymes in aldoxime–nitrile pathway
133
the genomes of R. erythropolis JCM3132 and JCM3191 were used as models, they gave PCR products with the primers. The sequences of R. erythropolis JCM3132 and JCM3191 NHases were homologous to that of the -subunit of R. rhodochrous IFO15564 NHase by 91 and 96.6%, respectively. Using the genomic DNA of some soil isolates, two types of NHase sequences were detected. The use of soil DNA (about 25 g per g soil) taken from acrylamide-producing plants, etc., gave Fe-type NHase sequences (450 bp DNA) by PCR. Using the PCR method, both types of Fe- and Co-NHase-encoding genes were detected in DNA from pure cultures and soil samples. Furthermore, consensus primers allowed rapid cloning and expression of novel NHases in Escherichia coli.
6. NITRILE SYNTHESIS USING A NEW ENZYME, ALDOXIME DEHYDRATASE 6.1. Aldoxime-converting enzymes Much studies have been carried out on nitrile-transforming enzymes, since NHase was shown to be highly chemoselective even with the whole microbial cells, and the accumulation of amides was achieved in a high concentration (up to 40%, w/v or more).4 The enzyme has been used in the industrial production of various chemicals. Not only the primary structure of the enzyme, but also the X-ray structure of NHase has been clarified.6ae−g At the beginning of the studies, NHase was considered to be a rare enzyme,4 but the following studies showed that the distribution of the enzyme is rather wide in microoganisms,6 although its physiological function is not yet clear. On the other hand, cyanogenesis is an ability of plants to release hydrogen cyanide in the cells and is considered a mechanism to protect plants from attack by fungi and predators. Cyanogenesis is believed to be distributed in over 2650 species of higher plants, and more than 20 kinds of cyanogenic glycosides are known.10 They are glycosides of aliphatic and aromatic cyanohydrins. The aglycons of the cyanohydrin have been considered to be biosynthesized from hydrophobic l-amino acids such as tyrosine, phenylalanine, valine, isoleucine, via aldoxime compounds, although enzymatic and genetic knowledge are scarce. Aldoximes are prepared from aldehydes and hydroxylamine by condensation reaction, and the dehydration reaction of aldoxime is one of the most important methods of nitrile synthesis in organic chemistry.11 We speculated that it would become one of the most important examples in “Green Chemistry” if the dehy dration reaction could be realized by an enzymatic method, and started studies on a new enzyme, aldoxime dehydratase, and its use in enzymatic nitrile synthe sis. Furthermore, we clarified the relationship between aldoxime dehydratase and nitrile-degrading enzymes in the genome of the microorganisms and the physio logical role of the enzyme.
134
Yasuhisa Asano
6.2. Isolation of microorganisms having aldoxime dehydratase activity12 By using acclimation for 3–4 months of soil microorganisms to a medium contain ing Z-phenylacetaldoxime (PAOx), a degrader Bacillus sp. OxB-1 was isolated, which has an activity of converting PAOx to phenylacetonitrile (PAN) and a strong nitrilase activity. Partial purification of the enzyme activity revealed that the enzyme catalyzed the stoichiometric conversion of PAOx to PAN. On the other hand, we isolated a degrader of E-pyridine-3-aldoxime (PyOx), Rhodococcus sp. YH3-3 from soil after 6 months of acclimation of soil. The strain contained a dehydratase converting PyOx to 3-cyanopyridine (CyPy). Different from Bacillus sp. OxB-1, Rhodococcus sp. YH3-3 possessed nitrile hydratase and amidase rather than nitrilase, active in the metabolism of CyPy. 6.3. Purification, characterization and primary structure determination of aldoxime dehydratase13 A novel dehydratase that catalyzes the stoichiometric dehydration of Z-phenylacetaldoxime to phenylacetonitrile has been purified to homogeneity from a cell-free extract of Bacillus sp. strain OxB-1 isolated from soil. It has a Mr of about 40 000 and is composed of a single polypeptide chain with a loosely bound protoheme IX. The enzyme is inactive unless FMN is added to the assay, but low activity is also observed when sulfite replaces FMN. The enzyme is active with arylalkylaldoximes and to a lesser extent with alkylaldoximes. The enzyme prefers the Z-form of phenylacetaldoxime over its E-isomer. The gene coding for the enzyme was cloned, and a 1053 bp open reading frame that codes for 351 amino acid residues was identified as the oxd gene. A nitrilase, which participates in aldoxime metabolism in the organism, was found to be coded by the region just upstream from the oxd gene. In addition, an open reading frame (orf2), whose gene product is similar to bacterial regulatory (DNA-binding) proteins, was found just upstream from the coding region of the nitrilase. These findings provide genetic evidence for a novel gene cluster that is responsible for aldoxime metabolism in this microorganism. With these results, we named the new enzyme as phenylacetaldoxime dehy dratase (EC 4.99.1.7). It was also suggested that the enzyme utilizes FMN as an electron acceptor, because the Vmax value was increased about five times under anaerobic condition and the sulfite ion could replace FMN, although the enzyme requires oxidized form of FMN. It was revealed that the enzyme is a quite unique enzyme whose apparent function is to catalyze a dehydration reaction. The reaction mechanism is of much interest.14 The gene for the dehydratase was expressed in E. coli under lac promoter, and an expression plasmid pOxD 9OF was constructed. The transformant was cul tivated under optimal condition at 30 C when much of the enzyme was expressed in a soluble form with more than thousand and several hundred times than the wild-type strain per culture (up to more than 50% of the total soluble protein of the
Enzymes in aldoxime–nitrile pathway Aldoxime OH N dehydratase
R H
Aldoxime
H2O
R C N
Nitrile Nitrile hydratase
135
Nitrilase
O R C OH
Carboxylic acid O R C NH2
Amidase
Amide
Figure 1: Microbial aldoxime-nitrile pathway. transformant). On the other hand, when the transformant was cultivated at 37 C, the enzyme was expressed as inclusion body. We also found that the occurrence of aldoxime dehydratase is as wide as that for nitrile-degrading enzymes such as nitrile hydratase, amidase and/or nitri lase. All of the nitrile degraders hitherto isolated contained aldoxime dehydratase activities. The author would like to propose that the pathway in which aldoximes are successively degraded via nitrile could be named as the “aldoxime–nitrile pathway” (Fig. 1). 6.4. Synthesis of nitriles from aldoxime with aldoxime dehydratase15 The dehydration reaction of aldoxime to form nitriles using the resting cells of Rhodococcus sp. YH3-3 was optimized. We found that the enzyme was induced by aldoxime and catalyzed the stoichiometric synthesis of nitriles from aldoximes at pH 7.0 and 30 C. Phenylacetonitrile once synthesized from phenylacetaldoxime was hydrolyzed to phenylacetic acid, since the strain has nitrile degradation enzymes such as nitrile hydratase and amidase. We have been successful in syn thesizing phenylacetonitrile and other nitriles stoichiometrically by a selective inactivation of nitrile hydratase by heating the cells at 40 C for 1 h. Various nitriles were synthesized under optimized conditions from aldoximes in good yields. On the other hand, 3-phenylpropionitrile was synthesized from Z-3-phenyl propionaldoxime (0.75 M) in a quanti